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ABSTRACT
MECHANISTIC STUDIES OF THE ELONGATION CYCLE OF PROTEIN
SYNTHESIS

Wei Liu
Barry S. Cooperman

During translation elongation, amino acid residues are repetitively added to the
growing nascent peptide chain, directed by the mRNA sequence and facilitated by two
elongation factors, EF-Tu and EF-G. In this thesis, translation elongation is
investigated from two new perspectives to further explore the underlying
mechanisms.
In the first approach, a functional EF-Tu derivative labeled with a fluorescence
quencher was prepared and used for the development of two fluorescent assays to
study EF-Tu:L11 and EF-Tu:tRNA FRET signals. Application of these two assays
revealed the tRNA discrimination on the ribosomal A-site, the effects of
error-inducing antibiotics on tRNA selection, and tRNA release from EF-Tu on the
ribosome regulated by EF-Tu:tRNA affinity. In combination with other assays
measuring pre-translocation complex formation, ensemble and single molecule FRET
studies of the EF-Tu:L11:tRNA triangle indicated that EF-Tu:L11 separation occurs
concurrently with inorganic phosphate release and tRNA accommodation, but prior to
EF-Tu separation from tRNA and dissociation from the ribosome. The latter process
vii

proceeds through two possible pathways, rapid but reversible dissociation followed by
a conformational change off the ribosome versus slow conformational change on the
ribosome followed by rapid dissociation.
Translation elongation was also studied using mRNAs specifically modified with
fluorescent isomorphic nucleoside mimetics. These modified mRNAs maintain
considerable functionalities in the formation of initiation, pre-translocation and
post-translocation complexes, although with different efficiencies, and show
fluorescence changes in different patterns upon ribosomal complex conversion.
Pre-steady state measurements of these fluorescence changes demonstrate the
responses of modified mRNAs to codon:anticodon interaction occurring after ternary
complex initial binding to the ribosome but before tRNA accommodation into the
A-site, and mRNA movements on the ribosome during translocation.
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CHAPTER 1
INTRODUCTION

1

1.1 Gene expression and the central dogma
For the propagation of all three kingdoms of life, except for some viruses, heredity
information is exclusively stored in genes made up of deoxyribonucleic acids (DNAs).
During propagation, the double-helical structure of DNA allows gene replication by
nucleotide polymerization using one DNA strand as a template according to
Watson-Crick base paring (Figure 1.1) (Watson and Crick, 1953a; Watson and Crick,
1953b; Crick, 1970). Within the living organism, the achievement of most of the
biological functions depends on transcription of genes into ribonucleic acids (RNAs)
and further translation of a portion of RNAs into proteins.
The transcription of DNA is performed by RNA polymerase using four
ribonucleosides as substrates (adenosine, A; guanosine, G; cytidine, C; uridine, U)
(Kornberg, 2007). Biosynthesized RNAs are classified according to their diverse
functions. Messenger RNA (mRNA) further serves as the template of translation to
direct protein biosynthesis. Transfer RNAs (tRNAs) act as an information bridge
between mRNA and protein. Ribosomal RNAs (rRNAs), accounting for ~80% of the
RNAs in prokaryote, is the major components of ribosome, the protein synthesis
machine. In eukaryotic cells, additional small non-coding RNAs are also transcribed
for various regulation purposes (Lee and Dutta, 2009).
In RNAs, genetic information is still encoded by the sequence of four
ribonucleosides. However, the huge amount of functions to be performed requires the
more complexity in both 3-dimensional structure and properties. Consequently, three
2

consecutive nucleosides in an mRNA are decoded as a codon to mediate the
polymerization of each of 20 natural amino acids, with diverse chemical and physical
properties conferred by the side chains of amino acids. Such a translation process is
performed on the ribosome, a macromolecule composed of rRNAs and ribosomal
proteins, with participation of numerous protein factors. In prokaryotic cells, mRNA
is bound to the ribosome for translation before the transcription is complete. In
eukaryotic cells, transcription is performed in the nucleus and the transcripts are
subject to necessary modification (e.g. splicing, 5’- capping and 3’- poly(A) addition)
with the help of small non-coding RNAs before their export to the cytoplasm for
translation (Nishikura, 2006; Wahl et al., 2009). Recent studies revealed that
co-translational recruitment of different factors to the ribosome helps the folding of
proteins into their native states and the transportation of proteins to the places for their
function performance (e.g. inner membrane proteins are targeted to the membrane by
signal recognition particle)(Luirink et al., 2005).

1.2 Prokaryotic ribosome
In prokaryotic cells, the 70S (S is the unit for sedimentation velocity) ribosome, a
macromolecule with a mass of ~ 2.6 MDa, is formed by association of the 30S and the
50S subunits, both of which are composed of rRNA and proteins (Figure 1.2; Table
1.1). The small 30S subunit consists of a 16S rRNA of ~1500 nucleotides and 20 or
21 ribosomal proteins, and the large 50S subunit consists of a 23S rRNA and a 5S
3

rRNA of ~3000 nucleotides in total, and 31-35 ribosomal proteins (Kaltschmidt and
Wittmann, 1970; Yonath, 2010). It is believed that many of the enzymatic and
functional sites on the ribosome are primarily constructed by rRNA with exquisitely
defined conformation e.g. decoding center (DC), peptidyl transferase center (PTC)
and GTPase-associated center (GAC). Ribosomal proteins are located mostly on the
periphery of the ribosome and assumed to maintain the ribosome’s architecture and
facilitate some of the functions of rRNA e.g. L11 in GAC (Qin et al., 2012) and S12
in signal transduction between DC and GAC (Gregory et al., 2009). A series of sites
have been defined in the ribosome for tRNA binding within both 30S and 50S
subunits: aminoacyl- (A) site, peptidyl- (P) site and exit (E) site (Yonath, 2010;
Schmeing et al., 2009a). During the translation process, incoming tRNA needs to bind
to each of these sites in turn for a complete elongation cycle.

1.3 Translation cycle
During translation, mRNA binds to the ribosome and its coding sequence directs
recruitment of aminoacyl-tRNA (aa-tRNA) and synthesis of nascent polypeptide.
Overall the translation cycle can be divided into 4 stages: initiation, elongation,
termination and recycling (Figure 1.3).
The formation of 70S initiation complex (70SIC) is facilitated by three initiation
factors (IF1–3). mRNA, initiator tRNA (fMet-tRNAfMet) and IF1–3 first bind to the
30S subunit to form a 30S pre-initiation complex (30S PIC) (Laursen et al., 2005).
4

The IF1 binding site on the 30S subunit partially overlaps with the DC, reflecting its
role as preventing the premature binding of any aa-tRNA to the ribosomal A-site
(Moazed et al., 1995). IF3 prevents the premature docking of the 50S subunit onto the
30S subunit before 30S IC formation (Grunberg-Manago et al., 1975; Sacerdot et al.,
1996).

IF2

promotes

binding

fMet-tRNAfMet,

of

in

the

form

of

IF2.GTP.fMet-tRNAfMet, to the ribosomal P-site, mediated by strict base paring of
three nucleotides on tRNA, denoted anti-codon, with the AUG start codon of mRNA
(Gualerz and Pon, 1990; Boelen and Gualerzi, 2002; Tsai et al., 2012), which is
facilitated and monitored also by IF1 and IF3 (Canonaco et al., 1986; Tedin et al.,
1999). The specific binding of mRNA on 30S is mediated by the complementary
base-pairing between a short segment of RNA in the 5’-untranslated region (5’-UTR)
of mRNA, denoted the Shine-Dalgarno sequence, and the anti-Shine-Dalgarno
sequence in 16S rRNA, thus precisely place the AUG start codon on mRNA at the
P-site of the 30S subunit (Shine and Dalgarno, 1974; Yusupova et al., 2006) (Figure
1.4). The codon-anticodon interaction between mRNA and fMet-tRNAfMet induces the
conformational transformation from 30S PIC to 30SIC, followed by the release of
IF1–3 and association of the 50S subunit with 30SIC to form 70SIC, in which only
ribosomal P-site is occupied by a tRNA (Grigoriadou et al., 2007a, b; Milón et al.,
2008; Milón et al., 2012).
Translation elongation can be further dissected in to two stages, peptide bond
formation and translocation. Peptide bond formation begins with the delivery of
aa-tRNA to the empty ribosomal A-site catalyzed by elongation factor Tu (EF-Tu), in
5

the form of ternary complex (TC) EF-Tu.GTP.aa-tRNA (Rodnina et al., 1994; Pape et
al., 1998) (Figure 1.5A). TC first binds to the highly flexible L7/L12 stalk (Schmeing
et al., 2009a; Gao et al., 2009), a common binding site for all translational GTPase,
then contacts the body of the ribosome at A/T site, with the anticodon on tRNA
interacting with the codon on mRNA in the 30S subunit, and EF-Tu, together with the
acceptor arm of tRNA, coming in proximity to GAC in the 50S subunit (Schmeing et
al., 2009a). In such a binding status, tRNA displays a distorted conformation
compared with what it has in unbound TC, which has been assumed to be functionally
significant in tRNA accommodation into the A-site (Schmeing and Ramakrisnan,
2009b; Cochella and Green, 2005). The recognition of cognate codon in the DC
triggers both local and global conformational changes in the ribosomal complex and
the activation of GTPse activity of EF-Tu bound within the GAC (Voorhees et al.,
2010). Rapid and irreversible GTP hydrolysis leads to a series of changes on the
ribosome resulting in new peptide bond formation via peptidyl transfer from the P-site
peptidyl-tRNA to the newly accommodated A-site aa-RNA, and the formation of
pre-translocation (PRE) complex.
Following peptide bond formation, PRE complex spontaneously fluctuates
between two states, accompanied by three different kinds of dynamic processes: 1) a
ratcheting movement of the 30S subunit relative to the 50S subunit and a swiveling of
the head domain of the 30S subunit (Frank and Agrawal, 2000; Zhang et al., 2009); 2)
fluctuation of tRNAs between A/A, P/P site (denoted classical state) and A/P, P/E site
(denoted hybrid state), respectively (Chen et al., 2011a); 3) a folding-in of L1 stalk,
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consisting of ribosomal protein L1 and 23S rRNA, permitting it to interact with the
elbow region of P/E tRNA (Valle et al., 2003a). Elongation factor G (EF-G) binds to
the ribosome in the form of EF-G.GTP and catalyzes the unidirectional movement of
tRNAs, together with mRNA, from A- and P- site to P- and E-site, respectively,
leading to the formation of post-translocation (POST) complex, in which
peptidyl-tRNA is bound at the ribosomal P-site, and the ribosomal A-site is empty and
ready for the next incoming aa-tRNA (Figure 1.5B).
The elongation cycle is repeated to decode the consecutive 3-nucleotide codons
until the ribosomal A-site encounters stop codons (UAA, UAG or UGA), a signal of
translation termination. Release factor 1 (RF1, reading UAA and UAG) or 2 (RF2,
reading UAA and UGA) is recruited to promote the hydrolysis of peptidyl-tRNA and
subsequent peptide release from the ribosome (Laurberg et al., 2008; Weixlbaumer et
al., 2008). A third release factor 3 (RF3) is also involved to facilitate the dissociation
of RF1 and RF2 from the ribosome after peptide hydrolysis in a GTP-dependent
manner (Freistroffer, 1997; Zhou et al., 2012). After RF3 dissociation, the remaining
ribosomal complex dissociates, assisted by ribosome recycling factor (RRF) and EF-G,
into the 50S subunit and the 30S complex carrying mRNA and a deacylated tRNA in
the P-site (Hirashima and Kaji, 1973; Franckenberg et al., 2012). Further dissociation
of mRNA and tRNA from the 30S subunit requires the action of IF3, thus is coupled
to next round of translation initiation (Karimi et al., 1999; Hirokawa et al., 2008).
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1.4 Crystallographic studies of the ribosome
Crystallography has long exhibited its power to elucidate the structure and
function of biomolecules. An early view of the 70S ribosome by cryo-electron
microscopy (cryo-EM) came in 1976 (Lake, 1976), and a reconstruction of the 70S
ribosome with three tRNAs at a resolution of 25 Å was obtained in 1995 (Frank et al.,
1995). Availability of high-quality crystals and advances in both instrument and data
refining method have pushed the resolution down below 10 Å, which permits further
understanding of the ribosome and translation. Stark et al. reported the structure of
70S-ribosome bound TC and described the interaction between EF-Tu and the
ribosome (Stark et al., 1997). Then the interaction of tRNA in the ribosomal A/T site
was also reported to suggest an active role of tRNA in accommodation (Valle et al.,
2002). High-resolution reconstruction of TC bound to 70S provided a more clear
snapshot of TC interaction with the ribosome, displayed the conformational changes
in tRNA, EF-Tu and GAC during codon recognition, and indicated possible
mechanisms for EF-Tu catalyzed GTP hydrolysis and codon decoding (Stark et al.,
2002; Valle et al., 2003a; Schuette et al., 2009; Villa et al., 2009). Later, the
development of time-resolved single particle cryo-EM and unbiased computational
sorting of cryo-EM images made possible following a dynamic biological event.
Application of these new techniques to tRNA translocation on the ribosome revealed
several intermediate states of tRNA, besides the classical and hybrid states reported
earlier, and defined the tRNA:70S interactions on the translocation pathway (Fischer
et al., 2010). It was indicated that tRNA movements during translocation are coupled
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with conformational changes of the ribosome, including the head and body of 30S and
the L1 stalk. The ribosome is believed to act as a Brownian machine to direct
translocation by coupling spontaneous conformational changes of various regions.
Despite its success in elucidating ribosomal structure and function, the relatively
low resolution of cryo-EM makes it hard to rationalize the mechanism of translation
at a molecular level. Higher resolution is provided by X-ray crystallography. The
structures of the 30S subunit from T. thermophilus (Wimberly et al., 2000) and the
50S subunit from H. marismortui (Ban et al., 2000) with resolutions of 3.0 and 2.4 Å ,
respectively, shed light on the organization of rRNA and ribosomal proteins in the
ribosome and served as the basis for phasing and molecular-level interpretation of all
subsequent ribosomal structures. In 2001, a crystal structure of the complete 70S
ribosome bound with mRNA and three tRNAs was reported by Noller and
collaborators, into the electron density map of which all of rRNAs, mRNA and tRNAs
and most of ribosomal proteins can be fitted (Yusupov et al., 2001). This
high-resolution picture of the ribosome complex, with a resolution of 5.5 Å, provided
a clear view of the interface between 30S and 50S subunit, especially the intersubunit
bridges, and the environments of three tRNA binding sites and the tRNA:ribosome
interaction, thus implying the coupling of intersubunit movements with tRNA
movements during translocation.
Since then, the X-ray structures have been reported of ribosome complexes
engaged in mRNA decoding (Demeshkina et al., 2012; Jenner et al., 2010),
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translocation (Gao et al., 2009; Dunkle et al., 2011) and termination (Korostelev et al.,
2008). Of particular relevance to the thesis here are two structures of 70S ribosome
complexes containing bound TC. In 2009, a structure with TC stabilized in A/T state
by kirromycin and paromomycin was published (Schmeing et al., 2009a), showing the
details of tRNA distortion in A/T state when it simultaneously interacts with the A-site
codon in the DC of the 30S subunit and EF-Tu. Such interactions, together with
EF-Tu:70S interactions (at the GAC of the 50S subunit) and with changes of
EF-Tu:tRNA interactions, led to the proposal of a possible signal transduction
pathway for inducing the GTPase activation of EF-Tu and GTP hydrolysis on EF-Tu
upon cognate codon:anticodon interaction (Schmeing and Ramakrishnan, 2009b).
Important for the work presented below, the Schmeing’s (Schmeing et al., 2009a)
structure showed that positions suitable for fluorophore or quencher labeling on i) A/T
site bound tRNA, ii) ribosomal protein L11 and iii) EF-Tu form an approximately
equilateral triangle, with distances suitable for FRET studies (see Chapter III for
details). This serves as the basis for EF-Tu studies presented in Chapter III and IV. A
second structure of TC stabilized on the ribosome by paromomycin and GDPCP, a
non-hydrolysable GTP analog, was reported later (Voorhees et al., 2010), focusing on
the details in GAC region and how EF-Tu is activated for catalyzing GTP hydrolysis.

1.5 Kinetic studies examining ribosome function
Ensemble kinetic studies of the ribosome during translation primarily rely on
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site-specific labeling of translation components, including tRNA and translation
factors, with organic fluorophores. Monitoring fluorescent signal change during
dynamic processes or fluorescence resonance energy transfer (FRET) signal between
two fluorophores in proximity, together with some other assays (e.g. GTP hydrolysis,
dipeptide formation and puromycin reactivity assays), allow comparison of relative
timing of different functional steps, provide evidence for functionally competent
intermediates, and provide extensive insights into the mechanism of translation.
The works in our lab, utilizing the FRET signal between labeled 50S subunit and
IF2 programmed on 30SIC, demonstrate the interaction of IF2 with GAC and the role
of fidelity control played by IF3 in monitoring the initiation codon (Qin et al., 2009).
A more recent report (Milón et al., 2012), using labeled IF1–3, fMet-tRNAfMet and
mRNA, illustrates a real-time assemble scheme of 30S PIC formation and the
checkpoints of mRNA selection. Rodnina and her colleague formulated a quantitative
kinetic scheme for tRNA dynamics during its selection, demonstrating how the correct
tRNA is differentiated from other tRNAs and how translation has evolved to optimize
the speed and accuracy of codon decoding (Pape et al., 1998; Gromadski and Rodnina,
2004a; Wohlgemuth et al., 2010). Pan et. al. (Pan et al., 2007), by using tRNAs with
fluorophore labels at the elbow region, successively isolated a kinetically competent
intermediate on the translocation pathway, suggesting that the movements of P- and
A-site tRNA on conversion from classical to hybrid state could be decoupled.
Translation termination was also investigated by using an short mRNA labeled at the
3’-end, showing how stop codon is precisely selected by RF1 against sense codon and
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how stop codon decoding is correlated with catalyzed peptide release (Hetrick et al.,
2009).

1.6 Monitoring ribosomal translation with smFRET
Biochemical and structural studies have demonstrated the complexity of
translation as a multi-step and multi-component process and the highly dynamic
nature of the ribosome during translation. Although ensemble kinetic studies have
greatly advanced our knowledge of the conformational changes of the ribosome and
its communication with translation factors, complete understanding of the mechanism
of translation on the molecular level has been confined by the temporal and
population averaging nature of current assays. To address these limitations, the
capability to characterize the single ribosome molecules was first demonstrated in
2003 (Vanzi et al., 2003). In this report, ribosome elongation complexes programmed
with poly(U) were non-specifically adsorbed to the mica surface and connected to a
fluorescently labeled polystyrene bead via biotin-neutravidin interaction at the 3’-end
of mRNA. Epifluorescence microscopy was used to track the contraction of the
diffusion range of the beads because of poly(Phe) synthesis and the slide of the
ribosome towards the 3’-end of mRNA.
After a decade of development, labeled ribosomal complexes in different
functional states can be specifically immobilized on the surface via various strategies,
with their translation functions fully retained, and single molecule FRET (smFRET)
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measurement was achieved based on total internal reflection fluorescence (TIRF)
(Marshall et al., 2008; Perez and Gonzalez Jr, 2011). An evanescent wave, which is
generated when the incident light is totally internally reflected at the interface, is used
to illuminate a selected area with a depth of ~100 nm into the sample. Thousands of
ribosome molecules could be simultaneously detected with the signal for each single
ribosome analyzed separately. Together with data sorting and synchronization, the
problem of heterogeneity in ensemble experiments was thus overcome. On the one
hand, multiple cycles of translation elongation have been observed by either placing
both FRET donor and acceptor on the immobilized ribosome complex to reduce
fluorescence background (Aitken and Puglisi, 2010), or introducing zero-mode
waveguide technique to limit the regional concentration of labeled components
(Uemura et al., 2010). On the other hand, smFRET has been applied to resolve the
elementary steps during translation and detect functionally competent intermediates
along the reaction coordinate (Chen et al., 2011a, b; Fei et al., 2008; Munro et al.,
2007).
smFRET studies by tRNA:tRNA FRET have identified three intermediates during
A-site codon decoding, corresponding to i) initial codon recognition, ii)
GTPase-activated and iii) fully accommodated states, respectively, and allowed
comparisons of different patterns of intermediate state sampling between cognate and
near-cognate tRNA binding (Blanchard et al., 2004). It was shown that tRNA thermal
fluctuation during codon decoding was utilized for the discrimination between
cognate and near-cognate tRNA (Geggier et al., 2010; Lee, 2007; Mishra et al., 2010).
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The effects of several antibiotics, including tetracycline, thiostrepton and kirromycin,
on tRNA selection were also investigated, with the observations consistent with those
observed in ensemble studies (Blanchard et al., 2004; Geggier et al., 2010; Gonzalez
et al., 2007).

1.7 EF-Tu in translation elongation
Elongation factor thermally unstable (EF-Tu) is encoded in two genes in E. coli,
tufA and tufB, and in this thesis, it’s the tufA gene and its expression product that are
utilized and investigated. EF-Tu, with a cellular concentration ~ 10 fold higher than
that of the ribosome (Furano, 1975), consists of 393 amino acids, including three
cysteine residues at position 81, 137 and 255. Among these three cysteines, Cys81 has
been found to be highly conserved within bacteria and functionally critical for
aa-tRNA binding, but not for GTP or GDP binding (Laurentiis et al., 2011).
EF-Tu is organized into three domains. Domain 1 contains the binding site for the
nucleotide with an affinity for GDP 100 times higher than for GTP. Before forming a
TC, the GDP on EF-Tu is replaced by GTP, catalyzed by elongation factor EF-Ts and
driven by high cellular GTP concentration. Such off-the-ribosome nucleotide
exchange is accompanied by a conformational change within domain 1 relative to
domains 2 and 3 (Kjeldgaard and Nyborg, 1992; Polekhina et al., 1996). Domains 2
and 3 regulate the interaction of EF-Tu with EF-Ts and antibiotics, maintain the bias
in favor of GDP binding in domain 1, and mediate EF-Tu interaction with the
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ribosome and aa-tRNA (Cetin et al., 1998). To form the TC, EF-Tu binds to an
aa-tRNA with the interface of domain 1 and 2 contacting the acceptor stem-loop and
amino acid, and domain 3 contacting the T stem (Nissen et al., 1995). The nucleotide
sequence in tRNA has evolved to compensate for the diverse thermodynamic
contributions of amino acid side chains, making EF-Tu:aa-tRNA affinity similar for
all tRNAs in such a way that every aa-tRNA can form a stable TC with EF-Tu·GTP
and be easily released from EF-Tu during accommodation (Dale et al., 2004).
EF-Tu:aa-tRNA affinity can be modulated by mutating the nucleotides within the T
stem of tRNA, which have direct contacts with EF-Tu (Schrader et al., 2011).
Although it’s now well accepted that EF-Tu binds to aa-tRNA in a 1:1 ratio, several
groups have reported that two EF-Tus can simultaneously bind to one aa-tRNA and
participate in the decoding process (Bilgin and Ehrenberg, 1995; Ehrenberg, 1990;
Rodnina and Wintermyer, 1995a).
Upon recruitment of a TC to the ribosome complex, EF-Tu consumes one GTP
molecule and releases the aa-tRNA to the ribosomal A-site (see Section 1.3 for more
details), with a dramatic conformational change from the GTP- to GDP-bound form
(Kjeldgaard and Nyborg, 1992; Polekhina et al., 1996). The antibiotic kirromycin
targets EF-Tu and inhibits elongation by stabilizing EF-Tu on the ribosome in a
GTP-like conformation after GTP hydrolysis (Schmeing et al., 2009a). The
conformational change of EF-Tu on the ribosome triggers its release from the
ribosome and the recruitment of EF-G.
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1.8 Fidelity control throughout protein synthesis and antibiotics
When a properly aminoacylated tRNA is delivered to the ribosome in the form of
a TC, several mechanisms at different functional stages operate together to ensure the
correct selection of cognate tRNA (Zaher and Green, 2009a). tRNA selection in the
decoding center of the 30S subunit primarily relies on the exact base pairing between
the codon programmed at the ribosomal A-site and the anticodon in tRNA. However,
the energetic difference resulting from the incorrect base pairing is not significant
enough to account for the observed precision of tRNA incorporation. The high fidelity
of tRNA selection is kinetically accomplished by the induced-fit mechanism
(Gromadski and Rodnina, 2004a), which consists of two stages, denoted initial
selection and proof-reading, separated by the irreversible EF-Tu mediated GTP
hydrolysis. In the codon recognition step, the signal of cognate codon:anticodon
interaction in the DC of the 30S subunit induces both local and global conformational
rearrangements, and is transduced remotely, via an unknown mechanism, to the GAC
in the 50S subunit, leading to EF-Tu activation and GTP hydrolysis. In contrast,
incorrect base pairing leads to ~ 600-fold slower or no GTP hydrolysis for
near-cognate or non-cognate tRNA, respectively. Consequently, most of the
near-cognate tRNAs and all of the non-cognate tRNAs are rejected in the initial
selection. After GTP hydrolysis, cognate tRNA is accommodated into the A-site,
while the improper codon:anticodon interaction of near-cognate tRNA destabilizes the
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tRNA binding to the ribosome and leads to tRNA dissociation during the
proof-reading step.
When an incorrect amino acid is incorporated into the growing polypeptide chain,
the codon:anticodon mismatch error can be amplified in the subsequent aa-tRNA
selection steps, ultimately leading to the premature translation termination (Zaher and
Green, 2009b). RF3 also exhibits a substantial effect in maintaining the high fidelity
of protein synthesis (Zaher and Green, 2011). The ribosome apparatus has evolved to
be optimized for speedy and accurate protein synthesis (Johansson et al., 2012;
Wohlgemuth et al., 2010), and the cooperation of various quality control mechanisms
achieves an overall in vivo error rate of 6 × 10-4 to 5 × 10-3 per amino acid
incorporated (Bouadloun et al., 1983; Edelmann and Gallant, 1977).
Because of its fundamental function in gene expression, the ribosome is a primary
target of antibiotics, and some of them have an effect in the quality control of protein
synthesis. Streptomycin and paromomycin from aminoglycoside family are two
well-documented ones, both of which could induce misreading, but with different
mechanisms (Gromadski and Rodnina, 2004b). Streptomycin contacts both S12 and
G530 loop of the shoulder and helices 27 and 44 in the central part of the 30S subunit,
and holds the 30S subunit in a particular conformation, which, in turn, stabilizes both
cognate and near-cognate aa-tRNA on the ribosome and blurs their differences in the
rates of EF-Tu-dependent GTP hydrolysis, thus diminishing the selection power of the
initial selection step. In contrast, paromomycin stabilizes the ribosome in a
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high-activity conformation, which has no effects on the cognate aa-tRNA recognition,
but significantly increases the rate of EF-Tu-dependent GTP hydrolysis in the case of
near-cognate aa-tRNA to a level comparable to that of cognate aa-tRNA, thereby
facilitating the incorporation of near-cognate aa-tRNA (Gromadski and Rodnina,
2004b).

1.9 Emissive nucleoside mimetics
Besides the labeling of biomolecules with organic fluorescent probes, an
alternative way to study the conformational change or dynamic processes of
biomolecules in a biological event by using fluorescence spectroscopy is to
incorporate the emissive analogs of the building blocks into the biomolecules.
Emissive nucleoside mimetics have demonstrated their abilities in probing the
secondary structure and the structure dynamics of nucleic acids (Sinkeldam et al.,
2010). Assays based on such emissive nucleoside analogs have recently been
developed to study the ribosome interactions with exogenous proteins and antibiotics
by either inserting the emissive nucleoside mimetic into a RNA segment
complementary to the rRNA (Srivatsan et al., 2008) or synthesizing a model sequence
of rRNA containing the emissive nucleoside analog (Sakakibara et al., 2012; Xie et al.,
2009; Xie et al., 2010).
Quite

recently,

a

fluorescent

ribonucleoside

alphabet

derived

from

thieno[3.4-d]-pyrimidine was reported with structural resemblance to the naturally
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occurring ribonucleoside (Figure 1.6) (Shin et al., 2011). These isomorphic analogs
result in minimal structural and functional perturbations to the oligonucleotides into
which they are incorporated, have desirable photophysical properties suitable for
fluorescent spectroscopy studies, and overcome the common drawback of emission
quenching of emissive nucleoside analogs upon incorporation into oligonucleotides.
These advantages of such thieno-modified emissive nucleoside mimetics offer the
potential for systematic real-time studies of the translation apparatus, utilizing both
their fluorescent response to the environmental change and energy transfer with other
fluorophores.

1.10 Frameshifting in translation
During translation elongation, mRNA repetitively undergoes a movement of three
nucleotides relative to the ribosome to place successive codons at the ribosomal A-site
for decoding, with the average frequency of spontaneous frameshifting on the order of
10-5 to 10-4 (Kurland, 1979). A second kind of controlled mRNA displacement relative
to the ribosome involves the change of open reading frame, denoted programmed
frameshifing, which is utilized for the regulation of gene expression (Dinman, 2012)
and replication of numerous viruses (Brierley and Dos Ramos, 2006). The two most
common programmed frameshiftings are +1 and -1 shifting, in which the mRNA
displacement relative to the ribosome is one nucleotide downstream or upstream,
respectively. +1 frameshifting is directed by homopolymeric runs of 3 or 4
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nucleotides within mRNA, while the -1 shifting is mediated by a slippery sequence of
X_XXY_YYZ (X can be any nucleotide, Y is A or U and Z is not G in the eukaryote)
in the original reading frame followed by a downstream secondary structure, usually a
pseudoknot. Although genetic and cell biological studies have provided insight into
the programmed frameshifing (Dinman, 2012; Giedroc and Cornish, 2009), especially
with respect to translation components other than mRNA that are involved in reading
frame maintenance, such as the ribosomal E-site (Devaraj et al. 2009) and tRNA
modification (Gustilo et al., 2008), real-time observation of programmed
frameshifting has not been achieved and its mechanism in the molecular level is still
elusive.
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Table 1.1. Components of E. coli ribosomes.
Ribosome/subunit

70S

50S

30S

Molecular weight (kD)

2520

1590

930

23S and 5S

16S

23S, 16S and
rRNA components
5S
2904 for 23S
Number of nucleotides in rRNA

4566

1542 for 16S
120 for 5S

rRNA molecular weight (kD)

1664

1104

560

Number of ribosomal proteins

55

34
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Protein molecular weight (kD)

857

487

370

This table is adapted from (Kaltschmidt and Wittmann, 1970; Voet et al., 2006).
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Figure 1.1. Central dogma of molecular biology (Modified from Crick, 1970).
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Figure 1.2. Three-dimensional structures of the two ribosomal subunits. Two subunits
are from eubacteria with a tRNA molecule placed between them. The rRNA is shown
in brownish colors, and each of the ribosomal proteins is shown in a different color.
A-, P- and E- sites are for tRNA binding. The approximate site of the peptidyl
transferase center is marked in red. Insert: Backbone of a tRNA molecule; circles
designate the regions interacting with each of the ribosomal subunits. This figure is
taken from (Yonath, 2010).
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Figure 1.3. Overview of translation cycle. This figure is taken from (Schmeing and
Ramakrishnan, 2009b).
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Figure 1.4. mRNA bound to the ribosome initiation complex. SD sequence (red in
mRNA sequence) interaction with anti-SD sequence (red in 16S RNA sequence)
places the AUG start codon (dark yellow in mRNA sequence) at ribosomal P-site.
This figure is taken from (Yusupova et al., 2006).
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B

Figure 1.5. Representative schemes of peptide bond formation (A) and translocation
(B). Figure A and B are taken from (Wohlgemuth et al., 2010) and (Pan et al., 2007),
respectively.
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Figure 1.6. Emissive RNA alphabet. This figure is reprinted with permission from
(Shin, D., Sinkeldam, R. W., and Tor, Y. (2011). Emissive RNA alphabet. J Am
Chem Soc 133, 14912–14915.). Copyright (2011) American Chemical Society.
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CHAPTER 2
MATERIALS AND METHODS
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2.1 Materials
2.1.1 Buffers
All of the following buffers were prepared and the pH was adjusted at 25°C. All
of the experiments in this thesis were performed in buffer A unless otherwise
specified.
Buffer A: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2
and 1 mM DTT.
Buffer B: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2
and 1 mM DTT, 100 μM GTP, 2 mM phosphoenolpyruvate, 10 μg/ml pyruvate
kinase.
Buffer C: 20 mM Tris-HCl pH 7.6, 200 mM NH4Cl, 10 mM MgAc2.
IF3 lysis buffer: 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 10 mM
2-mercaptoethanol, 0.2 mM PMSF.
IF3 purification buffer A: 10 mM Tris-HCl pH 8.0, 200 mM NaCl, 5% glycerol, 1
mM 2-mercaptoethanol.
IF3 purification buffer B: 10 mM Tris-HCl pH 8.0, 500 mM NaCl, 5% glycerol, 1
mM 2-mercaptoethanol.
L11 dialysis buffer: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 6 mM
2-mercaptoethanol, 10 mM NaCl.
L11 purification buffer A: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea,
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6 mM 2-mercaptoethanol, 10 mM NaCl, 10 mM MgCl2.
L11 purification buffer B: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea,
6 mM 2-mercaptoethanol, 400 mM NaCl, 10 mM MgCl2.
L11 labeling buffer: 25 mM Tris-HCl pH 7.0, 100 mM NaCl, 2 mM EDTA.
EF-Tu purification buffer A: 50 mM Tris-HCl pH 7.6, 60 mM NH4Cl, 7 mM
MgCl2, 7 mM 2-mercaptoethanol, 15 μM GDP, 15% glycerol.
EF-Tu purification buffer B: 50 mM Tris-HCl pH 7.6, 60 mM NH4Cl, 7 mM
MgCl2, 300 mM KCl, 7 mM 2-mercaptoethanol, 15 μM GDP, 15% glycerol.
EF-Tu purification buffer C: 50 mM Tris-HCl pH 7.6, 60 mM NH4Cl, 7 mM
MgCl2, 300 mM KCl, 20 mM imidazole, 7 mM 2-mercaptoethanol, 15 μM GDP, 15%
glycerol.
EF-Tu elution buffer: 50 mM Tris-HCl pH 7.6, 60 mM NH4Cl, 7 mM MgCl2, 300
mM KCl, 300 mM imidazole, 7 mM 2-mercaptoethanol, 15 μM GDP, 15% glycerol.
EF-Tu storage buffer: 50 mM Tris-HCl pH 7.6, 100 mM NaCl, 10 mM MgCl2, 15
μM GDP.
Hybridization buffer: 100 mM Tris-HCl pH 7.5, 1 M NaCl, 10 mM EDTA.
TMA buffer: 10 mM Tris-HCl pH 7.6, 0. 1 mM EDTA pH 8.0, 0.9 M
tetramethylamonium chloride.
Aminoacylation buffer A: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 20 mM MgCl2,
1 mM EDTA pH 8.0, 7 mM 2-mercaptoethanol, 10 mM KCl, 0.01 unit/μl
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thermostable inorganic pyrophosphatase, 720 μM formyl donor, 67 μM [35S]fMet
mixture, 0.75 mg/ml E coli. aminoanyl-tRNA synthetases.
Aminoacylation buffer B: 100 mM Tris-HCl pH 8.0, 10 mM ATP, 50 mM MgCl2,
2.5 mM EDTA pH 8.0, 3 mM 2-mercaptoethanol, 200 μM [3H]Phe mixture, 1.5
mg/ml yeast aminoanyl-tRNA synthetases.
Aminoacylation buffer C: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 5 mM MgAc2,
250 μM EDTA pH 8.0, 7 mM 2-mercaptoethanol, 150 μM [3H]Phe mixture, 1 μM E
coli. Phe-tRNA synthetases.
Aminoacylation buffer D: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 20 mM MgCl2,
1 mM EDTA pH 8.0, 7 mM 2-mercaptoethanol, 0.005 unit/μl inorganic
pyrophosphatase, 100 μM [3H]Val mixture or 67 μM [3H]Arg mixture or 100 μM
[3H]Lys mixture, 0.75 mg/ml E coli. aminoanyl-tRNA synthetases.
Aminoacylation buffer E: 30 mM Hepes-HCl pH 7.0, 30 mM KCl, 15 mM MgCl2,
5 mM DTT, 4 mM ATP, 100 μM [3H]Val, 0.01 unit/μl thermostable inorganic
pyrophosphatase, 0.75 mg/ml of E coli. aminoacyl-tRNA synthetase.

2.1.2 Reagents
All of the aqueous solutions and buffers were prepared using double-deionized
water from Milli-A Water System (Millipore) and treated with a BioPak filter
(Millipore) to remove the DNase, RNase and protease.
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The following materials were purchased from the indicated suppliers: IPTG, GDP,
GTP, GDPNP, streptomycin, paromomycin, kirromycin, poly(U), puromycin, glucose,
glucose oxidase, phenylmethanesulfonylfluoride (PMSF), streptavidin agarose bead,
tris(2-carboxyethyl)phosphine hydrochloride (TCEP), N-hydroxysuccinimide ester,
folinic acid, glutathione, 6-hydroxy-2,5,7,8-tetramethyl- chromane-2-carboxylic acid
and bovine pancreatic RNase A (Sigma); Talon Superflow Metal Affinity Resin
(Clontech); QSY9 maleimide, dNTP, S.O.C. medium and Top 10 competent cells
(Invitrogen); Cy3 maleimide, Cy5 maleimide, NAP-5 column and pTZ18R plasmid
(GE Healthcare); phosphoenolpyruvate (PEP), pyruvate kinase (PK), RNase T1,
catalase and bulk tRNA from E coli. MRE600 cells (Roche);

proflavin (MB

Biomedicals); Phusion DNA polymerase and DpnI (New England Biolabs); PCR
purification kit and Ni-NTA Superflow resin (QIAGEN); BL21(DE3) competent cells
(Stratagene); ampicillin, trichloroacetic acid (TCA), saturated phenol pH 4.3 and
saturated phenol pH 6.6 (Fischer Scientific); AG 50W-X8 cation exchange resin,
Silver Stain Plus kit (Bio-Rad); thermostable inorganic pyrophosphatase (New
England BioLabs); Amicon Ultra-4 ultrafiltration units, Ultrafree-MC GV centrifugal
filter unit, and nitrocellulose filters (Millipore); LI Silver Stain kit (Nanoprobes); E.
coli tRNAfMet, E. coli tRNAPhe, E. coli tRNAVal, E. coli tRNAArg, E. coli tRNALys, and
yeast tRNAPhe (Chemical Block, Moscow).

2.2 Methods
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2.2.1 Preparation of proteins
Cloned E. coli His-tagged proteins IF1, IF2, EF-G and labeled phosphate binding
protein (MDCC-PBP) were prepared and purified as previously reported (Pan et al.,
2008). E. coli aminoacyl-tRNA synthetases were prepared following an established
procedure (Kemkhadze et al., 1981). Yeast aminoacyl-tRNA synthetases were
prepared based on the published procedure (Lagerkvist and Waldenstrom, 1964).

2.2.1.1 Purification of IF3
pET21a plasmid carrying His-tagged IF3 is a kind gift from Dr. Ueda, University
of Tokyo (Shimizu et al., 2001). All steps below were performed at 4 °C. 10 g of
frozen BL21(DE3) pET21a IF3 cells were kept on ice for 10min, and then
resuspended in 30 mL of IF3 lysis buffer followed by two passes through a French
Press (12,000–14,000 psi). The resulting mixture was subject to centrifugation (10k
rpm, 30 min, SS-34 rotor) to pellet the cell debris. The supernatant was loaded onto an
8 ml Ni-NTA column (18 mm in diameter) pre-washed with 60 ml of water and
pre-equilibrated with 60 ml of IF3 lysis buffer. The column was washed by 60 ml of
IF3 purification buffer A followed by 30 ml of IF3 purification buffer B. IF3 protein
was eluted by use of a hyperbolic imidazole gradient in IF3 purification buffer B (5
mM imidazole, 40 ml; 10 mM imidazole, 20 ml; 20 mM imidazole, 10 ml; 300 mM
imidazole, 50 ml) and collected in fractions. Fractions with large amounts of IF3 were
identified by 18% SDS-PAGE gel and pooled for dialysis against buffer A. IF3 was
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concentrated by an Amicon Ultra ultrafiltration units [molecular weight cutoff
(MWCO): 10,000] and the concentration was determined by Bradford assay
(Bradford, 1976).

2.2.1.2 Purification and labeling of L11(C38S/S87C)
L11(C38S/S87C)

double

mutant

from

12

g

of

BL21(DE3)

pLysS

L11(C38S/S87C) cells (Chen et al., 2011a) was first purified using an 8 ml Ni-NTA
column (18 mm in diameter), following the procedure used for IF3 and using the
same buffers for IF3. All proteins eluted with 300 mM imidazole were dialyzed
against L11 dialysis buffer overnight and L11 purification buffer A for 3 hours at 4 °C.
After concentrated using Amicon Ultra ultrafiltration units (MWCO: 10,000), crude
L11 product was further purified on a SourceS column (4.6 × 100 mm) and pure L11
was eluted using a linear gradient from L11 purification buffer A to L11 purification
buffer B. Then an Amicon Ultra ultrafiltration units (MWCO: 10,000) was used to
remove the urea and replace the buffer with buffer A (6 times), after each cycle of
which L11 sample was kept on ice for at least 30 min to facilitate protein refolding.
L11 concentration was determined by Bradford assay (Bradford, 1976), with the
concentration multiplied by a correction factor of 0.6 (Wang et al., 2007).
L11 labeling with either Cy3 or Cy5 was performed as described (Chen et al.,
2011a). Nap-5 column (bed volume 0.5 ml) was used to exchange the buffer from
buffer A to L11 labeling buffer following the manufacture instructions. L11 (100 μM)
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was incubated at room temperature for two hours in the presence of TCEP (300 μM)
and Cy5 maleimide (1.1 mM) in 900 μl of L11 labeling buffer. The reaction was
quenched with 3 μl of 14.3 M 2-mercaptoethanol, and labeled L11 was purified on
Source S column as in L11 purification. Fractions were monitored at A280 and A550,
and pooled for dialysis against buffer A, followed by concentration using an Amicon
Ultra ultrafiltration units (MWCO: 10,000). L11 concentration was determined by
Bradford assay as above and dye concentration was determined by A550 for Cy3 and
A650 for Cy5 (extinction coefficients: 150,000 and 250,000 M-1 cm-1 for Cy3 and Cy5,
respectively). Typical dye/L11 ratio was 0.9.

2.2.2 Preparation of EF-Tu variants and their derivatives
2.2.2.1 Purification of EF-Tu variants
Expression vectors for C-terminal His-tagged E. coli EF-Tu variants were based
on the pET15b vector. pET15b EF-Tu plasmids (50–80 ng) (Perla-Kajan et al., 2010)
were transformed into BL21(DE3) competent cells, and the strains were grown in
Super Optimal Broth (S.O.C.) medium at 37 °C for one hour. The cell cultures were
plated onto LB-Agar plate with 100 μg/ml of ampicillin and grown overnight at 37 °C.
Single colony on the plate was innoculated into 6 ml of LB medium with 100 μg/ml
of ampicillin for overnight growth at 37 °C. The cell culture was transferred into 1 L
of LB medium with 100 μg/ml of ampicillin for growth until A260 reached ~0.6–0.8.
Protein expression was started by addition of 1mM IPTG and lasted for 3 hours at 37
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°C.
The purification of the expressed proteins was performed as previously described
with some changes (Perla-Kajan et al., 2010). BL21(DE3) pET15b EF-Tu cells (6 g)
were resuspended in 25 ml of EF-Tu purification buffer A and the mixture was
magnetically stirred for 30 min at 4 °C. A second incubation at room temperature for
20 min was performed after addition of lysozyme to 0.75 mg/ml. Cell was broken by
French press twice (12,000–14,000 psi) and centrifuged (4 °C, 20k rpm with SS34
rotor, 20 min) to remove the cell debris. The supernatant was mixed with
Co(II)-Sepharose (Talon) resin (bed volume 3 ml), pre-washed twice with 30 ml of
EF-Tu purification buffer A, and shaken at 4 °C for 1 hour. Resins bound with EF-Tu
were pulled down by centrifugation (4 °C, 700 xg, 5 min), washed twice with 30 ml
of EF-Tu purification buffer A, and transferred to a small gravity column (18 mm in
diameter). The column was washed sequentially with 10 ml of EF-Tu purification
buffer A, 10 ml of EF-Tu purification buffer B and 10 ml of EF-Tu purification buffer
C. EF-Tu was eluted using EF-Tu elution buffer, and Amicon Ultra ultrafiltration units
(MWCO: 10,000) were used to concentrate the samples, remove imidazole and
replace the buffer with EF-Tu storage buffer. EF-Tu concentration was determined by
Bradford assay.

2.2.2.2 Labeling of EF-Tu with quencher or fluorophore
EF-Tu labeling was carried out in 150 µl EF-Tu storage buffer by incubating
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EF-Tu (0.8 mg, 0.1 mM), QSY9, Cy3 maleimide or Cy5 maleimide (1.35 mM) and
TCEP (1 mM) at room temperature for 6 hours. The reaction was quenched by
addition of 2-mercaptoethanol (final concentration: 300 mM). The mixture was
diluted to 0.5 ml with EF-Tu storage buffer and loaded onto a NAP-5 column (bed
volume 0.5 ml) at room temperature to remove free QSY9. 1 ml of EF-Tu storage
buffer was used to elute the EF-Tu. Three fractions of volumes 200, 400 and 400 µl
were collected, and labeled EF-Tu was eluted in the middle 400 µl. EF-Tu
concentration was determined by Bradford assay. Cy3 or Cy5 concentration was
determined by A550 or A650 as in section 2.2.1.2. QSY9 concentration was determined
using a standard curve of free QSY9 measured at A562 (extinction coefficient: 88,000
cm-1 M-1).

2.2.2.3 Functional analysis of EF-Tu variants
EF-Tu interaction with aa-tRNA was monitored by the ability of EF-Tu to protect
aa-tRNA against RNase degradation as described (Pan et al., 2008). Ternary
complexes with 0.10–0.15 μM of yeast [3H]Phe-tRNAPhe and different concentrations
of EF-Tu were made in 50 μl buffer B (see Section 2.2.6.2) and chilled on ice for 30
min. 5 μl of 0.05 mg/ml RNase A was added to ternary complex to digest the tRNA at
4 °C for 15 sec, and then quenched with 200 μl of 10% TCA. Filter binding with a
nitrocellulose filter was used to collect protected [3H]Phe-tRNAPhe followed by three
washes with chilled 5% TCA. Filters were dried, dissolved with 1 ml of ethyl acetate,
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and counted in scintillation liquid.
The poly(Phe) assay was carried out in buffer C. All concentrations below are
final concentrations after mixing. Initiation complex was made by mixing 70S
ribosome (0.3 μM), poly(U) (0.3 g/L), [3H]-AcPhe-tRNAPhe (0.36 μM) at 37 °C for 5
min. 2-Mercaptoethanol (2 mM), PEP (0.4 mM), PK (4 mg/L), GTP (0.5 mM),
[3H]-Phe-tRNAPhe (4.5 μM) and EF-G (0.5 μM) were then added, and the mixture was
fractionated into 6 μl aliquots. Reaction was started by adding 0.5 μM of EF-Tu (2 μl)
to the aliquots. After incubation at 37 °C for 30 min, the reaction mixtures were
quenched with 0.3 ml of 5% TCA, heated to 95 °C for 15 min and cooled on ice for 1
hour. Filter binding was performed using a nitrocellulose filter followed by three
washes with chilled 5% TCA, and the radioactivity of [3H]-Phe-tRNAPhe was
determined.
Determination of quenching efficiency was performed in buffer B. 0.17 μM of
Phe-tRNAPhe (Cy3) was incubated with different concentrations of free QSY9 or
EF-TuQSY variants at 37 °C for 10 min, and fluorescent emissions of the resulting
mixtures were determined at room temperature (see Section 2.2.7.1).

2.2.3 Preparation of mRNAs
All modified mRNAs containing thG, thA, thU or thC are from Prof. Yitzhak Tor
and Dr. Dongwon Shin at University of California, San Diego.
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2.2.3.1 Preparation of mRNA 022 MFTI and 022 CUC
mRNA 022 and 022CUC were prepared and purified as previously reported (Pan
et al., 2008). In 400 μl buffer provided in the T7 transcription kit, plasmid (150 ng/μl)
was mixed with NTP (100 mM for each of ATP, CTP, GTP and UTP), DTT (100 mM)
and 40 μl of T7 enzyme. The mixture was incubated at 42°C for 2 hours, followed by
addition of 20 μl of provided DNase I and 15 min incubation at 37°C. The aqueous
layer after one extraction with 1:1 phenol pH 4.3/chloroform mixture and one
extraction with chloroform, was mixed with 1 volume of chilled 5 M LiCl, followed
by incubation on ice for 1 hour, and the precipitate was collected by centrifugation
(Heraeus Instrument D-37520, 15k rpm, 20 min). mRNA pellet was resuspended in
DDI H2O and further purified by addition of 2.5 volumes of EtOH for precipitation,
washed with 70% ethanol and subjected to a second resuspension and EtOH
precipitation. mRNA purity was confirmed by electrophoretic analysis on a 2%
agarose gel (Figure 2.1).

2.2.3.2 Preparation of mRNA MRF and MVF
For mRNA MRF, the corresponding coding sequence with a T7 promoter
sequence (GGG AAU UCG AAA UAG AAG UCU UCU UUU UGG A AAA AUU
UAA AAG UUA AUA AGG AUA CAU ACU AUG CGU UUC UUC CGU UUC
UUC CGU AAA UUC CGU GUG CGU UUU UUC AAA UUU GUG UUC CGU
UAA CGC GUC UGC AGG CAU GCA AGC UAA AAA AAA AAA AAA AAA
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AAA AAA AAA GCU U; IDT, IA) was ligated into plasmid pTZ18R. Overexpression
and purification were performed following the procedures similar to mRNA 022
MFTI. mRNA MVF was prepared the same as mRNA MRF with the corresponding
synthesized sequence (GGG AAU UCG AAA UAG AAG UCU UCU UUU UGG A
AAA AUU UAA AAG UUA AUA AGG AUA CAU ACU AUG GUG UUC UUC
CGU UUC UUC CGU AAA UUC CGU GUG CGU UUU UUC AAA UUU GUG
UUC CGU UAA CGC GUC UGC AGG CAU GCA AGC UAA AAA AAA AAA
AAA AAA AAA AAA AAA GCU U; IDT, IA).

2.2.3.3 Preparation of mRNA MVYF and MKF
mRNA MVYF was prepared by mutation of the mRNA 022 MFTI sequence via
PCR (Chiu et al., 2004), using the following primers: forward, 5’-TTA ACT TTT
AAA TTT TTG AAT TCC CTA TAG TGA GTC GTA TTA AAT TC-3’; overreverse,
5’-CAG GTA TAC ATA CTA TGG TCT ACT TTA CTA CGA TCT TCT TCA CTT
AAC GCG TCT GCA GGC ATG-3’; reverse, 5’-CTT CAC TTA ACG CGT CTG
CAG GCA TG-3’; overforward, 5’-AAG ATC GTA GTA AAG TAG ACC ATA GTA
TGT ATA CCT GTT AAC TTT TAA ATT TTT GAA TTC CCT ATA GTG AGT CGT
ATT AAA TTC-3’. Two PCR samples were prepared with primer forward and
overreverse or primer reverse and overforward, respectively. After PCR, parent
plasmid was digested by incubation with DpnI enzyme (0.2 Unit/μl) at 37°C for 1
hour and the PCR products were purified using a QIAGEN PCR purification kit. Two
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PCR products were combined for hybridization of single strand DNA in hybridization
buffer using PCR again, and the resulting plasmids were transformed into TOP 10
competent cells for small scale expression. Plasmid was extracted using QIAGEN
Miniprep kit and the target mutation was confirmed by DNA sequencing. Correct
plasmid was transformed into TOP 10 competent cells for large scale expression and
purification as for mRNA 022 MFTI.
mRNA MKF was prepared following a similar procedure to mRNA MVYF using
the following primers: forward, the same as mRNA MVYF; overreverse, 5’-CAG
GTA TAC ATA CTA TGA AAT TCC GTA CTA CGA TCT TCT TCA CTT AAC GCG
TCT GCA GGC ATG-3’; reverse, the same as mRNA MVYF; overforward, 5’-AAG
ATC GTA GTA CGG AAT TTC ATA GTA TGT ATA CCT GTT AAC TTT TAA ATT
TTT GAA TTC CCT ATA GTG AGT CGT ATT AAA TTC-3’.

2.2.4 Preparation of tRNAs
2.2.4.1 Preparation of formyl donor
Formyl donor was made as described (Dubnoff and Maitra, 1971). 25 mg of
folinic acid was dissolved in 2.0 ml of 50 mM 2-mercaptoethanol. Following addition
of 0.22 ml of 1.0 M HCl, the mixture was allowed to react for 3 hours at room
temperature. Some precipitation may occur during the reaction, which could be
dissolved on gentle heating in a water bath set to 37 °C. Formyl donor concentration
was determined by A355 (at 355 nm, 1 μmol/ml = 25 A355). The product was then
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aliquoted for storage in the freezer. Before being used for tRNAfMet aminoacylation,
the pH of formyl donor was activated by adjusting its pH to neutrality with 1/4
volume of 1 M Tris-HCl, pH 8.0 and incubating at room temperature for 20 minutes.

2.2.4.2 Purification of E. coli tRNAfMet from bulk tRNAs
24 nmol (400 μl) of streptavidin agarose beads was washed twice with 400 μl
of 10 mM Tris-HCl pH 7.6, using Ultrafree-MC GV centrifugal filter units (1 min at
5580 xg). The collected beads were incubated, in the presence of 8 nmol of oligo
(5’-ATG AGC CCG ACG AGC TAC CAG GCT GCT C-3’-biotin) in 400 μl of 10
mM Tris-HCl pH 7.6 buffer, at room temperature for 30 min, shaken by hand every 5
min and washed twice with 400 μl of 10 mM Tris-HCl pH 7.6 to remove the unbound
oligos, as monitored by A260. 200 units of bulk tRNA from E coli. MRE600 cells (360
nmol bulk tRNA; ~3.6 nmol tRNAfMet) in 300 ul of DDI water were heated at 80 °C
for 10 min, quickly mixed with 300 ul of TMA buffer, and immediately added to oligo
bound beads. The resulting mixture was heated at 65 °C for 10 min, followed by
gradual temperature decrease to 37 °C and 30 min incubation at 37 °C. Unbound
tRNAs were removed by 7 washes with 400 μl of 10 mM Tris-HCl pH 7.6. Bound
tRNAs were eluted by a stepwise incubations at 45°C, 55°C and 65°C, respectively.
At each temperature, beads were heated for 7 min in the presence of 400 μl of 10 mM
Tris-HCl pH 7.6, centrifuged at 10k rpm for 1 min, and washed twice with 400 μl of
10 mM Tris-HCl pH 7.6 by centrifugation. Each centrifugation was performed in the
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presence of 2 μl of 1 M MgCl2, and the flow-through was collected separately. For
those fractions containing tRNAfMet as measured by A260, 1/10 volume of 1 M
Tris-HCl pH 9.0 was added and the mixtures were incubated at 37°C for 3 hours.
tRNAs were obtained by EtOH precipitation with addition of 2.5 volumes of EtOH.
To

roughly

estimate

the

aminoacylation

efficiency,

tRNAfMet

formylaminoacylation was done in a 10 μl scale for the tRNA product eluted at each
temperature (see section 2.2.4.3), with a negative control performed in the absence of
aminoacyl-tRNA synthetases. After incubation, 400 μl of 5% TCA was added and the
samples were left on ice for 1 hour. Filter binding was performed using a
nitrocellulose filter followed by three washes with chilled 5% TCA, and the
radioactivity of [35S]-fMet-tRNAfMet was determined. tRNAfMet was in factions eluted
at 65 °C.

2.2.4.3 Formylaminoacylation of tRNAfMet
Procedures described in Pan et al. (Pan et al., 2007) were used to
formylaminoacylate commercial tRNAfMet from E. coli. 36 nmol of tRNAfMet was
incubated in 2000 μl of aminoacylation buffer A at 37°C for 45 min. The reaction was
quenched with 200 μl of 20% KAc pH 5.0, extracted once with phenol (Tris-saturated,
pH 4.3) and once with chloroform, both in 1:1 volume ratio, and, after addition of
1/10 volume of 20% KAc pH 5.0, was precipitated with 2.5 volumes of EtOH.
Formylaminoacylated tRNA was further purified on FPLC with a self-packed column
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(5×50 mm) using Q-Sepharose resin. tRNAs on the column were washed with 15 ml
of 50 mM NaAc pH 5.0, and eluted by a gradient of 0–1 M NaCl in 50 mM NaAc pH
5.0. tRNA concentration was determined by A260 and [35S]-fMet-tRMAfMet
concentration by radioactivity counting. A typical aminoacylation efficiency of
850–1200 pmol/A260 was normally obtained. tRNAfMet purified from bulk tRNA was
formylaminoacylated in a similar procedure except that 4 nmol of tRNAfMet was used
in every 2000 μl of aminoacylation mixture, to a level of 1250-1800 pmol/A260.
Commercial tRNAfMet was used in all of the experiment in Chapter III and IV.
Purified tRNAfMet was used for most of the experiments in Chapter V and commercial
tRNAfMet was used for some of the experiments. In control experiments, no difference
was observed between using commercial and purified tRNAfMet within the
experimental error.

2.2.4.4 Aminoacylation of tRNAPhe
Commercial tRNAPhe from yeast was aminoacylated using a procedure similar to
commercial tRNAfMet except for in the aminoacylation buffer B and the use of yeast
PheRS (Pan et al., 2007). A typical aminoacylation stoichiometry was 550–700
pmol/A260.
Commercial E coli. tRNAPhe was aminoacylated similar to yeast tRNAfMet except
that: 1) aminoacylation buffer C was used; 2) incubation was 20 min at 37°C (Pan et
al., 2007). E coli. tRNAPhe could be aminoacylated to a level of 550–700 pmol/A260.
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2.2.4.5 Preparation of yeast AcPhe-tRNAPhe
1.2 nmol yeast [3H]-Phe-tRNAPhe was lyophilized and re-dissolved in 50 μl 0.1 M
NaAc pH 5.0. 0.0484 g N-hydroxysuccinimide ester was dissolved in 480 μl of dry
DMSO, 400 μl of which was added to the [3H]-Phe-tRNAPhe solution. After
incubation on ice for 2 hours, the sample was mixed with 50 μl of 20% KAc pH 6.5,
EtOH precipitated, and centrifuged at 15k rpm for 20 min (Heraeus Instrument
D-37520). Precipitation was repeated twice and the tRNA was resuspended in 150 μl
of H2O. A fraction of 10 μl was aliquoted out and added into 1 M NH4OH as a control
for overall [3H]-Phe-tRNAPhe radioactivity counting, and the remaining sample was
diluted 25-fold in H2O. To pack a small column, 200 μl of cation exchange resin AG
50W-X8 resuspended in 0.01 M HCl was loaded onto small spin column and washed
5 times with 500 μl of H2O. Diluted sample in 500 μl portions was loaded onto a
packed column, and washed 5 times with 500 μl of H2O and 5 times with 1 M
NH4OH, all of the flow-through being collected separately. 50 ul aliquot from each
fraction and the control were incubated at 75°C for 5 hours, mixed with 500 μl of H2O
to dissolve everything, and counted in scintillation liquid to identify the fractions
containing the product. Ac-[3H]-Phe-tRNAPhe was eluted with H2O, and EtOH
precipitated with addition of 2.5 volumes of EtOH and dissolved in H2O at a final
concentration of ~ 5 μM.
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2.2.4.6 Aminoacylation of E. coli tRNAVal, tRNAArg and tRNALys
E. coli tRNAVal, tRNAArg and tRNALys were aminoacylated by using a similar
procedure to tRNAfMet, except that 1) aminoacylation buffer D was used; 2) the
incubation time for tRNALys was 10 min. Typical aminoacylation stoichiometries were
500–700 pmol/A260 for tRNAVal, 1000–1200 pmol/A260 for tRNAArg, 500–650
pmol/A260 for tRNALys.

2.2.4.7 Aminoacylation of tRNAVal2B variants
tRNAVal2B variants were kind gifts from Dr. Olke C. Uhlenbeck (Northwestern
University). tRNAVal2B was aminoacylated following reported procedures (Dale et al.,
2004) with some modifications. 1.2 nmol tRNA was incubated in 600 μl of
aminoacylation buffer E at 37°C for 15 min. The reaction was quenched by 60 μl of
20% KAc pH 5.0, and extracted once with phenol (Tris-saturated, pH 4.3) and once
with chloroform, both in 1:1 volume ratio. tRNA was EtOH precipitated with addition
of 2.5 volumes of EtOH and used with no further purification. [3H]-Val-tRNAVal2B
concentration was determined by radioactivity counting.

2.2.4.8 tRNA labeling with proflavin
A modified procedure for the preparation of fMet-tRNAfMet(prf) (Pan et al., 2007)
was utilized to perform tRNA labeling with proflavin. To reduce the dihydrouridine
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residues in the tRNA D-loop, 36 nmol of tRNA in 324 μl of 40 mM Tris-HCl pH 7.5
was rapidly mixed with 36 μl of 100 mg/ml NaBH4 in 0.01 M KOH, followed by 1
hour incubation on ice and H2 release every 10 min. The reduction reaction was
terminated by drop-wise addition of 60 μl of 6 N HAc, and the product was purified
by EtOH precipitation for three times in the presence of 1/10 volume of 20% KAc pH
5.0 and 2.5 volumes of EtOH. Reduced tRNA was aminoacylated and purified by
FPLC as described above, resuspended in 100 μl of H2O, and mixed with 1 ml of 0.52
mg/ml proflavin in 0.1 M HCOONa pH 3.7 for 45 min incubation at 37°C. After
incubation, the solution was adjusted to about pH 7.5 by addition of 1/10 volume of 1
M Tris, and extracted twice with phenol (Tris-saturated, pH 6.5). Labeled tRNA was
EtOH precipitated twice after addition of 1/10 volume of 20% KAc pH 6.5 and 2.5
volumes of EtOH. Aminoacylation and labeling efficiencies were generally obtained
as following: 700–900 pmol/A260 and 0.9–1.1 prf/tRNA for tRNAfMet; 250–400
pmol/A260 and 0.8–1.0 prf for E coli. tRNAPhe; 250–400 pmol/A260 and 1.0–1.2
prf/tRNA for tRNAVal; 800–1000 pmol/A260 and 0.9–1.1 prf/tRNA for tRNAArg;
200–350 pmol/A260 and 1.0–1.2 prf/tRNA for tRNALys.

2.2.4.9 tRNAPhe labeling with Cy3
Yeast tRNAPhe was labeled with Cy3 (Pan et al., 2009) or Cy5 (Kaur et al., 2011)
as previously reported. tRNAPhe was reduced and aminoacylated as above described,
then purified using phenyl RP-HPLC (RP-C18 column, 4.6 × 250 mm, Alltech) with a
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gradient of 0% to 30% ethanol in 20 mM NH4Ac pH 5.0, 10 mM Mg(Ac)2 and 400
mM NaCl. Pooled fractions were EtOH precipitated with 20% KAc pH 5.0 and 2.5
volumes of EtOH, and resuspended in 10 μl of 0.1 M HCOONa pH 3.7. Labeling was
performed by mixing reduced and aminoacylated tRNA with 2 μl of 270 mM of Cy3
or Cy5 hydrazide in DMSO, followed by a incubation at 37°C for 2 hours. Then the
sample was lyophilized, EtOH precipitated as above for three times with 1/10 volume
of 20% KAc pH 5.0. Phe-tRNAPhe(Cy3 or Cy5) was obtained with an aminoacylation
efficiency of ~900 pmol/A260 and ~0.5 Cy3/tRNA.

2.2.4.10 Preparation of highly labeled tRNAPhe with Cy5
Yeast tRNAPhe was highly labeled with Cy5 as above described except that: 1)
reduced and aminoacylated tRNAPhe was purified on FPLC; 2) 20% KAc pH 6.5 was
used all the times. Phe-tRNAPhe(Cy5) was obtained with an aminoacylation efficiency
of ~500 pmol/A260 and a labeling efficiency of ~0.8 Cy5/tRNA.

2.2.5 Preparation of the 70S ribosomal complex and ternary complex
Tightly-coupled wild-type 70S ribosomes from E.coli MRE600 cells and mutant
70S ribosomes lacking L11 from E.coli AM77 cells were prepared and purified as
previously reported (Pan et al., 2008).

48

2.2.5.1 Preparation of the 70S ribosome labeled with Cy3 or Cy5
The reconstitution of 70S ribosomes containing L11Cy3 (70SCy3) or L11Cy5 (70SCy5)
was performed as described (Chen et al., 2011a). 100 μl of 30 μM labeled L11 and 40
μl of 50 μM 70S lacking L11 were first incubated at 37°C for 5 min separately, then
combined for a further incubation at 37°C for 15 min. After an increase of magnesium
concentration to 20 mM, the mixture was subject to centrifugation through a sucrose
cushion in buffer A with 1.1 M sucrose and magnesium concentration increased to 20
mM (SORVALL S120-AT2 rotor, 110K rpm, 40 min, 4 oC) to pull down the labeled
70S. The pellet was suspended in buffer A. 70S concentration was determined by A260
and dye concentration was determined by A550 for Cy3 or A650 for Cy5, respectively. A
typical labeling efficiency is 0.8–1.0 dye/70S.

2.2.5.2 Preparation of ribosomal complexes and ternary complex
All ribosome complexes were prepared in buffer A at 37 oC. 70SIC was made by
incubating 70S ribosome (0.8–4 μM) with mRNA (4-fold excess over 70S for all
experiments in Chapter III and IV; half of 70S for experiments presented in Chapter V,
Figure 5.2–5.3; 2-fold excess over 70S for all other experiments in Chapter V), IF1–3
(1.5-fold excess over 70S), GTP (1 mM) and [35S]-fMet-tRNAfMet (1.5-fold excess
over 70S) for 25 min. For experiments using fMet-tRNAfMet(prf), MDCC-PBP or
GDPNP in Chapter III and IV and all experiments in Chapter V except for
experiments presented in Figure 5.2C,D and 5.3B, 70SIC was purified by
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centrifugation through a 1.1 M sucrose cushion in buffer A (SORVALL S120-AT2
rotor, 110K rpm, 40 min, 4 oC). In all other experiments, the ultracentrifugation step
was omitted. Purified 70SIC was quantified (Figures 5.2A,B and 5.3A) as
co-sedimenting [35S]-fMet-tRNAfMet per mRNA, where mRNA stoichiometry was
assumed to be half of 70S.
TC was formed by incubating aminoacyl-tRNA (0.8–8 μM) with EF-Tu (4-fold
excess over aa-tRNA), GTP (1 mM), phosphoenolpyruvate (1.5 mM) and pyruvate
kinase (10 μg/mL) for 10 min. No PEP and PK were added when GDPNP was used.
For Pi release experiments, GTP concentration was 50 µM, and no PEP and PK were
added. TC solution was premixed with MDCC-PBP (2.5 µM), 7-methylguanosine
(200 µM) and nucleoside phosphorylase (0.2 Unit/ml) before kinetic experiments.
PRE complex was formed by incubating 70SIC (0.5–2 μM, as measured by A260 of
70S) with TC (2-fold ratio to 70S) for 1 min. Purified PRE complex was prepared by
centrifugation through a 1.1 M sucrose cushion in buffer A with 20 mM MgCl2,
performed as 70SIC, and quantified (Figures 5.2C,D and 5.3B) as co-sedimenting
[3H]-Val (thG4- or

th

G6-programmed ribosomes), [3H]-Arg (thG5-programmed

ribosomes) or [3H]-Lys (thA1-,

th

A4-,

th

A5- or

th

A6-programmed ribosomes). All

experiments reported in this thesis used purified PRE complexes, except for those
shown in Figure 5.2E, for which the ultracentrifugation step was omitted.
POST complex was prepared and quantified (Figures 5.2E,F and 5.3C) using two
different procedures. PRE complexes programmed with thG4, thG6 or MVF (0.8 μM,
50

as measured by A260 of 70S) were incubated with EF-G.GTP (2 μM) and puromycin
(2.5 mM) at 37 oC for 30 s, the reaction was quenched with 1 volume of 0.3 M NaAc,
pH 5.0, fMet-[3H]-Val-puromycin was quantitatively extracted with ethyl acetate and
the radioactivity in the extract was determined. A different procedure was required for
PRE complexes programmed with thG5, MRF, thA1, thA4, thA5, thA6 or MKF, because
of the insolubility of fMet-[3H]-Arg-puromycin and fMet-[3H]-Lys-puromycin in
ethyl acetate. Here PRE complex (5 μM, as measured by A260 of 70S) was incubated
with EF-G.GTP (10 μM) and puromycin (15 μM) at 20 oC for 30 s, and the reaction
was quenched by adding 5 volumes of buffer A adjusted to pH 5. These conditions
were sufficient for full puromycin reaction with translocated fMet-[3H]-Arg-tRNAArg
or fMet-[3H]-Lys-tRNALys, resulting in fMet-Arg-puromycin or fMet-Lys-puromycin
formation. The resulting mixture was subject to ultracentrifugation through a 1.1 M
sucrose cushion in buffer A with 20 mM MgCl2, performed as above.
fMet-Arg-puromycin or fMet-Lys-puromycin remained in the supernatant during
centrifugation. Unreactive fMet-Arg-tRNAArg or fMet-Lys-tRNAALys co-sedimented
with the ribosome. Radioactivity in the pellet was determined.
The relative amount (RA) of EF-G- and mRNA-dependent POST complex
formation was obtained by correcting the results obtained for differences in the
efficiencies of formation of the 70SIC (Figure 5.2E) and PRE (Figures 5.2E–F and
5.3C) complexes and normalizing to the value found for unmodified mRNA. This was
accomplished by measuring the amounts of [3H]-Val, [3H]-Arg, [3H]-Lys or found in
either the ethyl acetate extract (thG4, thG6, or MVF) or sucrose cushion pellet (thG5,
51

MRF, thA1, thA4, thA5, thA6 or MKF) in four different samples formed in the presence
(a) or absence (c) of EF-G in the presence of mRNA, or in the presence (b) or absence
(d) of EF-G, in the absence of mRNA, and calculating the efficiencies using Equation
2.1A (thG4, thG6 or MVF) or 2.1B (thG5, MRF, thA1, thA4, thA5, thA6 or MKF).
RA = 1-[(c-d)/(a-b)] (2.1A); RA = 1-[(a-b)/(c-d)] (2.1B)
Data for

th

G4,

th

G6 and

th

G5 were used for sample calculation of relative

translocation. The relative amounts of [3H]-Val per ribosome in the ethyl acetate
extract were: (a) 0.057, 0.030 and 0.052 for MVF, thG4 and thG6, respectively; (c)
0.009, 0.006 and 0.012 for MVF, thG4 and thG6, respectively. The values of [3H]-Val
per ribosome for (b) and (d) were 0.002 and 0.001, respectively. From Equation 2.1A,
the translocation efficiencies were 0.85, 0.82 and 0.78 for MVF,

th

G4 and

th

G6,

respectively, which were all normalized to the efficiency of MVF. Therefore, the
relative POST complex formation efficiencies, as shown in Figure 5.2E, were 1.0,
0.96 and 0.92 for MVF, thG4 and thG6, respectively. The relative amounts of [3H]-Arg
per ribosome in sucrose cushion pellet were: (a) 0.032 and 0.040 for MRF and thG5,
respectively; (c) 0.100 and 0.084 for MRF and thG5, respectively. The values of
[3H]-Arg per ribosome for (b) and (d) were 0.010 and 0.015, respectively. From
Equation 2.1B, the translocation efficiencies were 0.75 and 0.57 for MRF and thG5,
respectively, which were both normalized to the efficiency of MRF. Therefore, the
relative POST complex formation efficiencies, as shown in Figure 5.2F, were 1.0 and
0.76 for MRF and thG5, respectively.
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2.2.5.3 Purification of ternary complex
To

evaluate

the

quenching

efficiency

between

E348C-EF-TuQSY9

and

Phe-tRNAPhe(Cy3), TC [formed by combining 2 nmol of E348C-EF-TuQSY9 and 0.7
nmol of Phe-tRNAPhe (Cy3)] was purified on Co(II)-Sepharose (Talon) resin (bed
volume 0.5 ml). TC and resin pre-washed with buffer A with no DTT were mixed and
shaken at 4 oC for 30 min, pulled down by centrifugation (Heraeus Instrument
D-37520, 8000 rpm, 2 min), and transferred to a small spin column. The resin was
washed sequentially with 4 ml of buffer A with no DTT, 2 ml of buffer A with no DTT
but 300 mM KCl and 10 mM imidazole. TC was eluted with 2 ml of buffer A with no
DTT but 300 mM KCl and 300 mM imidazole. All of the washes and elutions were
collected in 500 μl fractions. TC was normally in the first fraction of the elution and
its concentration was determined by scintillation counting.

2.2.6 Fluorescence experiments
2.2.6.1 Static fluorescence experiments
Steady-state fluorescence was measured on a Fluorolog-3 spectrofluorometer
(Horiba Jobin Yvon). The emission spectrums were recorded with an excitation at 530
nm for Cy3, 360 nm for thA and thG. Excitation spectrums of modified nucleosides
were performed by monitoring the emission at 410 nm for

th

A and 450 nm

th

G.

Distances between FRET donor and acceptor were calculated using the equation
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shown as below:
Distance = R0*(1/E-1)1/6
where R0 is the Förster distance (Medintz et al., 2003) and E is measured FRET
efficiency.

2.2.6.2 Stopped-slow experiments
Kinetic experiments were performed in buffer A at 25 oC on KinTek SF-300X
stopped-flow spectrofluorometer. Cy3 was excited at 530 nm and monitored using
either a 570-nm long-pass filter for experiments employing QSY9 or a 570 ± 10-nm
band-pass filter for all other experiments. Cy5 fluorescence was monitored using a
680 ± 10-nm band-pass filter. Proflavin was excited at 462 nm and monitored using a
515 ± 15-nm band-pass filter. MDCC-PBP was excited at 436 nm and monitored
using a 455 nm long-pass filter. thG was excited at 360 nm and monitored using a 450
± 10-nm band-pass filter. thA was excited at 360 nm and monitored using a 410 ±
10-nm band-pass filter. In each independent kinetic experiment, traces of fluorescence
intensity changes were obtained as an average of at least 4 shots. Each experiment
was performed twice. Apparent rate constants (kapps) were obtained by either single
(Equation 2.2) or double (Equation 2.3) exponential fitting of each independent
experiment using Origin (OriginLab), respectively. Global fittings of selected data
sets were carried out using Scientist (MicroMath Research).
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F = F0 + F1e-k1appt

(Equation 2.2)

F = F0 + F1e-k1appt + F2e-k2appt

(Equation 2.3)

2.2.6.3 Single-molecule experiments
smFRET studies were carried out at 23 °C. 70S ICs formed using a
5’-biotinylated mRNA (Dharmacon RNAi Tech.) were immobilized on a
biotin/PEG-streptavidin coated glass surface (Roy et al., 2008). After washing away
unbound complexes, collection of real-time fluorescence traces began 5 s prior to
injecting 10 nM ternary complexes, which were preformed from EF-Tu, GTP and
charged tRNAs. Recording continued for 60 s without further washing. An enzymatic
deoxygenation system of 3 mg/ml glucose, 100 µg/ml glucose oxidase, 40 μg/ml
catalase, and 1.5 mM 6-hydroxy-2,5,7,8-tetramethyl-chromane-2-carboxylic acid (by
dilution from a DMSO solution) was present in the final single-molecule imaging
solutions to diminish fluorophore photobleaching and blinking. A custom-built
objective-type total internal reflection fluorescence (TIRF) microscope was used to
collect Cy3 and Cy5 (due to FRET from Cy3) fluorescence intensities on excitation
by a 532 nm laser (Chen et al., 2011a). The 11 ms integration time was achieved by
cutting the exposure area down to 128 pixels × 512 pixels without further binning.
Other details of materials preparation, experimental setup, and data analysis were as
previously described (Chen et al., 2011a).
FRET probability density plots were two-dimensional contour maps plotted from
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time-resolved FRET histograms. For each plot, FRET traces were synchronized at the
same specific event, such as the first or the last time points of FRET events. The
FRET value was set to 0 when there are no Cy3 and Cy5 fluorescence signals.
Synchronized FRET traces were averaged traces from FRET traces synchronized
at the same specific event, such as the first or the last time points of FRET events
(Veigel et al., 2002; Stevens et al., 2012). Before averaging, for the
pre-synchronization process, FRET traces were synchronized at the time points of
FRET appearance and were extended after FRET disappearance using the FRET value
of the last time point of FRET event. Similarly, for the post-synchronization process,
FRET traces were synchronized at the time points of FRET disappearance and were
back-extended before FRET appearance using the FRET value of the first time point
of the FRET event.

2.2.7 Quenched-flow experiments
Kinetics of fMetPhe dipeptide formation were measured following previous
procedures (Pan et al., 2008) by mixing IC (1.2 µM) and TC (0.3 µM) containing
[3H]-Phe-tRNAPhe at 25°C on quench-flow machine (KinTek Chemical Quench-Flow
Model RQF-3). Reaction was quenched with 5 M NH4OH at different time points (e.g.
0.01, 0.02, 0.05, 0.1, 0.2, 0.4, 0.5, 0.7. 3, 5, 7, 10, 15, 30, 45, 60 sec). Quenched
samples were lyophilized and resuspended in 500 µl of H2O. 50 µl aliquot from each
sample was scintillation counted as positive control to measure total radioactivity. The
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remaining samples were loaded onto cation exchange resin AG 50W-X8 (bed volume
400 µl) pre-washed with 5× 400 ul of 0.01 M HCl and 5× 400 ul of H2O. Dipeptide
was eluted with 2 ml of H2O. Dipeptide was in both flow-through of sample loading
and elution, and they are combined for scintillation counting determination of
dipeptide. .
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mRNA

marker

Figure 2.1. Electrophoretic analysis of purified mRNA. The gel contains 2% agarose.
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022 MFTI:
GGG AAU UCA AAA AUU UAA AAG UUA ACA GGU AUA CAU ACU AUG
UUU ACG AUU ACU ACG AUC UUC UUC ACU UAA CGC GUC UGC AGG
CAU GCA AGC UAA AAA AAA AAA AAA AAA AAA AAA AAA GCU U

022 CUC:
GGG AAU UCA AAA AUU UAA AAG UUA ACA GGU AUA CAU ACU AUG
CUC ACG AUU ACU ACG AUC UUC UUC ACU UAA CGC GUC UGC AGG
CAU GCA AGC UAA AAA AAA AAA AAA AAA AAA AAA AAA GCU U

MRF:
GGG AAU UCA AAA AUU UAA AAG UUA AUA AGG AUA CAU ACU AUG
CGU UUC UUC CGU UUC UAU CGU UUC

MVYF:
GGG AAU UCA AAA AUU UAA AAG UUA ACA GGU AUA CAU ACU AUG
GUC UAC UUU ACU ACG AUC UUC UUC ACU UAA CGC GUC UGC AGG
CAU GCA AGC UAA AAA AAA AAA AAA AAA AAA AAA AAA GCU U
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MVF:
A GGU AUA CAU ACU AUG GUG UUC CGU AAA UAU UUG CCC GGG CCC
GGG AAAA CCC GGG CCC GGG CCC TT TTT TCT GCA

MKF:
GGG AAU UCA AAA AUU UAA AAG UUA ACA GGU AUA CAU ACU AUG
AAA UUC CGU ACU ACG AUC UUC UUC ACU UAA CGC GUC UGC AGG
CAU GCA AGC UAA AAA AAA AAA AAA AAA AAA AAA AAA GCU U

Figure 2.2. Unmodified mRNA sequence. AUG initiation codons are underlined.
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CHAPTER 3
LABELED EF-TUS FOR RAPID KINETIC STUDIES OF
PRE-TRANSLOCATION COMPLEX FORMATION
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3.1 Abstract
As one of the two universally conserved translation elongation factors, EF-Tu
delivers aminoacyl (aa)-tRNA in the form of a ternary complex (TC) to the ribosome
to decode the codon programmed at the ribosomal A-site. Here, a QSY9 derivative of
E348C-EF-Tu was prepared and shown to be fully functional in translation elongation.
Together with fluorophore derivatives of aa-tRNA and L11, labeled EF-Tu was
utilized for the development of two new assays to study the relative dynamics within
the EF-Tu:L11:tRNA triangle. Our results showed that EF-Tu comes into proximity to
L11 when delivering aa-tRNA to the ribosome, and leaves L11 and releases aa-tRNA
after EF-Tu mediated GTP hydrolysis. These assays were used to examine the effects
of two misreading antibiotics, streptomycin (Str) and paromomycin (Par), on tRNA
selection at the ribosomal A-site in both initial selection and proof-reading stages. It
was also shown that the contacts between T stem-loop of aa-tRNA and EF-Tu have
crucial effects in tRNA release from EF-Tu and accommodation into the A-site.
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3.2 Introduction
EF-Tu is, along with EF-G, one of two G-protein factors that are required for
nascent polypeptide elongation by the prokaryotic 70S ribosome (Kavaliauskas et al.,
2012). These factors are crucial for controlling the speed and accuracy of the
polymerization of amino acids into polypeptides encoded by mRNA. 70S ribosomes
are formed by the association of the 30S and the 50S subunits, within which the
mRNA codon : tRNA anticodon interaction and peptide bond formation occur,
respectively. During an elongation cycle, a tRNA binds sequentially to several sites in
the 70S ribosome. These sites are named according to several major defined locations
within the 30S and the 50S subunits, as follows: A/T, A/A (or just A), A/P, P/P (or just
P), P/E, and E/E (or just E) (Schmeing et al., 2009). In the first elongation cycle,
EF-Tu acts as a chaperone in accelerating the binding of a cognate aa-tRNA, in the
form of a EF-Tu.GTP.aa-tRNA ternary complex (TC), to the ribosomal A/T-site of a
70S initiation complex (70SIC), which contains initiator fMet-tRNAfMet bound in the
P-site. TC binding to the ribosome brings EF-Tu into proximity with ribosomal
protein L11 within the GTPase associated center (GAC) of the 50S subunit, to which
all ribosomal G-proteins bind (Allen et al., 2005). Formation of Watson-Crick base
pairs between the anticodon loop of cognate aa-tRNA and the three-nucleotide codon
sequence in mRNA at the decoding center of the 30S subunit leads to changes in
ribosome conformation and an activation of the EF-Tu GTPase activity. GTP
hydrolysis is followed by Pi release, movement of aa-tRNA from the A/T to the A/A
site, a process also known as “accommodation” into the A-site, peptide bond
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formation between fMet-tRNAfMet and aa-tRNA, and EF-Tu.GDP release from both
peptidyl-tRNA and the ribosome, resulting in pretranslocation (PRE) complex
formation. Structural studies show a dramatic conformational difference between the
GTP- and GDP-bound forms of EF-Tu (Kjeldgaard and Nyborg, 1992; Polekhina et
al., 1996). The antibiotic kirromycin inhibits elongation by "freezing" EF-Tu.GDP on
the ribosome in a GTP-like conformation (Schmeing et al., 2009a).
Selection of the correct isoacceptor tRNA takes place in two steps, one preceding
and one following GTP hydrolysis. During initial selection, all non-cognate and the
major fraction of near-cognate TCs dissociate. After GTP hydrolysis, almost all
remaining near-cognate tRNAs are rejected in the so-called proofreading step; a small
fraction goes forward and participates in peptide bond formation. The selectivity of
the decoding process for cognate tRNA is reduced by aminoglycosides (Vicens and
Westhof, 2003).
Although the movement of tRNA through the ribosome during PRE complex
formation has been extensively studied by kinetic, structural and modeling studies
(Pape et al., 1998; Pan et al., 2007; Schmeing and Ramakrishnan, 2009b), tools
allowing description of the dynamic properties of EF-Tu as it interacts with both the
ribosome and aa-tRNA have heretofore been unavailable. Here we describe the
preparation and utilization of functionally active fluorescent and fluorescence
quencher derivatives of EF-Tu that address this deficiency. In conjunction with either
ribosomes containing fluorescent-labeled L11, or with fluorescent-labeled forms of
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aa-tRNA, these derivatives allow the development of real-time fluorescence
resonance energy transfer (FRET) assays that monitor EF-Tu proximity to L11 (FRET
assay 1) and contact with aa-tRNA (FRET assay 2). These assays, along with a
previously described assay measuring aa-tRNA movement from the A/T-site to the
A-site (Pan et al., 2008) permit us to measure the rates of several key substeps of PRE
complex formation, including i) initial TC interaction with the A/T site, ii) movement
of EF-Tu.GDP away from its initial binding site during accommodation, and iii)
release of EF-Tu.GDP from aa-tRNA. In addition, they allow us to determine how the
rates of these processes are influenced by mechanistically important variables, such as
substitution of near-cognate for cognate mRNA in the presence or absence of
aminoglycoside antibiotics, and the strength of EF-Tu interaction with aa-tRNA.

3.3 Results
3.3.1 Nomenclature
The labeled protein synthesis components employed in this work are named and
described in Table 3.1. QSY9 is an efficient quencher of Cy3 fluorescence.

3.3.2 Probe-labeled EF-Tu variants and their formation of TCs with Phe-tRNAPhe
We chose positions for probe introduction into E. coli EF-Tu based on the
structure of a kirromycin- and paromomycin-stabilized ribosome complex containing
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bound EF-Tu.GDP and aa-tRNA (Protein Data Bank accession codes 2WRN, 2WRO,
2WRQ, and 2WRR) (Figure 3.1). Three EF-Tu residues, K324, G325, and E348
(using E. coli EF-Tu numbering), met the criteria of i) falling within <50 Å of residue
87 in L11 (Chen et al., 2011b) and of residues 16/17 of A/T-bound tRNA (Kaur et al.,
2011); ii) pointing toward solvent, and iii) not being highly conserved (Perla-Kajan et
al., 2010). They were thus suitable for probe introduction via replacement by a Cys
residue and reaction with a QSY9 or Cy3 maleimide derivative.
EF-Tu contains three endogenous Cys residues (C81, C137 and C255), which can
potentially be labeled, possibly leading to decreased EF-Tu functional activity and/or
interference with interpretation of FRET signals. As expected based on lack of
conservation, Cys 137 and Cys 255 could be replaced by Ala or Val, respectively,
without affecting aa-tRNA binding (unpublished from Dr. Darius Kavaliauskas and
Prof. Charlotte R. Knudsen). Efforts to replace Cys 81 consistently led to loss of
EF-Tu activity (unpublished from Dr. Darius Kavaliauskas and Prof. Charlotte R.
Knudsen; also in Figure 3.2B), consistent with a previous study of the functional role
of Cys 81 (Anborgh et al., 1992). In contrast, a more recent study claimed that
aa-tRNA binding to EF-Tu was retained when Cys 81 is replaced by Ala (Laurentiis et
al., 2011). However, in this latter work concentrations of both aa-tRNA and EF-Tu
were in great excess over the dissociation constant, so that even comparatively large
decreases in affinity would not have been detected.
In view of our results, EF-Tu variants containing cysteines at positions K324,
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G325, and E348 were prepared by single mutation of wt-EF-Tu. The Cys at position
324, 325, or 348 was much more reactive toward derivatization than the endogenous
Cys residues. As a result, stoichiometric labeling at these positions could be obtained
with only minor labeling of the endogenous residues (Table 3.2) that was
inconsequential for subsequent EF-Tu:tRNA or EF-Tu:L11 FRET measurements (see
Figures 3.2A and 3.5B).
Two QSY9-labeled derivatives of single EF-Tu variants, E348C-EF-TuQSY9 and
K324C-EF-TuQSY9, showed similar high affinities for Phe-tRNAPhe(Cy3) as measured
by the quenching of Phe-tRNAPhe(Cy3) fluorescence (Figure 3.2A) or protection of
Phe-tRNAPhe(Cy3)

from

hydrolysis

(Figure

3.2B),

and

both

supported

poly(U)-dependent poly(Phe) synthesis by ribosomes to equal extents (Figure 3.2C).
A third QSY9-labeled derivative, G325C-EF-TuQSY9, showed clearly weaker affinity
for Phe-tRNAPhe(Cy3) in the fluorescence quenching assay (Figure 3.3A) and in this
same assay the apparent quenching by E348C-EF-TuQSY9 was greater than by
K324C-EF-TuQSY9. On the basis of these results, E348C-EF-TuQSY9 was selected for
subsequent studies.
Phe-tRNAPhe(Cy3) fluorescence is decreased 82% within the TCs it forms with
E348C-EF-TuQSY9 (Fig. 3.3A). Based on the FRET Ro values for the pairs Cy3/QSY9
(55Å) (Medintz et al., 2003), this decrease corresponds to dye-dye distances of ~ 43 Å
for the TC formed by E348C-EF-TuQSY9, assuming that the dye rotates freely. This
distance is in reasonable accord with an expected distance of 34 Å (Cα,348, EF-Tu; to
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16 N1, tRNA) measured in ternary complexes (Nissen et al., 1999), allowing for some
increase due to the dye dimensions. Measuring the rate of Phe-tRNAPhe(Cy3)
quenching as a function of E348C-EF-TuQSY9 concentration allowed estimation of
kon = 1.3 ± 0.1 µM-1s-1 and koff = 0.17 ± 0.07 s-1 for TC formation (Figure 3.3B),
consistent with previous estimates of the Kd value using unlabeled EF-Tu (Pan et al.,
2008).

3.3.3 Interaction of TCs containing labeled EF-Tu with 70SICs
Rapid mixing in a quenched-flow apparatus of the TC formed from
E348C-EF-TuQSY9.GTP and Phe-tRNAPhe, denoted TCQSY9, with a 70SIC programmed
with mRNA022 MFTI, which has a UUU codon following the AUG initiation codon,
led to an apparent rate constant for fMetPhe-tRNAPhe formation, 4.5 s-1, similar to the
values reported earlier using unlabeled TC and unlabeled 70SIC (Figure 3.4)
(Gromadski and Rodnina, 2004a; Pan et al., 2008). This result demonstrates the
functionality of E348C-labeled EF-Tu in catalyzing dipeptide formation during PRE
complex formation.
We developed two new stopped-flow FRET assays for monitoring TC interaction
with 70SIC in real time. The FRET-1 assay involves rapid mixing of 70SIC
containing Cy3-labeled L11, denoted 70SICCy3, with TCQSY9 (Figure 3.5). Such
mixing results in a biphasic change in Cy3 fluorescence, with an initial decrease
corresponding to TC binding to the ribosome that places EF-Tu position 348 in
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proximity to L11 position 87, followed by a restoration of fluorescence intensity as
these two positions move apart (Figure 3.5B). These changes are completely
dependent on the presence of mRNA, with barely any change observed when mRNA
is omitted.
The FRET-2 assay involves rapid mixing of unlabeled 70SIC with the TCs
formed from Phe-tRNAPhe(Cy3), GTP and E348C-EF-TuQSY9, denoted TCQSY9/Cy3,
which resulted an increase in Cy3 fluorescence (Figure 3.6B), ultimately leading to a
complete loss of FRET interaction between labeled tRNA and labeled EF-Tu (Figure
3.6C). This corresponds most probably to EF-Tu·GDP release from the ribosome.
Although the curves obtained could be adequately fit with single exponentials, in both
cases superior fits were obtained using double exponentials, giving the kapp1 and kapp2
values provided in Table 3.3.

3.3.4 Kirromycin and GTP hydrolysis effects on TC interaction with 70SIC
Perturbing the interaction of TC with 70SIC by adding kirromycin or replacing
GTP with a non-hydrolyzable analogue in both cases has the effect of holding EF-Tu
in proximity to L11, in each case resulting in a stalled ribosome. High resolution
structures of both stalled complexes show similar placements of EF-Tu, although
some differences are seen in the switch 1 and G-domain regions (Schmeing et al.,
2009a; Voorhees et al., 2010). Not unexpectedly, these perturbations display similar
effects in eliminating the second phase of the FRET-1 assay that corresponds to
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moving EF-Tu away from L11 and in forming stalled ribosome complexes having
virtually identical EF-Tu:L11 FRET efficiencies (Figure 3.5B). Other studies
measuring aa-tRNA(A/T site):L11 and tRNA(A/T site):tRNAfMet(P site) FRET
efficiencies have also provided evidence for the structural similarity of stalled
ribosomes formed in the presence of kirromycin- or of a non-hydrolyzable GTP
analogue (Geggier et al., 2010; Lee et al., 2007).
However, the results presented in Figures 3.5 and 3.6 also show some interesting
differences in the two types of stalled complexes: 1) the first phase of the FRET-1
assay proceeds more rapidly when kirromycin is added than when GDPNP replaces
GTP (Figure 3.5B; Table 3.3); 2) more strikingly, while substitution of GDPNP for
GTP completely blocked the increase in Cy3 fluorescence in the FRET-2 assay, a
partial increase of this fluorescence is seen in the presence of added kirromycin,
indicative of a partial separation of EF-Tu from tRNA, monitored at the D-loop of
tRNA, in the absence of EF-Tu separation from L11.

3.3.5 tRNA misreading
The FRET-1 and FRET-2 assays provide convenient measures of the selectivity of
TC binding to 70SIC programmed at the decoding center with cognate (UUU),
near-cognate (CUC), and non-cognate (CGU) codons, and of the ability of
aminoglycoside antibiotics to modulate such selectivity.
As measured in the FRET-1 assay, reaction of TCQSY9 with 70SICCy3 programmed
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with near-cognate CUC leads to a monophasic decrease in Cy3 fluorescence intensity,
which proceeds with a rate constant similar to that found for the first phase of TCQSY9
binding to 70SICCy3 programmed with cognate UUU (Figure 3.7A; Table 3.3). The
magnitude of the intensity drop is somewhat lower than in the cognate case, but it can
be increased by raising the TCQSY9 concentration. However, the second phase of
reaction is strongly inhibited, mimicking the results obtained in the binding of a
cognate TC either in the presence of kirromycin or on substitution of GDPNP for GTP
(Figure 3.5B). These results indicate that near-cognate TC binding closely mirrors that
of cognate TC binding to the A/T site, albeit with somewhat lower affinity, but that
subsequent movement away from the A/T site must be at best very slow, consistent
with conclusions reached in earlier studies (Gromadski et al., 2006). Almost no
change in Cy3 fluorescence is observed with either non-cognate mRNA or when
mRNA is omitted.
TCQSY9/Cy3 reacts more slowly with near-cognate mRNA than with cognate
mRNA programmed 70SICs (FRET-2 assay, Figure 3.7B; Table 3.3), with substantial
decreases in the apparent rate constants for both phases of Cy3 fluorescence increase
(~ 3- and 8-fold, respectively). In addition, although the overall fluorescence change
is similar in both reactions, for the near-cognate programmed 70SIC the amplitudes of
the first and second phases show a large decrease and a large increase, respectively,
with respect to the cognate-programmed 70SIC. The magnitude of the decrease in the
overall rate of fluorescence increase is similar to that seen for the rate of GTPase
hydrolysis measured under comparable conditions (Gromadski et al., 2006). For
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ribosomes programmed with near-cognate mRNA, there is a relatively rapid rise in
Cy3 fluorescence intensity in the FRET-2 assay (Figure 3.7B) in a time period, 0.2 – 3
s, over which there is no change in Cy3 fluorescence in the FRET-1 assay (Figure
3.7A). This indicates that partial movement of aa-tRNA away from EF-Tu can take
place in the absence of any movement of EF-Tu away from L11, paralleling what was
found for cognate-programmed ribosomes in the presence of kirromycin (Figures 3.5
and 3.6).
Addition of the antibiotics streptomycin (Str) or paromomycin (Par), each of
which is known to induce misreading, albeit by different mechanisms (Gromadski and
Rodnina, 2004b), decreases the differences in TC interactions with cognate or
near-cognate programmed 70SIC, as measured in both FRET assays. In the FRET-1
assay, the presence of either antibiotic gives rise to similar biphasic changes in Cy3
fluorescence for ribosomes programmed with either mRNA (Figure 3.7C). Relative to
what is observed for cognate mRNA and near-cognate mRNA in the absence of
antibiotic, the decrease of fluorescence in the first phase is much less pronounced, an
indication that the binding of either antibiotic has the effect of increasing the L11 to
EF-Tu distance within the initial complex formed on TC binding. kapp1 is little affected
by either antibiotic. For cognate-programmed 70SICs, both antibiotics slow kapp2 by
~2-fold (Table 3.3). For near-cognate-programmed 70SICs, both antibiotics restore
the second phase reaction by which EF-Tu moves away from L11, with kapp2 values
~5-fold lower than for cognate-programmed 70SICs in the absence of antibiotic. In
the FRET-2 assay (Figure 3.7D), added Str leads to almost identical Cy3 fluorescence
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increases for near-cognate and cognate programmed 70SICs, reflecting, relative to
cognate programmed 70SICs in the absence of Str, ~2-fold decreases in both apparent
rate constants and a large shift in the relative amplitudes of phases 1 and 2 in favor of
phase 2 (Table 3.3). Added Par has a less effect on the results obtained with cognate
programmed 70SICs, decreasing both kapp1 and kapp2 by ~ 35% without altering the
relative amplitudes of phases 1 and 2, but gives results with near-cognate
programmed 70SICs similar to those obtained with added Str.

3.3.6 Altering EF-Tu:aa-tRNA interaction
Schrader et al. have recently presented results leading to the conclusion that the
affinities of aa-tRNAs for EF-Tu are constrained to be uniform by their need to bind
tightly enough to form the ternary complex but weakly enough to release from EF-Tu
during decoding (Schrader et al., 2011). In this work the affinity of variant tRNAVal2Bs
for EF-Tu was varied by manipulating a portion of the aa-tRNA stem that binds directly
to EF-Tu. Their principal finding was that overall activity, as measured by the rate of
dipeptide formation with a 70SIC, was conserved for variants binding to EF-Tu.GTP up
to 100 times more weakly than wt, but that such activity fell off very quickly for
variants binding to EF-Tu more tightly than wt. Here we re-examine this question at
higher kinetic resolution by examining the influence of aa-tRNA affinity for EF-Tu on
the L11-tRNA interactions measured by the FRET-1 assay, and on movement of
aa-tRNA from the A/T site into the A/A site, as measured by a third assay. In this work
73

we compare measurements on TCs formed by wt Val-tRNAVal2B and two variants,
denoted T1 and Ψ, which bind to EF-Tu.GTP with much higher or slightly lower
affinities compared to wt, respectively (Table 3.4).
We

first

examined

TC

formation.

The

fluorescence

intensity

of

E348C-EF-TuCy3.GTP increases on forming a TC with each of the Val-tRNAVal2B
transcripts examined. The second-order association rate constant for the wt-transcript,
determined by measuring the apparent association rate constant as a function of
E348C-EF-TuCy3 concentration, is 0.74 ± 0.06 µM-1s-1 (Figure 3.8A). A measure of
the dissociation rate constant, equal to 0.039 ± 0.001 s-1, is provided by the rate of
decrease in Cy3 fluorescence when the labeled complex is mixed with a large excess
of unlabeled EF-Tu, under conditions where dissociation of the labeled complex is
rate limiting for formation of unlabeled TC (Figure 3.8B). Similar measurements were
made for the Ψ and T1 variants, giving relative values comparable to those measured
by Schrader et al (Schrader et al., 2009) using a different approach (Table 3.4).
Carrying out the FRET-1 assay with the TC formed by combining
E348C-EF-TuQSY9·GTP

with

wt-Val-tRNAVal2B

transcript

with

a

70SICCy3

programmed with mRNA MVYF gave biphasic changes in Cy3 fluorescence (Figure
3.8C) similar to those displayed in Fig. 3.5B for the TC containing native
Phe-tRNAPhe, with somewhat lower values of kapp1 (14.7 s-1 vs. 26 s-1, respectively)
and kapp2 (4.3 s-1 vs. 6.2 s-1, respectively). The corresponding results for the Ψ variant,
with respect to both fluorescence changes and rates are comparable to those for wt,
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although both rate constants have slightly larger values (Table 3.4). For the T1 variant,
however, both reaction phases are considerably slower, with a significant reduction in
kapp1 (2.7-fold) and a very large reduction in kapp2 (22-fold). The much more
pronounced decrease in Cy3 fluorescence in phase 1 for the T1 variant as compared
with the wt and Ψ variant is due, at least in part, to more complete formation of the
intermediate formed in phase 1 as a result of kapp2 being so much less than kapp1. For
this variant, measurement of kapp1 and kapp2 as a function of TC concentration provides
clear evidence that they approximate actual rate constants for a 2nd order binding step
and a first-order conformational change step, respectively (Figure 3.9). Thus,
tightening aa-tRNA binding to EF-Tu markedly decreases the rate of EF-Tu
movement away from L11 that follows initial TC binding (Table 3.4, kapp2).
Proflavin-labeled fMet-tRNAfMet [denoted fMet-tRNAfMet(prf)] bound in the
P-site of a 70SIC displays a decrease in fluorescence when aa-tRNA bound in the
A/T-site is accommodated into the A-site, providing a convenient tool for measuring
the rate of the accommodation process (Pan et al., 2008). Applying this assay to the
reaction of the TCs formed by the three Val-tRNAVal2B variants with a 70SIC
programmed with mRNA MVYF gave the results shown in Figure 3.8D. Interestingly,
allowing for some differences in experimental conditions, there is fairly close
agreement for the wt and Ψ variants with respect to both the absolute and relative
values of the rate constants for accommodation measured in this work (kaccom) and
those for dipeptide formation (kdipep) measured by Schrader et al. (Schrader et al.,
2011) (Table 3.4), consistent with the prevailing view that peptide bond formation
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proceeds rapidly after accommodation.
However, it is worth noting that whereas the values of kapp2, kaccom and kdipep are
all fairly similar to one another for both the wt and Ψ variants, indicating that for
these variants movement of EF-Tu away from L11, aa-tRNA accommodation and
peptide bond formation occur roughly simultaneously, for the T1 variant
accommodation clearly proceeds significantly faster (3-fold) than the movement of
EF-Tu away from L11. Thus, for this variant, some movement of aa-tRNA toward the
P-site, as measured by the change in fMet-tRNAfMet(prf) fluorescence, precedes the
full accommodation that allows rapid peptide formation, in accord with previous
results demonstrating that movements of the elbow and 3′-end regions of tRNA
during both forward (Whitford, 2010) and reverse (Liu et al., 2010) translocation can
be decoupled from one another.

3.4 Discussion
EF-Tu.GTP acts as a chaperone in accelerating the binding of a cognate aa-tRNA
to the ribosomal A-site during PRE complex formation, and, following GTP
hydrolysis, is released from the ribosome as EF-Tu.GDP. Such release requires the
breaking of strong contacts that EF-Tu makes both with aa-tRNA and with the
ribosomal GAC. Here we demonstrate that EF-Tu variants labeled at position 348
with a fluorescent quencher form functional labeled TCs with wild-type or
fluorescent-labeled wild-type Phe-tRNAPhe and with several unlabeled Val-tRNAVal2B
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variants. We use such labeled TCs to develop two new FRET assays that provide tools
for determining the dynamics, during PRE complex formation, of distance changes
between EF-Tu and both ribosomal protein L11, located within the GAC (FRET-1
assay), and aa-tRNA (FRET-2 assay). Application of these assays, in conjunction with
related measurements, has led to several new mechanistic insights concerning the
details of PRE complex formation, as well as demonstrating the potential that such
assays have for high throughput screens of protein synthesis inhibitors.
The first insight concerns the order in which EF-Tu breaks its contacts to the
GAC and to aa-tRNA. Our results, as summarized in Table 3.3, indicate that,
following cognate TC binding to the 70SIC leading to PRE complex formation,
movement of EF-Tu away from L11, and presumably therefore from the GAC, as
measured by kapp2 in FRET-1 assay, consistently proceeds somewhat faster (1.5 –
3-fold) than movement of EF-Tu away from aa-tRNA, as measured by kapp1 in
FRET-2 assay. This inequality is found in the absence or presence of the antibiotics
Str or Par. It is also seen for near-cognate TC in the presence of Par, although for
near-cognate TC in the presence of Str, the two apparent rate constants are equal.
These results indicate that movement of EF-Tu away from the GAC generally
precedes movement of EF-Tu away from aa-tRNA, and that, given the relatively
small differences in the values of the two rate constants, the second step follows
rapidly after the first. However, it is also possible for EF-Tu to move away from
aa-tRNA when EF-Tu is constrained to remain in close proximity to L11, as when
70SIC is combined with either cognate TC in the presence of kirromycin (Figsures 3.5
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and 3.6) or with near-cognate TC in the absence of antibiotic (Figures 3.7A–B). Such
movement may require GTP hydrolysis, since it is not observed when EF-Tu is
constrained to remain in close proximity to L11 by replacing GTP with GDPNP
(Figures 3.5 and 3.6). Thus, under certain circumstances, GTPase-dependent
movement of EF-Tu away from aa-tRNA could precede movement of EF-Tu away
from the GAC during PRE complex formation.
The second insight concerns the effects of strengthening the binding of aa-tRNA
to EF-Tu via mutation of the T-stem (Table 3.4). Comparing the wt and Ψ variants of
Val-tRNAVal2B, which have comparable binding affinities for EF-Tu, the values of
each of the rate constants kapp2 (FRET-1 assay), kaccorm and kdipep are quite similar to
one another. Furthermore, for each of these variants, all three of these rate constants
have similar values, indicating that for both variants, the movements of EF-Tu away
from L11 and of aa-tRNA from the A/T site to the A/A site, and peptide bond
formation occur roughly simultaneously. The situation is quite different for the T1
variant of Val-tRNAVal2B, which binds to EF-Tu considerably more tightly than the
other two variants. This variant was previously shown to also have a markedly
decreased rate of dipeptide formation (Table 3.4, kdipep). Here we show that this
decreased rate is likely a consequence of decreases in the rates of two distinct
processes that precede dipeptide formation, the movement of aa-tRNA from the A/T
site to the A/A site (kaccorm), and the movement of EF-Tu away from L11 (kapp2). Based
on the similarities in the values of kapp2 and kdipep (Table 3.4), this latter movement
may be rate limiting for dipeptide formation. The >20-fold reduction of kapp2 for the
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T1 variant (Table 3.4) likely reflects an allosteric effect transmitted through the EF-Tu
structure, since the region of EF-Tu that interacts with the GAC is far removed from
the region of EF-Tu that interacts with the tRNA T-stem (Schmeing et al., 2009a;
Voorhees et al., 2010). The T1 variant also differs from wt and Ψ variants in having a
kaccorm that is substantially (3-fold) greater than kapp2, indicating that movement of
aa-tRNA toward the P-site precedes the full accommodation of aa-tRNA into the A/A
site that allows rapid peptide bond formation. This is in accord with previous results
demonstrating that movement of the flexible 3’-end region of ribosome-bound tRNA
can be kinetically decoupled from movement of the rest of the tRNA molecule (Liu et
al., 2010; Liu et al., 2011).
The third insight concerns the function of ribosomal protein L11. L11 is
encompassed by L7/L12 stalk consisting of L7/L12 protein and 23S rRNA, and
together with a 58-nucleotide stretch of 23S rRNA, forms GAC for the GTPase
activation of all translational GTPase, including EF-Tu. The 70S ribosome lacking
L11 maintains considerable activity in protein synthesis (Rosenblum et al., 2012), but
the specific function of L11 remains elusive. Previous studies indicated that TC
initially binds to the ribosome at L7/L12 stalk and then at A/T site with EF-Tu
contacting both aa-tRNA and GAC on the 50S subunit (Sheiming et al., 2009a). Very
recently, Wang et al. showed that TC binding to the ribosome brings EF-Tu in close
proximity to L11 N-terminal region, and some residues from domain I and domain III
of EF-Tu (Arg117, Lys121, Tyr310 and Lys312), functioning together as a
peptdyl-prolyl cis-trans isomerase, catalyze the configuration change at Pro22 of L11,
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which then bring the L11 N-terminal region into a conformation contacting L12
C-terminal region (Wang et al., 2013). Our results confirm the EF-Tu:L11 proximity
upon TC binding and implicate that EF-Tu movement away from L11 has close
correlation with tRNA selection and accommodation, possibly through proper L11
configuration and L11:L12 contacts. During cognate tRNA binding, EF-Tu:L11
separation may occur in a time scale prior to EF-Tu:tRNA separation, whereas,
near-cognate tRNA binding leads to EF-Tu:tRNA separation before observable EF-Tu
movement away from L11. Binding of antibiotics that promote near-cognate tRNA
accommodation alters the patterns of EF-Tu:L11 proximity upon both cognate and
near-cognate tRNA binding and blurs their differences in the absence of antibiotic.
Moreover, a tighter EF-Tu:tRNA binding slows down tRNA accommodation, as well
as EF-Tu:L11 separation. A possible explanation for all these observations is that
cognate mRNA:tRNA base paring in the DC of the 30S subunit put EF-Tu in a proper
position that triggers L11 configuration change and L11:L12 interaction, which
subsequently induces relatively fast GTPase activation and GTP hydrolysis on EF-Tu,
and tRNA accommodation and EF-Tu release from the ribosome reverse the L11
configuration change and break L11:L12 contacts. In contrast, near-cognate tRNA
binding places EF-Tu only in proximity to L11 but not in a position required for L11
configuration change and GTPase hydrolysis, therefore EF-Tu mediated GTP
hydrolysis is significantly slowed down.
The fourth insight concerns step-wise tRNA accommodation. The tertiary
structure of tRNA in L shape consists of four regions: acceptor stem-arm, D stem-loop,
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T stem-loop and anticodon stem-loop. On binding at the A/T site of the ribosome in
the form of TC, tRNA interacts with EF-Tu though its 3’-end and T-stem and mRNA
with its anticodon; thus D stem-loop is the only region that has no contacts with the
surroundings at all. During accommodation, tRNA relieves its distortion in the A/T
state with the anticodon maintaining its base pairing with mRNA codon and the
acceptor end, together with D and T stem-loop, fully entering the A-site on the 50S
subunit. Whitford et al. suggested that tRNA accommodation is a step-wise process,
with D stem-loop accommodated prior to 3’-end by using theoretical calculations
(Whitford et al., 2010). Previous results from our lab also indicated that, during EF4
catalyzed back-translocation, the movement of different tRNA regions was decoupled.
The results reported here provide further clues for the step-wise tRNA movement on
the ribosome. The presence of antibiotic kirromycin allows GTPase activation and
GTP hydrolysis but freezes EF-Tu in a GTP-bound form on the ribosome. Our results
show that, although full tRNA release from EF-Tu is inhibited, tRNA D-stem, where a
fluorophore was placed in our experimental setup, can still step into its
accommodation site, which is reflected by the Cy3 fluorescence release in the
EF-Tu:tRNA FRET experiment (Figure 3.6B). Additional evidence comes from the
fact that D-stem movement to the A-site could be probed with fMet-tRNAfMet (prf)
programmed at the ribosomal P-site faster than EF-Tu:L11 separation and dipeptide
formation (Table 3.4), which were all slowed down by the nucleotide mutation at
tRNA T-stem. It is unclear whether this decoupled movement of tRNA has any
functional implications.
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The FRET-1 and FRET-2 assays provide convenient measures of the selectivity of
TC binding to 70SIC programmed at the decoding center with cognate (UUU),
near-cognate (CUC), and non-cognate (CGU) codons, and of the ability of
aminoglycoside antibiotics to modulate such selectivity. The effects of substituting
near-cognate- for cognate-programmed 70SIC on reaction with TC, and the Str and
Par modulation of these effects, as measured using the FRET-1 and FRET-2 assays,
are, with one caveat, in generally good agreement with those derived from earlier
studies

using

different

assays

(binding

of

fluorescent-labeled

tRNA,

ribosome-dependent EF-Tu GTPase, dipeptide formation) in showing similar but
weaker binding of the near-cognate vs. cognate TC to the 70SIC, and in the lower
overall rate of aa-tRNA separation from EF-Tu that parallels the lower rate of
ribosome-dependent EF-Tu GTPase (Gromadski and Rodnina, 2004a; Gromadski et
al., 2006). Str and Par have previously been characterized as misreading-inducing
antibiotics that act either by slowing cognate 70SIC reaction and speeding up
near-cognate 70SIC reaction, such that the kinetic behavior of both complexes
becomes quite similar (Str) (Gromadski and Rodnina, 2004b; Cochella et al., 2007),
or by selectively speeding near-cognate reaction while having only a minor effect on
cognate reaction (Par) (Pape et al., 2000; Cochella et al., 2007). The Str effects
measured in the FRET-1 and FRET-2 assays and the Par effects measured in the
FRET-2 assay support such characterization. The caveat concerns the Par effect in the
FRET-1 assay in significantly slowing cognate reaction (phase 2). Based on the lower
FRET efficiency of cognate complexes formed in the presence of either antibiotic
82

(Figure 3.7A), we speculate that this result may be due to propagation of Str- and
Par-induced structural changes at the decoding center in the 30S subunit (Demirci et
al., 2013) through the ribosome structure that results in a distancing of the labeled
positions in EF-Tu and L11 when TC binds to the ribosome. Such structural changes
need not necessarily affect either GTPase or dipeptide formation activities.
Notwithstanding this caveat, it is clear that the fluorescence changes seen in the
FRET-1 and FRET-2 assays make them desirable candidates as high throughput
assays for screening new misreading-inducing antibiotics. The FRET-2 assay is likely
to be superior for this purpose for two reasons. First, fluorescence increases
monotonically as a function of time, eliminating the need for millisecond time
resolution, and second, it is less subject to potential complications arising from
antibiotic-induced changes in ribosome conformation.

3.5 Conclusions
Functional EF-Tu variants labeled with a fluorescent quencher were prepared and
found capable of forming TCs with wild-type or labeled Phe-tRNAPhe with stabilities
equivalent to that of the wild-type ternary complex. Subsequently, the labeled EF-Tu
variant was utilized for studying the EF-Tu dynamics relative to ribosomal protein
L11 and aa-tRNA during PRE complex formation. In addition, the effects on PRE
complex formation of antibiotics, of substituting near-cognate for cognate tRNA, and
of manipulating the EF-Tu:tRNA interface were investigated.
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Kirromycin and GDPNP fix EF-Tu relative to L11, as expected. In contrast, a
partial rearrangement of aa-tRNA relative to EF-Tu is observed in the presence of
kirromycin. The binding of a near-cognate TC to the A/T site resembles that of
cognate TC binding, while the subsequent movement away from the A/T site is very
slow for the near-cognate TC. The antibiotics streptomycin and paromomycin blur the
distinction between cognate and near-cognate codon:anticodon interactions. This
appears to be the case during both initial binding and proofreading. Altering of the
EF-Tu·tRNA interface via mutation within the tRNA T-stem shows that an increase in
the strength of this interaction decreases the rate of EF-Tu movement away from L11.
This movement occurs after at least partial aa-tRNA accommodation, and may be
rate-limiting for subsequent dipeptide formation.
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Table 3.1. Labeled protein synthesis components.

Labeled Component

Description

E348C-EF-TuQSY9

E348C variant of wt-EF-Tu labeled with QSY9

E348C-EF-TuCy3

E348C variant of wt-EF-Tu labeled with Cy3

K324C-EF-TuQSY9

K324C variant of wt-EF-Tu labeled with QSY9

G325C-EF-TuQSY9

G325C variant of wt-EF-Tu labeled with QSY9

Phe-tRNAPhe(Cy3)

Yeast Phe-tRNAPhe labeled at positions 16/17 with Cy3

fMet-tRNAfMet(prf)

E. coli fMet-tRNAfMet labeled at position 20 with proflavin

TCQSY9

TC containing E348C-EF-TuQSY9.GTP and Phe-tRNAPhe

TC QSY9/Cy3

TC containing E348C-EF-TuQSY9.GTP and Phe-tRNAPhe(Cy3)

TCCy3

TC containing EF-Tu.GTP and Phe-tRNAPhe(Cy3)

70SICCy3

70S initiation complex made
C38S/S87C-L11 labeled with Cy3
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with

ribosomes

containing

Table 3.2. Labeling stoichiometries of EF-Tu variantsa.

EF-Tu variant

Label/EF-Tu

wt

0.5 QSY9
0.4 Cy5

K324C

1.6 QSY9

G325C

1.8 QSY9

E348C

1.5 QSY9
1.4 Cy3

a

Labeling conditions as described in Chapter II.
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Table 3.3. Kinetic parameters for EF-Tu:L11 or EF-Tu:tRNA FRET
experiments.

Figure

and

conditions

kapp1, s-1

kapp2, s-1

Relative

Relative

A1

A2

a

Samples

70SICCy3(0.1)

Standard

26 ± 4

6.2 ± 0.3

(-1.0 ± 0.2)d

1.0 ± 0.2

+TCQSY9(0.4)

+kirrob

35 ± 1

3.0 ± 0.7

-0.8 ± 0.1

-0.8 ± 0.2

GDPNPc

5.1 ± 0.2

–

-0.7 ± 0.1

–

70SIC (0.4)

Standard

2.1 ± 0.3

0.31 ± 0.05

(1.0 ± 0.2)

0.7± 0.1

+ TC QSY9/Cy3(0.1)

+kirro

5.1 ± 0.8

1.1 ± 0.2

0.3 ± 0.1

0.5± 0.1

Coge

26 ± 4

6.2 ± 0.3

(-1.0 ± 0.2)

1.0 ± 0.2

NCog

24 ± 6

–

-0.4± 0.1

–

NCog (1.0)f

22 ± 6

–

-1.0± 0.3

–

Cog + Str

22 ± 2

3.0 ± 0.2

-0.3± 0.1

0.2 ± 0.1

Cog + Par

17 ± 3

2.5 ± 0.1

-0.4± 0.1

0.3 ± 0.1

NCog + Str

32 ± 1

1.0 ± 0.3

-0.2± 0.1

0.2 ± 0.1

NCog + Par

23 ± 2

1.6 ± 0.4

-0.3± 0.1

0.2 ± 0.1

2.1 ± 0.3

0.31 ± 0.05

(1.0 ± 0.2)

0.7 ± 0.1

0.74 ± 0.02

0.04 ± 0.01

0.3± 0.1

1.6 ± 0.1

0.13 ± 0.02

0.4± 0.2

1.0 ± 0.3

0.22 ± 0.01

1.0± 0.1

0.8 ± 0.1

0.15 ± 0.04

0.4± 0.2

1.0 ± 0.2

0.15 ± 0.06

0.4± 0.2

0.8 ± 0.2

70SICCy3
QSY9

TC

(0.1)

(0.4)

+

70SIC (0.4)

Cog

+ TCQSY9/Cy3(0.1)

NCog
Cog + Str
Cog + Par
NCog + Str
NCog + Par

0.94 ± 0.04
1.4 ± 0.1
1.1 ± 0.3
0.89 ± 0.10
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a

Numbers in parentheses are final concentrations in µM. All antibiotics had final
concentrations of 100 µM. Average ± average deviation, 2–4 independent
determinations, except as otherwise indicated
b

Antibiotic abbreviations: kirro, kirromycin; Str, streptomycin; Par, paromomycin

c

GDPNP substituted for GTP in TC

d

Normalized value. All amplitudes are normalized to A1 of standard (cognate)
experiment
e

mRNA abbreviations: Cog, cognate; NCog, near cognate

f

1 µM TC was used in this experiment. The lack of dependence of kapp1 on TC
concentration suggests that phase 1 includes a reversible step following binding, in
agreement with Pape et al. (1998).
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Table 3.4. Thermodynamic and kinetic parameters for tRNAVal2B variants.

tRNAVal2B
varianta


wt

T1

Ψ

UAA

UGC
GCG

UUC
GGG

GUU
b

constant

a

TC, rel Kdc

1.0 ± 0.8

0.16 ± 0.12

1.8 ± 0.7

TC, rel. kdc

1.00 ±
0.31

0.15 ± 0.04

1.7 ± 0.4

TC, rel. kdd

1.00 ±
0.05

0.085 ±
0.003

1.4 ± 0.1

70SICCy3e
+
QSY9
-1
TC
, kapp1, s

14.7 ± 0.7

5.8 ± 0.4

19.0 ± 0.7

70SICCy3
+
TCQSY9, kapp2, s-1

4.3 ± 0.5

0.20 ± 0.01

5.1 ± 1.1

kaccom, s-1

7.2 ± 0.1

0.6 ± 0.2

5.5 ± 1.1

kdipepf, s-1

4.5 ± 0.7

0.32 ± 0.02

4.5 ± 0.8

Sequences show portion of T-loop stem: top line: nts 65–63; bottom line: nts 49-51

b

Values are from this work, measured at 25 oC, unless otherwise specified.
Measurements were generally performed in duplicate, with average deviations
indicated.
c

Kd and kd, equilibrium and dissociation rate constants, 4 oC. Values for wt are 1.2 ×
10-8 M and 0.0013 s-1, respectively (Schrader et al., 2011).
d

This work. Value for wt is 0.039 s-1. The increase of ~30-fold from the value
measured at 4 oC is consistent with the high ΔH† for this reaction reported in Schrader
et al. 2011 (Schrader et al., 2011).
e

This 70SIC has the cognate codon for tRNAVal2B, GUC, in the A-site.

f

20 oC, Schrader et al. 2011.
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tRNACy3
36.4 Å
39.0 Å
40.4 Å
EF-TuQSY9

L11Cy3

Figure 3.1. Distances within EF-Tu:L11:aa-tRNA triangle. These distances are
between residue numbers 348 (Cα, EF-Tu), 87 (Cα, L11) and 16 (N-1,
aminoacyl-tRNA) in a kirromycin- and paromomycin- stabilized ribosome complex
with Thr-tRNAThr bound in the A/T site. In this chapter, EF-Tu at position 348, L11 at
position 87 and aa-tRNA at positions 16/17 are labeled with QSY9, Cy3 and Cy3,
respectively. Protein Data Bank accession codes 2WRN, 2WRO, 2WRQ, and 2WRR.
This figure is adapted from (Cooperman et al., 2011).
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Figure 3.2. Characterization of ternary complexes (TCs) formed by labeled EF-Tus. A.
Quenching of the fluorescence of Phe-tRNAPhe (Cy3), 0.17 µM, by QSY9 derivatives
of K324C-EF-Tu, G325C-EF-Tu, or E348C-EF-Tu or by free QSY9. No quenching is
seen with wt-EF-Tu labeled at a background level with QSY9. B. Protection of
[3H]-Phe-tRNAPhe or [3H]-Phe-tRNAPhe (Cy3) (0.10 – 0.15 µM) from RNase A
hydrolysis by variant EF-Tus and as well as QSY9 derivatives of K324C-EF-Tu and
E348C-EF-Tu. EF-Tu variants containing cysteines at possible positions K324, G325
and E348 were prepared by 1) single mutation of wt-EF-Tu; 2) two further mutations
at position C81 and C137 (denoted K324C-EF-TuSA, G325C-EF-TuSA and
E348C-EF-TuSA); 3) three further mutations at position C81, C137 and C255 (denoted
K324C-EF-TuSAV, G325C-EF-TuSAV and E348C-EF-TuSAV, respectively). C.Relative
poly(U)-dependent polyPhe activity using different EF-Tus.
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Figure 3.3. FRET in TCs formed from E348C-EF-TuQSY9 variants and
Phe-tRNAPhe(Cy3). A. Quenching of the fluorescence of [3H]-Phe-tRNAPhe (Cy3) by
E348C-EF-TuQSY9 in a purified TC (0.05 µM). B. Kinetics of quenching of
Phe-tRNAPhe(Cy3) (0.1 µM) fluorescence following rapid mixing with various
concentrations of E348C-EF-TuQSY9. A plot of kapp vs. EF-Tu gives a kon value of 1.3 ±
0.1 µM-1s-1 and koff value of 0.17 ± 0.07 s-1.
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Figure 3.4. Dipeptide formation of E348C-EF-TuQSY9. Dipeptide is formed by mixing
TC formed from E348C-EF-TuQSY9.GTP and Phe-tRNAPhe, denoted TCQSY9 (0.3 µM
final concentration), with a 70SIC (1.2 µM final concentration). Solid lines are single
exponential results.
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Figure 3.5. Labeled TC interaction with 70SICCy3. A. Cartoon showing placement of
labels. Cy3 fluorescence intensity decreases on TCQSY9 binding to the A/T-site and
increases on accommodation of tRNA into the A-site. B. Changes of 70SICCy3
fluorescence on rapid mixing with TCQSY9 (black); in the presence of kirromycin
(precombined with 70SICCy3, red); with GDPNP in place of GTP (green). Very little
change in fluorescence is seen with wt-EF-Tu labeled at a background level with
QSY9 (light blue) or when mRNA is omitted (dark blue). Final concentrations were:
70SICCy3, 0.1 µM; TCs, 0.4 µM; kirromycin, 100 µM; GDPNP, 250 µM.
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Figure 3.6. Interaction of double-labeled TC with 70SIC. A. Cartoon showing
placement of labels. A Cy3 fluorescence intensity increase occurs on EF-Tu
dissociation from the ribosome. B. TCQSY9/Cy3 (0.1 µM) was rapidly mixed with 70SIC
(0.4 µM) and Cy3 fluorescence was monitored (black); in the presence of kirromycin
(precombined with 70SIC, red); with GDPNP in place of GTP (green). When GDPNP
replaced GTP, adding kirromycin had no effect (data not shown). C. Complete loss of
fluorescence quenching due to FRET on rapid mixing of TCQSY9/Cy3 (0.1 µM) and
70SIC (0.4 µM) in a stopped-flow spectrofluorometer, as shown by an increase in
Cy3 fluorescence (black) on EF-Tu release from the ribosome. The red trace is a
control showing that rapid mixing of TCCy3 (0.1 µM) and 70SIC (0.4 µM), for which
there is no FRET, gives a nearly constant fluorescence equal to the final fluorescence
seen in the black trace.
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Figure 3.7. Transfer RNA selection and antibiotic effects. tRNA selectivity
demonstrated by A. TCQSY9 effects on the fluorescence of 70SICCy3 or B. by 70SIC
effects on the fluorescence of TCQSY9/Cy3. Cognate mRNA (UUU, black); near-cognate
mRNA (CUC, red); near-cognate mRNA, high TC concentration (CUC, cyan);
non-cognate mRNA (CGU, green); -mRNA (blue). Parts C and D repeat the assays
shown in A and B, respectively in the presence of aminoglycoside antibiotics. Cognate
mRNA, no antibiotic (black); cognate mRNA, Str (green); cognate mRNA, Par
(blue); near-cognate mRNA, no antibiotic (red); near-cognate mRNA, Str (cyan);
near-cognate mRNA, Par (lavender). Final concentrations: 70SICCy3 in A, 0.1 µM;
70SIC in B, 0.4 µM; TCQSY9 in A, 0.4 µM, high concentration, 1.0 µM; TCQSY9/Cy3 in
B, 0.1 µM; Str, 100 µM; Par, 100 µM.
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Figure 3.8. Effects of tRNAVal2B mutation. A. TC formation. Increase in
E348C-EF-TuCy3·GTP (0.4 µM) fluorescence intensity on rapid mixing with
wt-Val-tRNAVal2B (0.1 µM) (Black line). Inset shows kapp dependence on
E348C-EF-TuCy3.GTP concentration. Wt-EF-Tu labeled to background levels showed
no fluorescence change (red line). B. TC dissociation. The dissociation of
E348C-EF-TuCy3.GTP.Val-tRNAVal2B (formed by premixing of 0.4 µM of labeled
EF-Tu and 0.1 µM of Val-tRNAVal2B), observed as a decrease in Cy3 fluorescence
intensity on rapid mixing with excess (8 µM) unlabeled EF-Tu. C. FRET with L11.
Changes of 70SICCy3 (0.1 µM) fluorescence on rapid mixing with TCs formed by
combination E348C-EF-TuQSY9.GTP (1.6 µM) with various Val-tRNAVal2B variants
(0.4 µM). D. Movement of Val-tRNAVal2B from the A/T position. Monitored as a
change in proflavin fluorescence intensity on rapid mixing of unlabeled Val TCs (0.4
µM) with 70SIC (0.1 µM) containing fMet-tRNAfMet(prf). All concentrations are final
after rapid mixing.
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Figure 3.9. Concentration dependent EF-Tu:L11 FRET of tightly coupled ternary
complex. Dependence of the apparent rate constants, kapp1 and kapp2, measuring
changes in 70SICCy3 (0.1 µM) fluorescence, on rapid mixing with varying
concentrations of the TC formed from E348C-EF-TuQSY9.GTP and the Val-tRNAVal2B
T1 variant. Values are normalized to those found at 0.4 µM TC.
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CHAPTER 4
EF-TU DYNAMICS DURING PRE-TRANSLOCATION
COMPLEX FORMATION: EF-TU.GDP DISSOCIATES VIA TWO
DIFFERENT PATHWAYS
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4.1 Abstract
During the first elongation cycle of protein synthesis, aa-tRNA having an
anticodon cognate to the codon programmed at the ribosomal A-site binds to the
70SIC via a TC, resulting in PRE complex formation. Fluorophore or fluorescence
quencher labels placed on L11, EF-Tu and aa-tRNA form an approximately
equilateral triangle within the ribosomal complex prior to accommodation, with their
distances appropriate for FRET studies. Here we combine time-dependent ensemble
and single-molecule FRET (smFRET) measurements of this triangle during PRE
complex formation with parallel ensemble assays measuring the rates of Pi release and
of accommodation. Our results suggest that Pi release, EF-Tu separation from L11 and
aa-tRNA accommodation occur in concert and all proceed prior to EF-Tu release from
aa-tRNA and the ribosome. Moreover, EF-Tu release can occur prior to the EF-Tu
conformational change, possibly from GTP to GDP bound form after GTP hydrolysis,
or either concomitant with or following such conformational change. Our results
provide direct real-time insights into the dynamics of EF-Tu during tRNA selection
and accommodation and the timing and possible pathways of EF-Tu release from
aa-tRNA and the ribosome.
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4.2 Introduction
Protein biosynthesis on the ribosome, also called translation, requires the
participation of various translational factors during each of its three stages: IF1–3 for
initiation, EF-Tu and EF-G for elongation, and RF1–3 and RRF for termination and
ribosome recycling. After the formation of 70SIC with fMet-tRNAfMet programmed at
the P-site and an empty A-site, aa-tRNA is delivered to the ribosome in the form of
TC formed with EF-Tu.GTP (Pape et al., 1998). The signal of cognate mRNA:tRNA
base pairing at the DC of the 30S subunit is transduced to the GAC of the 50S subunit
and activates EF-Tu GTPase activity (Voorhees et al., 2010). GTP hydrolysis on
EF-Tu is followed by Pi release, aa-tRNA accommodation into the A-site, EF-Tu
conformational change as a result of GTP hydrolysis to form GDP, peptide bond
formation, and, finally, EF-Tu.GDP dissociation from the ribosome, resulting in PRE
complex formation (Rodnina and Wintermyer, 1995b; Pape et al., 1998).
Translocation of fMet-aa-tRNA from the A-site to the P-site, along with the mRNA
codon to which it is bound, a reaction catalyzed by EF-G.GTP, completes the first
elongation cycle (Valle et al., 2003b; Frank and Gonzalez, 2010; Chen et al., 2011a).
This opens up the A-site for the binding of the next cognate TC, which initiates the
next elongation cycle.
Although the movement of tRNA through the ribosome during PRE complex
formation has been extensively studied by kinetic, structural and modeling studies
(Pape et al., 1998; Pan et al., 2007; Schmeing and Ramakrishnan, 2009b), very little is
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known about the dynamics of EF-Tu interaction with either the ribosome or aa-tRNA
during this process, including the timing of the major conformational change in EF-Tu
that accompanies conversion of EF-Tu.GTP to EF-Tu.GDP (Kjeldgaard and Nyborg,
1992; Polekhina et al., 1996), and the interplay between EF-Tu and EF-G during their
repetitive recruitments to the ribosome in the elongation stage. In Chapter III, two
assays, based on functional derivatives of EF-Tu, were developed to investigate
relative movements in the EF-Tu:L11:tRNA triangle during tRNA selection at the
ribosomal A-site. Here we use these assays, in both ensemble and single molecule
format, together with other assays measuring TC interaction with 70SIC, to formulate
a quantitative kinetic scheme describing EF-Tu dynamics during PRE complex
formation. Our results indicate that EF-Tu moves away from L11 in concert with Pi
release and tRNA accommodation, but prior to releasing its hold on aa-tRNA, and that
EF-Tu.GDP can dissociate from the ribosome by two different pathways, one more
rapid but readily reversible, while the slower pathway proceeds essentially
irreversibly. They also lead to the suggestion that the rapid and slower pathways
correspond to EF-Tu.GDP dissociation from the ribosome occurring prior to or
accompanying the major conformational change in EF-Tu, respectively.

4.3 Results
4.3.1 Labeled component nomenclature
Labeled initiation complexes, denoted 70SICCy3 or 70SICCy5, contained protein
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L11 labeled at position 87 with Cy3 or Cy5, respectively. EF-Tu derivatives, denoted
E348C-EF-TuQSY9 and E348C-EF-TuCy3, were labeled at a Cys residue introduced by
site-directed mutagenesis at position 348 by reaction of E348C-EF-Tu with the
maleimide derivatives of the quencher QSY9 and the fluorophore Cy3, respectively.
tRNAs labeled at dihydrouridine positions are denoted Phe-tRNAPhe(Cy3) and
fMet-tRNAfMet (prf), where prf is an abbreviation for proflavin. Labeled TCs were
prepared from labeled EF-Tu derivatives and either unlabeled Phe-tRNAPhe or
Phe-tRNAPhe(Cy3), and named as indicated in Table 4.1.

4.3.2 Ensemble experiments
Rapid mixing in a stopped-flow spectrofluorometer of TCQSY9 with a 70SICCy3
programmed with mRNA022 MFTI, which has a UUU codon following the AUG
initiation codon, leads to a biphasic change in Cy3 fluorescence, with an initial
decrease corresponding to TC binding to the ribosome that places EF-Tu position 348
in proximity to L11 position 87, followed by a restoration of fluorescence intensity as
these two positions move apart. In Figure 4.1, we compare, all as a function of TCQSY9
concentration, rates of fluorescence change on rapid mixing of TCQSY9 and 70SICCy3
as measured by: biphasic changes in Cy3 fluorescence (Figure 4.1A), increases in
MDCC-labeled phosphate binding protein (MDCC-PBP) fluorescence on binding of
released Pi (Figure 4.1B) (Pan et al., 2006), and decreases in P-site bound
fMet-tRNAfMet(prf) fluorescence (Figure 4.1C), which measures accommodation of
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aa-tRNA into the A-site (Pan et al., 2007). Fitting of the Cy3 fluorescence change to
Equation 2.2 demonstrates that kapp1 increases linearly with TCQSY9 concentration
whereas kapp2 is largely independent of TCQSY9 concentration (Figure 4.1D),
corresponding to a binding step and a following conformational rearrangement step,
respectively. The results in Figure 4.1A were obtained using 70SICCy3 containing
fMet-tRNAfMet(prf) in the absence of MDCC-PBP. Quantitatively similar results were
obtained using unlabeled fMet-tRNAfMet or in the presence of MDCC-PBP (Figure
4.2).
Both of the signal traces of fluorescent PBP and fMet-tRNAfMet(prf) show
essentially monophasic changes, giving kapp values at various TCQSY9 concentrations,
when fitted with Equation 2.1, that are in close agreement with each other and are
approximately equal to the values of the overall rates of EF-Tu separation from L11
[given by kapp1kapp2 /(kapp1 + kapp2)] measured in the reaction of TCQSY9 with 70SICCy3
(Figure 4.1D). These results indicate that EF-Tu separation from L11, Pi release and
aa-tRNA accommodation occur approximately in concert under the conditions
employed in our experiments.
In parallel experiments, the rate of increase in Cy3 fluorescence as a function of
70SIC concentration on rapid mixing of TCQSY9/Cy3 with 70SIC made with
fMet-tRNAfMet(prf) (Figure 4.3A), measuring EF-Tu release from aa-tRNA, was
compared directly with the rate of aa-tRNA accommodation (Figure 4.3B) measured
as above by fitting each set of results to Equation 2.1 (Figure 4.3C). The values of kapp
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for accommodation measured in this experiment are quite similar to those measured in
Figures 4.1C–D but are ~1.7-fold greater than the values of kapp measured for EF-Tu
release from aa-tRNA (Figure 4.3C). Since accommodation occurs in concert with
EF-Tu separation from L11 (Figure 4.1D), the difference in the rate constants
presented in Figure 4.3C provides strong evidence that, as measured by ensemble
reactions, ribosome-bound EF-Tu separates from L11 prior to its release from
aa-tRNA. Importantly, simultaneous rapid mixing of both EF-G.GTP and TCQSY9/Cy3
with 70SIC, while having no effect on kapp for accommodation, increases the value of
kapp for EF-Tu:tRNA separation (Figure 4.3D), nearly abolishing the gap between the
two kapp values. Direct comparison in the presence and absence of a saturating
concentration of EF-G.GTP (4 µM) of the rates of EF-Tu:tRNA separation and tRNA
accommodation as a function of 70SIC shows that added EF-G consistently increased
the rate of EF-Tu:tRNA separation while having only a negligible effect on the rate of
tRNA accomodation (Fig. 4.3E; Table 4.2).

4.3.3 Single molecule FRET studies of PRE complex formation
PRE complex formation using labeled TCs was further examined by smFRET,
using a total internal reflection fluorescence (TIRF) microscope as described earlier
(Chen et al., 2011a, b). PRE complex formation was monitored by addition of either
TCCy3 or TCCy3/Cy5 to immobilized 70SICCy5 (Figure 4.4A) or unlabeled 70SIC (Figure
4.4B), respectively. The results in both cases are very similar to one another, both
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showing single FRET states over the entire duration of the FRET signal, as
demonstrated by analysis of both FRET probability density plots (Figures 4.4C–D)
and synchronized FRET traces (Figures 4.5A–B, and D–E) (Chen et al., 2012), with
efficiencies equal to 0.90 ± 0.01 and 0.69 ± 0.01, respectively. Further, for both
experiments essentially identical values were obtained for the 2nd order rate constant,
kassoc, for TC binding to the ribosome (Figures 4.6A–B) and kdissoc of EF-Tu from the
ribosome (Figures 4.6D–E). For the reaction of TCCy3 and immobilized 70SICCy5,
neither of these rate constants changed significantly (Figures 4.6C and F) in the
presence of a near-saturating value of EF-G.GTP (4 µM, Figure 4.3D) which catalyzes
PRE complex conversion to POST complex. Here again, only a single FRET state for
ribosome-bound EF-Tu is observed (Figures 4.5C and F).

4.3.4 A simplified quantitative model for TC interaction with 70SIC leading to
PRE complex formation
The ensemble and smFRET measurements presented in Figs. 4.1–4.6 allow
formulation of a quantitative kinetic model for PRE complex formation (Scheme 4.1;
Figure 4.7)

A+B

k1

C

k3

D

k 2 (=a*k 1)
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k4

E

(Scheme 4.1)

that, while building on the more complete model formulated by Pape et al (Pape et al.,
1998), stresses changes in the interactions of EF-Tu with both the ribosome and
aa-tRNA that occur during the process. The main features of this model are:
1. The identification of two distinct complexes, C1 and C2, prior to PRE complex
formation.
2. C1 corresponds to what Rodnina et al. (Rodnina et al., 1994) identify as the codon
recognition complex that forms prior to GTP hydrolysis, and thus is stabilized when
GDPNP is substituted for GTP, as shown in Chapter III. In this complex, position 87
in L11 and the D-loop in aminoacyl-tRNA are each close enough to position 348 in
EF-Tu to give rise to strong FRET signals (Figure 3.1), as measured by quenching of
either Cy3 fluorescence (Figures 4.1A and 4.3A) or increase in Cy5 fluorescence
(Figures 4.4A–B; see also Chapter III).
3. C2 is formed from C1 by a multistep process, grouped as Step 2, that is initiated by
GTP hydrolysis and is followed by four processes occurring approximately
concurrently: Pi release, aa-tRNA accommodation into the A-site, dipeptide formation
and EF-Tu separation from L11 (Figure 4.1A). Two of these processes, tRNA
accommodation and EF-Tu separation from L11, are likely to be reversible
(Agirrezabala et al., 2012; Fischer et al., 2010). As a consequence, the overall rate
constant for step 2 could reflect sums of forward and reverse rate constants. This,
along with differences in experimental conditions and dye labeling [TCQSY9 +
70SICCy3 (Fig. 4.1) vs. TCCy3 + 70SICCy5 (Figure 4.4)], might account for a somewhat
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higher apparent rate constant for step 2 (k2 = 18 ± 3 s-1, Table 4.3) as compared with
kdissoc (6.3 ± 0.4 s-1, Figure 4.6D) determined from ensemble and single molecule
studies, respectively.
4. EF-Tu.GDP separation from L11 in Step 2 occurs prior to EF-Tu.GDP separation
from Phe-tRNAPhe and dissociation from the ribosome by either Step 3 or Step 3A.
Here it should be noted that, conversely, EF-Tu can separate from aa-tRNA without
separating from L11 either in the presence of kirromycin, an antibiotic that stabilizes
EF-Tu.GDP binding to the ribosome (Rodnina et al., 1994), or when EF-Tu GTPase
activity is strongly inhibited by replacement of cognate TC, as used in this paper, with
near-cognate TC (Gromadski et al., 2006; also see Chapter III).
5. Step 3A proceeds more rapidly than Step 3 (i.e., k3A > k3). Under ensemble
conditions, in which relatively high concentrations of ribosomes and TC are employed,
Step 3A is rapidly reversible and, in the absence of EF-G, C2 accumulates transiently.
Under single molecule conditions, performed at very low concentrations of ribosomes
and TC, Step 3A is essentially irreversible, C2 does not accumulate, and virtually all
EF-Tu dissociation proceeds via step 3A. The failure to detect C2 in the smFRET
experiment indicates that its lifetime must be ≤ 20 ms, given the 11 ms integration
time per frame used in the experiment. Step 3 is an essentially irreversible step under
both ensemble and single molecule conditions.
6. Addition of EF-G.GTP has no effect on the residence time of EF-Tu on the
ribosome, as determined by smFRET (Figures 4.6D, F). However, it does accelerate
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EF-Tu separation from tRNA in the ensemble experiment, such that its rate constant
approaches that seen for accommodation (Figure 4.3D). This acceleration results from
EF-G.GTP sequestration of the PRE complex that is the product of step 3A, which
converts step 3A into an essentially irreversible step, even under ensemble conditions.
7. Dye incorporation into Phe-tRNAPhe can significantly alter rate constants for C1
formation and dissociation, but has little effect on the rate of C1 conversion to C2.
Rate constants for two dye combinations, derived from results presented in Figures
4.1 and 4.3, are compared in Table 4.3. Replacement of TCQSY9 with TCQSY9/Cy3 leads
to a ~10-fold increase in the equilibrium dissociation constant for TC binding, largely
due to an increase in k-1, indicating that Cy3 labeling of Phe-tRNAPhe reduces TC
affinity for the ribosome. This is consistent with other studies of ours showing
reduced activity in protein synthesis of Cy3-labeled vs. unlabeled Phe-tRNAPhe under
conditions of limiting Phe-tRNAPhe concentration (Rosenblum et al., 2012).

4.3.5 The timing of EF-Tu conformational change
While it is clear from the differences between the structures of the GTP- and
GDP-bound forms of EF-Tu (Kjeldgaard and Nyborg, 1992; Polekhina et al., 1996)
that dissociation from EF-Tu of the Pi produced on GTP hydrolysis must ultimately
lead to a major conformational change within EF-Tu, the timing of such change, and
whether it occurs on or off the ribosome, is unclear. Our scheme posits two pathways
for EF-Tu.GDP dissociation from the ribosome. Our results are consistent with the
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assumption that the rapid, reversible dissociation step, 3A, corresponds to dissociation
of EF-Tu.GDP*, which retains the “EF-Tu.GTP” conformation, while the slower,
essentially irreversible step corresponds to dissociation of EF-Tu.GDP, having the
altered “EF-Tu.GDP” conformation. Experiments testing this assumption more
directly, and reaching the same conclusion, are described elsewhere (unpublished data
from Dr. Darius Kavaliauskas and Prof. Charlotte R. Knudsen). The suggestion that
EF-Tu.GDP* has an at least transient existence both on and off the ribosome is
supported by considerable evidence, summarized recently (Hauryliuk et al., 2008),
that GTPases like EF-Tu fluctuate in a dynamic equilibrium between different
conformational states, independently of which nucleotide, GTP or GDP, is bound. A
particularly striking example of this phenomenon is provided by the X-ray crystal
structure of a Rab6A' mutant containing bound GDP, which shows the protein to be in
a GTP-like conformation (Shin et al., 2012). As we have demonstrated (Figure 4.3D),
addition of EF-G.GTP accelerates overall EF-Tu.GDP dissociation, which we attribute
to its binding to the PRE complex produced via reaction 3A. Given the high cellular
concentration of EF-G (~20 µM, stoichiometrically equivalent to ribosomes), it seems
probable that reaction 3A is the major route for EF-Tu dissociation in vivo.

4.4 Discussion
A quantitative kinetic model has been proposed more than a decade ago to
describe the elementary steps during PRE complex formation (Pape et al., 1998).
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Herein, we add more details to this model by ensemble multi-color experiments
combining FRET assays based on a labeled EF-Tu derivative (see Chapter III) and
assays measuring fluorescence changes of Pi release and aa-tRNA accommodation, as
well as smFRET experiments utilizing fluorophore labeled EF-Tu. Our results
indicate that EF-Tu gets into proximity to L11 upon TC binding to the 70SIC, and
moves away from L11 in concert with Pi release after GTP hydrolysis and tRNA
accommodation. After tRNA release, EF-Tu can dissociate from the ribosome via two
different pathways depending on the timing of EF-Tu conformational change.
Previous studies using labeled tRNA showed that TC binding to the ribosome
proceeded through an initial mRNA-independent binding, presumably to the L7/L12
stalk (Schmeing et al., 2009a), followed by a mRNA-dependent binding to the
ribosome body, with roughly equal forward rates for these two steps (Rodnina et al.,
1994). Our EF-Tu:L11 FRET experiments show that the step by which EF-Tu
achieves proximity to L11 is second order, with an apparent rate constant that
increases linearly as a function of TC concentration, but is much slower than what has
previously been measured for initial TC binding (Pape et al., 1998). This result
suggests the possibility that initial TC binding to the L7/L12 stalk is immediately
followed by repositioning of EF-Tu to bring it to the proximity to L11, consistent with
recent results showing that part of EF-Tu interacts with L11 to induce L11
conformational change and construct L11:L12 contacts (Wang et al., 2012). However,
we can not exclude the possibility that TC initial biding to L7/L12 stalk directly put
EF-Tu at a position interacting with L11 or binding to L7/L12 stalk is not a
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pre-requisite for TC to reside at the A/T site of the ribosome.
After GTP hydrolysis, EF-Tu moves away from L11 approximately at the same
time as Pi release and tRNA accommodation, which is evidenced by their similar
apparent rate constants in concentration dependence experiments and successfully
fitting to a global kinetic scheme with all of these three processes occurring in one
step. Concurrent EF-Tu:L11 separation and tRNA accommodation confirms their
correlation as revealed in experiments using tight tRNAVal2B mutant, in which delayed
tRNA release from EF-Tu slowed down EF-Tu:L11 separation and tRNA
accommodation to the same level (see Chapter III).
In multi-color experiments simultaneously measuring tRNA accommodation by
fMet-tRNAfMet(prf) programmed at ribosomal P-site and EF-Tu:tRNA separation by
TCQSY9/Cy3, the rates of EF-Tu:tRNA separation were apparently slower than those of
tRNA accommodation (Figure 4.3C), presumably also slower than those of Pi release
and EF-Tu:L11 separation, indicating a delayed EF-Tu dissociation from the ribosome.
Global fitting results suggest that EF-Tu:tRNA separation can be treated as a separate
step after EF-Tu:L11 separation, Pi release and tRNA accommodation, with the latter
three steps proceeding with the same rate constant. In our scheme (Figure 4.7), it is
proposed that, EF-Tu undergoes a conformational change after GTP hydrolysis, which
occurs after EF-Tu:L11 separation, Pi release, and tRNA accommodation. This
proposal is consistent with what was previously reported that Pi release after GTP
hydrolysis is much slower than GTP hydrolysis, leading to slow EF-Tu
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conformational rearrangement from GTP to GDP bound form after GTP hydrolysis
(Kothe and Rodnina, 2006), in which the rate of conformational change was indirectly
obtained from the difference between the lag phase of Pi release and tRNA
accommodation experiments.
This dissociation occurs via two possible pathways: 1) rapid but reversible
dissociation from the ribosome in the high-affinity state followed by the
conformational change off the ribosome (Step 3A in Figure 4.7); or 2) conformational
change on the ribosome followed by slow but irreversible dissociation from the
ribosome in the low affinity state (Step 3 in Figure 4.7). Under ensemble condition,
because of the relatively high concentration components used, backward
re-association in Step 3A becomes significant and intermediate C2 is accumulated,
making Step 3 dominantly observable. Thus, presence of EF-G has no effect on the
rates of tRNA accommodation but increase the rates of EF-Tu:tRNA separation to a
level similar to tRNA accommodation by trapping the ribosome complex after
EF-Tu.GDP* dissociation, pushing the reaction mostly though Step 3A. In contrast,
under single molecule conditions, highly diluted components make the rapid TC
dissociation in the high affinity state essentially irreversible and C2 mostly proceeds
through Step 3A. EF-Tu and EF-G share the same binding site on the ribosome both
as translational GTPase and are recruited to the ribosome regulated by the ribosome
states. Our observations raise the question of, if EF-Tu conformational rearrangement
changes its affinity with the ribosome and facilitates its dissociation from the
ribosome, why a second pathway exists with this rearrangement occurring off the
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ribosome, and whether the EF-Tu:EF-G interplay has any functional significance
during translation elongation.

4.5 Conclusions
Here we describe the dynamics of EF-Tu interaction with tRNA and with the
ribosome during PRE complex formation by combining the results of multi-color
ensemble stopped-flow and single-molecule FRET measurements. We demonstrate
that EF-Tu separation from L11 within the GTPase associated center of the ribosome
occurs prior to EF-Tu separation from Phe-tRNAPhe and that EF-Tu.GDP dissociates
from the ribosome via two different pathways, one more rapid and reversible and one
slower and essentially irreversible, that are likely to correspond to two different
EF-Tu.GDP conformations on the ribosome.
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Table 4.1. Labeled ternary complexes (TCs).

TC name

Labeled EF-Tu variant

Phe-tRNAPhe

TCQSY9

E348C-EF-TuQSY9

Phe-tRNAPhe

TCQSY9/Cy3

E348C-EF-TuQSY9

Phe-tRNAPhe(Cy3)

TCCy3

E348C-EF-TuCy3

Phe-tRNAPhe

TCCy3/Cy5

E348C-EF-TuCy3

Phe-tRNAPhe(Cy5)
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Table 4.2. Comparison of apparent rate constants between TCQSY9/Cy3 and
fMet-tRNAfMet(prf)a.

No EF-Gb

EF-G (4 µM)c

70SIC
kapp(Cy3)

kapp(prf)

kapp(Cy3)

kapp(prf)

(s-1)

(s-1)

(s-1)

(s-1)

0.4

3.2 ± 0.8

4.9 ± 0.5

4.9

4.9

0.8

3.9 ± 0.5

6.1 ± 0.4

6.9

8.0

1.2

5.2 ± 0.8

8.7 ± 0.9

8.0

10.2

2.4

6.5 ± 1.1

8.8 ± 0.8

11.0

13.5

(µM)

a

TCQSY9/Cy3 (0.1 µM) was rapidly titrated with 70SIC programmed with
fMet-tRNAfMet(prf) at indicated concentrations, in absence or presence of EF-G (4
µM).

b

Average ± error of two determinations.

c

Single determination.
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Table 4.3. Fitted rate constants for schemea.

Reaction
Components

TCQSY9 + 70SICCy3
Fig. 4.1
TuQSY9/Cy3 + 70SIC
Fig. 4.3

a

k1, s-1 µM-1

k-1/k1, µM

k2, s-1

k3, s-1

39.3 ± 1.3

0.12 ± 0.03

17.7 ± 2.5

(19.6)

100 ± 39

1.2 ± 0.1

19.9 ± 0.5

19.6 ± 1.1

Rate constants in parentheses are fixed during fitting using Scientist.
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Figure 4.1. Ensemble studies of TCQSY9 reaction with 70SICCy3. A – C. Changes of
fluorescence on rapid mixing of 70SICCy3 (0.1 µM) with TCQSY9 as a function of
TCQSY9 concentration. Lines through the traces are fit to Scheme 4.1 (Table 4.3). A.
Cy3 fluorescence. B. MDCC-PBP fluorescence. C. fMet-tRNAfMet(prf) fluorescence.
In parts A and C, 70SIC contained fMet-tRNAfMet(prf). Unlabeled fMet-tRNAfMet was
used in part B. D. kapp values derived from measurements of changes in the
fluorescence: Cy3, kapp1 (black); Cy3, kapp2 (red); Cy3, kov (green); prf (blue);
MDCC-PBP (cyan). Rate constants for Cy3 are averaged values obtained in the
presence of MDCC-PBP or fMet-tRNAfMet(prf).
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kapp1 (- prf, - MDCC-PBP);

kapp2 (- prf, - MDCC-PBP)

kapp1 (+ prf, - MDCC-PBP);
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0.4
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0.8

1.0

TC (μM)
Figure 4.2. Concentration dependence of EF-Tu:L11 FRET. kapp1 and kapp2 are as a
function of TCQSY9 concentration for the reaction with 70SICCy3 (0.1 µM). These
experiments were carried out with 70SICCy3 containing either fMet-tRNAfMet(prf) or
fMet-tRNAfMet (indicated as +prf and –prf, respectively) and in the presence or
absence of MDCC-PBP (indicated as +MDCC-PBP and –MDCC-PBP, respectively).
The values at 0.4 µM are mean ± standard deviation of four determinations.
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Figure 4.3. Ensemble studies of TCQSY9/Cy3 reaction with 70SIC. Changes of
fluorescence on rapid mixing of 70SIC with TCQSY9/Cy3 (0.1 µM) as a function of
70SIC concentration. 70SIC was made up with fMet-tRNAfMet(prf). A. Cy3
fluorescence. B. fMet-tRNAfMet(prf) fluorescence. In A and B lines through the traces
are fit to Scheme 4.1 (Table 4.3). C. kapp values for parts A and B. Data shown are
average ± error of two determinations. D. kapp(Cy3)/ kapp(prf) as a function of
EF-G.GTP concentration. Data shown in the absence or in the presence of EF-G (4
μM) are average ± error of two determinations. 70SIC, 0.4 µM. E. Relative rates of
EF-Tu:tRNA separation and tRNA accommodation in the presence of EF-G (4 μM) at
different 70SIC concentrations. Data in the absence of EF-G come from part C.
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A

C

B

D

Figure 4.4. Real-time courses of single molecule fluorescence intensities and FRET.
EF-Tu.GTP assisted tRNA delivery was measured between A. TCCy3 and 70SICCy5
and B. TCCy3/Cy5 and 70SIC. TC (10 nM) was injected at time zero into the imaging
chamber with immobilized 70SIC. Cy3 (green) and Cy5 (red) fluorescence intensity
traces were under excitation of 532 nm TIRF illumination at 11 ms integration time
per frame. The FRET ratio was calculated as ICy5/(ICy5 + ICy3) C. and D. FRET
probability density plots for the reactions described in A and B, respectively. Upper
and lower traces are aligned to the first or last time points, respectively, of the FRET
events as t = 0. Besides the 0 FRET state, which corresponds to no fluorescence signal,
only one FRET state is observed in each reaction. The same conclusion is reached
from consideration of the synchronized FRET traces shown in Fig. 4.5.
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Figure 4.5. Synchronized smFRET values. A. and D. Synchronized to FRET
appearance and disappearance, respectively, for TCCy3 added to 70SICCy5. B. and E.
Synchronized to FRET appearance and disappearance, respectively, for TCCy3/Cy5
added to 70SIC. C. and F. Synchronized to FRET appearance and disappearance,
respectively, for TCCy3 added to 70SICCy5 in the presence of 4 µM EF-G.GTP.
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Figure 4.6. Association (A, B, and C) and dissociation (D, E, and F) times and rate
constants for TC interaction with immobilized 70SIC. A. and D. TCCy3 (5 nM) and
70SICCy5; B. and E. TCCy3/Cy5 (10 nM) and 70SIC; C. and F. TCCy3 (10 nM) and
70SICCy5 in the presence of EF-G (4 µM) and 400 µM GTP. Lines are best fits to
single exponentials, giving the indicated association (tassoc) and dissociation (tdissoc)
times and corresponding values of kassoc and kdissoc.
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Figure 4.7. A simplified quantitative model for TC interaction with 70SIC. The rate
constants shown are for reaction of TCQSY9 with 70SICCy3. Rate constants for this and
other TC/70SIC combinations are summarized in Table 4.3. The metastable species
EF-Tu.GDP* has a conformation characteristic of EF-Tu.GTP, even though the GTP
has hydrolyzed. Only upper and lower limits, respectively, can be given for Kd and k3A.
These limits require a rapid association rate constant (≥ 1.5 x 108 M-1s-1) for
EF-Tu.GDP* binding to the PRE complex. Rate constants of this order have
previously been found for TC binding to 70SIC (Gromadski, 2004; Pape, 1998).
Because of uncertainty regarding the position of equilibrium in Step 3A under
ensemble conditions, the simplifying assumption was made in carrying out the fitting
that C2 was dominant. Thus, the fitted value for k3 is a lower limit.

127

CHAPTER 5
MONITORING TRANSLATION WITH MODIFIED
mRNAS STRATEGICALLY LABELED WITH ISOMORPIC
FLUORESCENT NUCLEOSIDE MIMETICS

[Part of the data in this chapter is adapted with permission from (Liu, W., Shin D.,
Tor, Y., and Cooperman, B. S. (2013). Monitoring translation with modified mRNAs
strategically labeled with isomorphic fluorescent guanosine mimetic. ACS Chem Biol
8, 2017–2023). Copyright (2013) American Chemical Society.]
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5.1 Abstract
Here we examine seven mRNAs with new emissive and responsive isosteric
nucleoside mimetics (thG and thA), with the goal of developing real time assays for
monitoring translation-related events at nucleotide resolution. In these mRNAs the
emissive nucleosides are placed site-specifically at codon positions 1, 4, 5, and 6,
counting the AUG start codon as positions 1–3. All emissive mRNAs tested form
initiation (70SIC), pretranslocation (PRE) and posttranslocation (POST) complexes.
In most cases spectral differences are seen on binding of the mRNA to the ribosome
during 70SIC formation, and on conversion of 70SIC to PRE complexes and PRE
complexes to POST complexes. These differences allow measurement of the kinetics
of such conversions by changes in the fluorescence of labeled mRNAs. Such
measurements directly identify a specific step during PRE complex formation,
provisionally assigned to codon:anticodon-loop base pair formation, that follows
EF-Tu.GTP.aa-tRNA ternary complex binding to the ribosome and precedes
aa-tRNA accommodation into the A-site of the ribosome. These observations not
only demonstrate the functionality of mRNAs modified with the emissive nucleoside
mimetic, but also the potential this mimetic offers for observing the formation and
disappearance of discrete intermediates during the polypeptide elongation cycle.

129

5.2 Introduction
The past dozen years or so have witnessed huge progress in our understanding of
ribosome function, fueled by high resolution structures (Schmeing et al., 2009a;
Wilson and Doudna Cate, 2012) and by increasingly sophisticated biochemical,
biophysical, and computational studies that probe the detailed workings of this
complex machine (Dever and Green, 2012; Frank and Gonzalez, 2010; Wohlgemuth
et al., 2011; Rodnina and Wintermeyer, 2011; Sanbonmatsu, 2012). Many of the
studies directed toward understanding of the dynamics of ribosome function rely
heavily on both ensemble and single molecule time-resolved observations made with
functional, fluorescent-labeled derivatives of components of the protein synthesis
machinery, for the most part including tRNAs, ribosomal proteins, and protein
auxiliary factors such as EF-Tu and EF-G (Frank and Gonzalez, 2010; Pan et al., 2009;
Chen et al., 2011a; Cooperman et al., 2011). For example, changes in the fluorescence
of labeled tRNAs and labeled ribosomal proteins, combined with several other assays
measuring GTP hydrolysis, dipeptide formation, Pi release, and peptidyl-tRNA
reactivity toward puromycin have resulted in the formulation of quantitative kinetic
schemes for the two major steps within the elongation cycle: i) ternary complex (TC,
consisting of EF-Tu.GTP.aminoacyl (aa)-tRNA) binding to a posttranslocation (POST)
or 70S initiation complex (70SIC) followed by accommodation of aa-tRNA within the
A-site of the ribosome and peptide bond formation, leading to pretranslocation (PRE)
complex formation (Pape et al., 1998; Geggier et al., 2010; Wohlgemuth et al., 2011),
and ii) EF-G.GTP-catalyzed translocation of tRNAs bound in the A- and P-sites to the
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P-and E-sites, respectively, along with mRNA to which they are bound, leading to
conversion of PRE complex to POST complex (Savelsbergh et al., 2003; Pan et al.,
2007; Munro et al., 2010; Chen et al., 2011a; Cunha et al., 2013), thus completing the
cycle.
Despite the central role of mRNA in protein synthesis, the use of fluorescent
mRNAs has, by contrast, been quite limited, confined almost exclusively to mRNAs
derivatized at the 3’-end with fluorophores that monitor the movement of this
terminus to a position at the entrance of the mRNA channel during translocation
(Savelsbergh et al., 2003; Studer et al., 2003; Liu et al., 2010; Cunha et al., 2013).
Although it would be of obvious interest to monitor mRNA codons that interact
directly with the anticodon loops of tRNAs bound within the A, P, and E sites of the
ribosome, progress in this direction has been held back by the expectation that bulky
fluorophores attached to codon nucleotides within the narrow confines of the mRNA
channel would either abolish or distort mRNA activity, making such derivatives
unreliable probes of normal mechanism. Recently, however, new emissive and
responsive nucleoside mimetics based on thieno[3,4-d]pyrimidine, which maintain
normal Watson-Crick base pairing, have been described for all four RNA nucleosides
(Shin, 2011 et al.; Samanta et al., 2012; Gedik and Brown, 2013), that either are
isosteric with the nucleoside being mimicked [thGuanosine (thG) or thAdenosine (thA),
Figure 1.5] or have the effect of converting pyrimidines into isosteres of purines
(thUridine and thCytosine).
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Here we describe the preparation of seven functional mRNAs containing emissive
nucleoside mimetics within the initiation or the second codon that display easily
measurable fluorescence changes at different stages of protein synthesis. Such
changes permit monitoring of the conversion of a 70SIC first to a pretranslocation
(PRE) complex and then to posttranslocation (POST) complex, at nucleotide
resolution. We use such monitoring, in conjunction with other fluorescence assays, to
directly identify a specific step during PRE complex formation, that follows
EF-Tu.GTP.aa-tRNA ternary complex binding to the ribosome and precedes aa-tRNA
accommodation into the A-site of the ribosome, and that we provisionally assign to
codon:anticodon-loop base pair formation.

5.3 Results
5.3.1 Modified mRNAs
Seven short mRNAs containing a single thG or thA within the AUG initiation
codon or the following second codon were prepared, and named as thG4, thG5, thG6,
th

A1, thA4, thA5, and thA6, respectively, according to the positions of the modification

at the 5’ position of initiation codon, or 5’, middle, and 3’-positions of the second
codon (Figure 5.1). The amino acids that these mRNAs encode at the second codon
position are: Val for thG4 and thG6, Arg for thG5, and Lys for thA1, thA4, thA5 and thA6.
Three additional mRNAs containing no modified nucleotides were also prepared and
named as MVF, corresponding to thG4 or thG6, MRF, corresponding to thG5, and MKF,
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corresponding to thA1, thA4, thA5 or thA6.

5.3.2 Formation of functional initiation and elongation complexes
Modified mRNAs were tested for their activities in different stages of translation:
70S initiation complex (70SIC) formation (Figures 5.2A–B and 5.3A), as measured
by fMet-tRNAfMet co-sedimentation with a 70S ribosome; pretranslocation (PRE)
complex formation (Figures 5.2C–D and 5.3B), as measured by Val-tRNAVal (thG4,
th

G6), Arg-tRNAArg (thG5), or Lys-tRNALys (thA1, thA4, thA5, thA6) co-sedimentation

with a 70SIC; and EF-G.GTP dependent translocation (Figures 5.2E–F and 5.3C), as
measured by fMet-Val-puromycin (thG4,

th

G6), fMet-Arg-puromycin (thG5) or

fMet-Lys-puromycin (thA1, thA4, thA5, thA6) formation.
The results in Figures 5.2 and 5.3 demonstrate that substantial functionality is
retained on nucleoside mimetic substitution at positions 1, 4, 5, or 6. Noteworthy are
the lower relative activities of thG4- and thG6-programmed ribosomes in stable PRE
complex formation (Figure 5.2C), and of thA5-programmed ribosomes in stable POST
complex formation (Figure 5.3C), respectively (see Section 5.4).

5.3.3 Fluorescence changes on functional complex formation
th

G and

th

A are both ideally emissive (Φ = 0.46 and 0.21, respectively) and

responsive fluorescent nucleoside mimetics (Shin et al., 2011). Although
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incorporation into oligonucleotides generally lowers the quantum yield of emissive
nucleosides (Sinkeldam et al., 2010), we anticipated that modified oligonucleotides
shown in Figure 5.1 would retain a high level of responsiveness that would allow one
to monitor mRNA binding, movement and subtle environmental changes within the
ribosome during the elongation cycle. thG4, thG5, thG6, thA1, thA4, thA5 and thA6
mRNAs each have a broad excitation maximum at 340–360 nm (Figure 5.4A and C).
To minimize the background fluorescence from the ribosome, 360 nm was chosen as
the excitation wavelength for fluorescence experiments.

5.3.3.1 Fluorescence changes of mRNA binding to the ribosome
Each of the three mRNAs with an thG substitution within the second codon shows
a negligible bathochromic shift on binding to the ribosome as part of a 70SIC but
clear emission intensity changes (Figure 5.4B), presumably arising from the altered
environment of emissive nucleoside mimetics on the ribosome compared to solution.
The four mRNAs with an thA substitution within the initiation or the second codon
also display emission intensity changes on binding to the ribosome as part of a 70SIC
(Figure 5.4D). However, the data of thA-containing mRNAs are preliminary and need
to be further confirmed.

5.3.3.2 Fluorescence changes of 70SIC conversion to PRE complex
Conversion of 70SIC programmed with six of the seven emissive mRNAs (all but
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th

A1)

to

the

corresponding

PRE

complex

via

addition

of

cognate

EF-Tu.GTP.aminoacyl-tRNA ternary complex (EF-Tu.GTP.aa-tRNA, denoted TC)
results in Watson-Crick base pairing of the thG or thA present in the first elongator
tRNA codon, so that observed changes (Figures 5.5 and 5.6; Table 5.1) reflect both
generalized environmental effects of converting a 70SIC into the first PRE complex
and the specific effects of codon:anticodon H-bonding at the A-site. No such changes
are seen on addition of non-cognate TCs in place of cognate TCs (Figures 5.7 and 5.8).
All 70SICs programmed with mRNAs with an thG or thA present in the first elongator
tRNA codon, show measurable changes in fluorescence intensity on conversion to
PRE complexes. In addition, the

th

G4- and

th

A4-programmed 70SIC show small

hypsochromic shifts. No clear fluorescence intensity change is observed when 70SIC
programmed with thA1 was mixed with cognate TC. However, an ~10% uncertainty in
intensity is expected due to the background fluorescence subtraction performed (see
legend of Figure 5.6). Therefore, the lack of fluorescence intensity change observed
for thA1 in the static experiment is not inconsistent with the small intensity decrease
seen in the kinetic experiment (Figure 5.10A).

5.3.3.3 Fluorescence changes of PRE conversion to POST complex
Conversion of a PRE complex to a POST complex via EF-G.GTP addition
proceeds with maintenance of the anticodon-loop:codon Watson-Crick base pairs. For
the thG4-, thG6- and thA4-programmed PRE complexes, such conversions result in
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fluorescence changes that either completely (thG4 and thA4) or partially (thG6) reverse
the changes seen on conversion of 70SIC to PRE complex (Figures 5.5A, C–D and
5.6B, E). thA1-programmed PRE complex to POST complex conversion shows a
significant fluorescence decrease (Figures 5.6A, E). Only a small fluorescence
increase was observed for both thA5- and thA6-programmed PRE complex to POST
complex conversion (Figures 5.6C–E). In contrast, conversion of the

th

G5-

programmed PRE complex to POST complex proceeds with virtually no fluorescence
change (Figures 5.5B, D). These changes (summarized in Table 5.1) provide sensitive
spectroscopic handles allowing us to monitor the changes in the microenvironments
of specific codon nucleotides at the decoding center during the first cycle of
polypeptide elongation.

5.3.4 Kinetics of PRE complex formation
We used the changes seen in Figures 5.5 and 5.6 to determine rates of PRE
complex formation. Earlier work showed that 1) proflavin(prf)-labeled aa-tRNA can
be used to monitor a two phase reaction of ternary complex (EF-Tu.GTP.aa-tRNA, TC)
with 70SIC, initial TC binding followed by aa-tRNA accommodation into the A-site
(Pape et al., 1998), that results in PRE complex formation; and 2) fMet-tRNAfMet(prf)
bound in the P-site monitors accommodation of aa-tRNA within the ribosome in an
essentially single-phase reaction (Pan et al., 2008). Rates of thG and thA fluorescence
change were determined in three parallel experiments, using either i) unlabeled
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fMet-tRNAfMet and

unlabeled

aa-tRNAaa,

ii)

unlabeled

fMet-tRNAfMet and

aa-tRNAaa(prf), or iii) fMet-tRNAfMet(prf) and unlabeled aa-tRNA (Figures 5.9 and
5.10. In ii) and iii), parallel measurements were made for the rates of proflavin
fluorescence change. Rates of proflavin fluorescence change were also determined
when unlabeled MVF, MRF and MKF were substituted for the corresponding
emissive mRNAs (thG4 or thG6; thG5; and thA1, thA4, thA5 or thA6, respectively). All
of the emissive mRNA changes proceeded as essentially single-phase reactions, with
the exception of thA5, which proceeded via a two-phase reaction.

5.3.4.1 thG4- and thG6-programmed ribosomes
Below we distinguish apparent rate constants, which are determined by fitting the
kinetic data in Figures 5.9A, and 5.9C to either a double exponential [aa-tRNA(prf)
fluorescence intensity changes] or to a single exponential [both fMet-tRNAfMet(prf)
and thG fluorescence changes], from microscopic rate constants, which are determined
by globally fitting all of the kinetic data obtained with a given mRNA to a posited
kinetic mechanism. For both mRNAs, the measured apparent rate constants fall in the
order

aa-tRNA(prf)-Phase

1

(denoted

kapp1)

>>

th

G

(denoted

kapp2)

>

aa-tRNA(prf)-Phase 2 ~ fMet-tRNAfMet(prf) (both denoted kapp3) (Table 5.2). That
kapp2 values, derived from thG fluorescence changes, differ from both kapp1 and kapp3
values, derived from prf-labeled tRNA fluorescence changes, demonstrates that
th

G-labeled mRNA provides evidence for a step in PRE complex formation not
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previously seen with prf-labeled tRNAs. kapp2 values for thG4 and thG6 fluorescence
change were very similar to each other and in both cases were little affected by prf
labeling of either fMet-tRNAfMet or Val-tRNAVal. Similarly, kapp1 values were
unaffected by thG substitution for unmodified G, although kapp3 values were reduced by
about one-third.
Microscopic rate constants for the two mRNAs were determined by globally
fitting each set of rate measurements in Figures 5.9A and 5.9C to a simplified
three-step kinetic scheme for the mixing of 70SIC and TC that results in PRE
complex formation (Scheme 5.1, Table 5.4). Such fittings were carried out ignoring
the quite minor changes resulting from carrying out experiments with unlabeled vs.
prf-labeled forms of fMet-tRNAfMet or Val-tRNAVal. Interpreted in the light of earlier
results (Gromadski and Rodnina, 2004a; Pan et al., 2008), steps 1 and 3 should
correspond, respectively, to an initial binding of TC to 70SIC that doesn’t involve
codon:anticodon base pairing, and to accommodation of aa-tRNA into the A-site that
is followed by peptide bond formation and EF-Tu.GDP release from the ribosome.
The thG fluorescence change provides a new probe for the intervening step 2, that we
presume corresponds to the base pairing step between the codon and the aa-tRNA
anticodon loop. Importantly, the rate constant values k1–k3 obtained with thG4- and
th

G6-programmed ribosomes are virtually identical to one another.
Scheme 5.1
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5.3.4.2 thG5-programmed ribosomes
Results with

th

G5-programmed ribosomes (Figure 5.9B) differed from those

discussed above in showing an apparent interaction between Arg-tRNAArg(prf) and
th

G5 that slowed PRE complex formation, as manifested by ~2-fold increased values

of kapp1 when MRF replaces thG5 and of kapp2 and kapp3 when Arg-tRNAArg replaces
Arg-tRNAArg(prf) (Table 5.2). As a result, we separately fit results obtained with
th

G5-programmed ribosomes to Scheme 5.1 according to whether they were obtained

with Arg-tRNAArg(prf) or unlabeled Arg-tRNAArg (Table 5.4).
The values obtained lead to two observations concerning

th

G5-programmed

ribosomes. First, using unlabeled Arg-tRNAArg, k2 and k3 are quite similar to the
values found for thG4- and thG6-programmed ribosomes, using either prf-labeled or
unlabeled Val-tRNAVal. Second, labeling Arg-tRNAArg with proflavin has major
(~3–4-fold) and minor (1.6-fold) inhibitory effects on k2 and k3, respectively.

5.3.4.3 thA4- and thA6-programmed ribosomes
Unlike Val-tRNAVal(prf) and Arg-tRNAArg(prf) (Figure 5.9), Lys-tRNALys(prf) can
only be used as a good probe for the initial TC binding to the ribosomes programmed
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with thA4- and thA6- containing mRNA. Thus, apparent rate constants of thA4- and
th

A6-programmed ribosomes are determined by fitting all of the kinetic data in

Figures 5.10B and 5.10D to a single exponential. Similar to

th

G-programmed

ribosomes, the measured apparent rate constants also fall in the order aa-tRNA(prf)
(denoted kapp1) >> thA (denoted kapp2) > fMet-tRNAfMet(prf) (denoted kapp3) (Table 5.3).
The kapp1 value for thA4 and thA6, corresponding to rate of initial TC binding to the
ribosome, were a little faster (~ 1.6 fold) than the kapp1 values for thG4 and thG6. Both
kapp2 and kapp3 values for thA4 and thA6 were very similar to the values for thG4 and
th

G6 fluorescence changes. In addition, kapp2 values for

th

A4 and

th

A6 were little

affected by prf labeling of either fMet-tRNAfMet of Lys-tRNAVal. kapp1 values were
unaffected by thA substitution for unmodified adenosine, although kapp3 values were
reduced by about one-fourth.
Microscopic rate constants for

th

A4 and

th

A6, determined by globally fitting

measurements in Figures 5.10B and 5.10D to Scheme 5.1, are listed in Table 5.4. The
rate constant values k1–k3 obtained with thA4- and thA6-programmed ribosomes are
similar to one another. Compared with microscopic rate constants for thG4 and thG6,
k1 and k2 for thA4 and thA6 are a little faster, while k3 values are essentially identical.

5.3.4.4 thA1 -programmed ribosomes
Although base pairing at the ribosomal P-site between AUG codon and
fMet-tRNAfMet anticodon is maintained during 70SIC to PRE complex formation, a
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consistent small decrease of thA1 fluorescence intensity was observed when 70SIC
programmed with thA1 was rapidly mixed with corresponding cognate TC, whether
fMet-tRNAfMet or Lys-tRNALys is unlabeled or labeled (Figure 5.10A). kapp2 with
unlabeled fMet-tRNAfMet and Lys-tRNALys was similar to those for thA4 and thA6, but
a little slower (1.5 – 2-fold ) when labeled tRNAs were used. More importantly, when
70SIC programmed with both

th

A1 and fMet-tRNAfMet(prf) was mixed with

EF-Tu.GTP.Lys-tRNALys, kapp2 was very similar to kapp3 (Table 5.3). These results
indicate that the thA1 response during 70SIC to PRE complex conversion monitors the
tRNA accommodation. kapp1 and kapp3 values for thA1 were essentially identical to
those for thA4 and thA6.

5.3.4.5 thA5-programmed ribosomes
Different from all other modified mRNAs,

th

A5 displayed a two-phase

fluorescence intensity change using either labeled or unlabeled Lys-tRNALys and
fMet-tRNAfMet (Figure 5.10C and Table 5.3). The apparent rate constants of the first
phase of

th

A5 fluorescence change using either unlabeled fMet-tRNAfMet and

unlabeled Lys-tRNALys, or unlabeled fMet-tRNAfMet and Lys-tRNALys(prf) are similar
to each other, but a little faster than when fMet-tRNAfMet(prf) and unlabeled
Lys-tRNALys are used. The major thA5 fluorescence change occurs in the second phase,
for which the apparent rate constants were 20 – 30 times lower than the fluorescence
changes of thA4 and thA6. Because the same amino acid sequence is encoded in all
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th

A-containing mRNAs, this large rate decrease likely arises from perturbations in

codon:anticodon base pairing at the middle position. Moreover, the slow second phase
rate constants, which varied from 0.28 – 0.66 sec-1 (Table 5.3), were in all cases
comparable to kapp3 measured by fMet-tRNAfMet(prf), suggesting that base pairing at
the middle codon position is rate-limiting for tRNA accommodation. Interestingly,
compared with thA4 and thA6, the kapp1 value measured by Lys-tRNALys(prf) was also
subject to a significant decrease (~ 3 fold).
Microscopic rate constants for

th

A5 were determined by globally fitting the

measurements in Figures 5.10C to a different three-step kinetic scheme (Scheme 5.2,
Table 5.4), ignoring the small changes resulting from carrying out experiments with
unlabeled vs. prf-labeled forms of fMet-tRNAfMet or Lys-tRNALys. Steps 1 correspond
to an initial binding of TC to 70SIC, the same as step 1 in Scheme 5.1. Different from
Scheme 5.1, codon:anticodon base pairing is accomplished in two steps. Step 2
presumably corresponds to the fast base pairing at the 5’ or 3’ positions of the A-site
codon, as measured by the fast phase of thA5 fluorescence changes; while step 3
presumably corresponds to the slow base pairing at middle codon position, as
measured by the slow phase of

th

A5 fluorescence changes. Because tRNA

accommodation is rate-limited by the full base pairing, the fMet-tRNAfMet(prf)
fluorescence signal change provides no information about tRNA accommodation, but
is presumed to be rapid compared with the rate of step 3. The rate constant value of k1
is modestly decreased (3 – 4 fold) compared with thA4 and thA6. Compared with the
rate of full base pairing measured for thA4 and thA6, initial base pairing is ~ 2 – 6-fold
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faster at the 5’ or 3’ positions and ~ 20-fold slower at the middle codon position.

Scheme 5.2

k1

70SIC + TC

k2a

70SIC.TC1

k2b

70SIC.TC2

70SIC.TC3

5.3.5 Kinetics of POST complex formation
5.3.5.1 thG-programmed ribosomes
Previous work demonstrated that fluorescence changes resulting from rapid
mixing of PRE complexes containing fMet-aa-tRNA(prf) with EF-G.GTP measures
the rate of translocation of fMet-aa-tRNA(prf) from the A- to the P-site of the
ribosome (Savelsbergh et al., 2003; Pan et al., 2007). When PRE complexes
containing thG4-labeled mRNA and fMet-Val-tRNAVal(prf) are rapidly mixed with
EF-G.GTP, the changes in both thG and fMet-Val-tRNAVal(prf) fluorescence intensity
are well fit by a single kapp value (4.7 ± 0.3 s-1; Figure 5.11A; Table 5.5), indicating
that both fluorophores are monitoring the same process. Similar results are obtained
for the PRE complex containing thG6-labeled mRNA, with a slightly lower kapp value
(3.4 ± 0.2 s-1; Figure 5.11B; Table 5.5). The PRE complex programmed with thG5 had
a rate constant of 6.2 ± 1.6 s-1 for fMet-Arg-tRNAArg(prf) fluorescence change (Table
5.5), but showed, as expected from the results presented in Figure 5.5B, almost no
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change in thG fluorescence. These results demonstrate that thG-programmed ribosomes
are fully functional in the translocation step that converts PRE complex to POST
complex, and that in some cases this step can be monitored by changes in

th

G

fluorescence.

5.3.5.2 thA-programmed ribosomes
According to the results in Figure 5.6, all of the four thA-containing mRNAs have
a response to EF-G catalyzed translocation; however, different patterns of real-time
fluorescence

changes

were

obtained

when

PRE

complexes

containing

fMet-aa-tRNA(prf) and thA were mixed with EF-G.GTP.
Change of

th

A1 fluorescence intensity was significantly slower that that of

fMet-Lys-tRNALys(prf) fluorescence intensity (1.3 ± 0.1 vs 4.2 ± 0.2 s-1; Figure 5.12A;
Table 5.5), suggesting, not unexpectedly, that thA1 fluorescence may respond to a step
after PRE to POST complex conversion, possibly tRNAfMet dissociation from the
ribosomal E-site. Similar to

th

G4 and

th

G6,

th

A4 and fMet-Lys-tRNALys(prf)

fluorescent signals can be well fit to a single kapp value (4.4 ± 0.3 s-1; Figure 5.12B;
Table 5.5), indicating that

th

A4 monitors the same translocation process as

fMet-Lys-tRNALys(prf). In contrast, when PRE complexes containing

th

A5 and

fMet-Lys-tRNALys(prf) are rapidly mixed with EF-G.GTP, the observed thA5 intensity
change proceeds with a apparent rate constant (2.3 ± 0.2 s-1; Figure 5.12C; Table 5.5)
that is much smaller than that for the major fluorescence change of
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fMet-Lys-tRNALys(prf), 13 ± 1 s-1 ( a minor slower phase, with a rate constant of
0.94 ± 0.16 s-1 is observed, possibly corresponding to tRNAfMet dissociation), so that,
in this case, tRNA translocation measured at the D-loop proceeds more rapidly than
mRNA translocation. thA6 has no fluorescence intensity change during PRE to POST
complex conversion ( the apparent small fluorescence intensity change of thA6 show
in Figure 5.6D is likely a result of intrinsic experimental error) though
fMet-Lys-tRNALys(prf) displays a signal change with an apparent rate constant of 2.6
± 0.2 s-1 (Table 5.5). These results suggest that all of the thA-programmed ribosomes
are functional in translocation, and that thA substitution at different positions can be
used to monitor different substeps during or after translocation.

5.4 Discussion
5.4.1 Functional activities
Modified mRNAs, site-specifically labeled with thG or thA nucleoside mimetics at
the 5’ position of initiation codon, or 5’, middle, and 3’-positions of the second codon,
were all shown to be functional in the formation of 70SIC, PRE and POST complexes
(Figures 5.2 and 5.3). In general, measured activities were similar to those found with
unmodified mRNAs. However, significantly lower activities were found in PRE
complex formation for thG4- and thG6-programmed ribosomes and in POST complex
formation for thA5-programmed ribosomes. The reasons for these lower activities are
not well understood. PRE complex formation was measured at a single TC
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concentration, and lower activities are most likely due to lower affinity and/or more
labile binding of TC to 70SIC, as compared with MRF-programmed ribosomes.
Lower activity in POST complex formation for thA5-programmed ribosome is also
likely due to more labile binding of peptidyl-tRNA to the ribosome arising from the
perturbation of nucleoside modification in base pairing (see Section 5.3.4.5), since
th

A5-programmed PRE complex is active in translocation as indicated by a rate

constant of translocation similar to those of PRE complex programmed with thG- or
other thA- containing mRNAs (see below, Table 5.5). The decoding center forms a
tight ‘‘mould’’ that strongly constrains the mRNA (Ogle et al., 2001; Demeshkina et
al., 2012; Demeshkina et al., 2013), so that such weakening of TC binding could
result from small structural perturbations arising from both the substitution of the
larger sulfur for carbon (atomic radii 1.0 Å and 0.7 Å, respectively) at purine position
8, and the loss of polar interactions resulting from carbon for nitrogen substitution at
purine positions 7 and 9.

5.4.2 Fluorescence changes
Correct codon recognition in the decoding center induces local conformational
changes, with base pairing at different codon positions stabilized by different rRNA
and ribosomal protein residues (Ogle et al., 2001; Demeshkina et al., 2012;
Demeshkina et al., 2013). In most cases, conversions between 70SIC and PRE
complex or between PRE and POST complexes were accompanied by fluorescence
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intensity changes (summarized in Table 5.1), with varied patterns seen for different
modified mRNAs. We are unable to attribute the fluorescence intensity changes,
shown in Figures 5.5 and 5.6 and summarized in Table 5.1, to specific changes in the
immediate surroundings of the modified base, since they may include contributions
from multiple effects, including changes in polarity, viscosity and H bonding, as well
as ground and excited state processes brought about by neighboring nucleobases.
Nevertheless, they provide sensitive spectroscopic handles (as summarized in Table
5.1), allowing us to monitor changes in the microenvironments of specific codon
nucleotides at the decoding center during the first cycle of polypeptide elongation.

5.4.3 Kinetics
For 70SICs programmed with six of the seven mRNAs tested (thA1 excepted),
fluorescence signal changes measured with thG- or thA-containing mRNAs during
PRE complex formation are slower than those of initial TC binding to the ribosome
and faster than tRNA accommodation, consistent with the notion that these changes
monitor a common event, the formation of anticodon-codon base pairs. The
similarities in the value of k2 (obtained from global fits) for all three thG-labeled
mRNAs and for

th

A4 and

th

A6 as well (Table 5.4) support this notion. It was

previously indicated that EF-Tu interacts with L11 after binding to the ribosome and
induces its conformational change (Wang et al., 2012). Our results suggest that this
conformational change may occur as a result of cognate codon:anticodon interaction,
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as part of a series of conformational changes during aa-tRNA accommodation.
During translocation, the base pairing between mRNA codon and tRNA
anticodon loop is maintained, and both mRNA and tRNA move relative to the
ribosome. It is well documented that tRNA movements during translocation occur in
essentially two stages: first from classical states (tRNAs in A/A and P/P states,
respectively) in PRE complex to hybrid states (tRNAs in A/P and P/E states,
respectively), and then from hybrid states to POST complex (tRNAs in P/P and E
states, respectively) (Pan et al., 2007; Zhang et al., 2009). Recently, experiments using
mRNA labeled at the 3’-end showed that mRNA movements occur dominantly in
coupling with ribosomal subunit rotation and tRNA movement from the hybrid state
to the state in POST complex (Ermolenko and Noller, 2011), but a small signal
change could be observed upon EF-G.GTP binding (Studer et al., 2003; Ermolenko
and Noller, 2011). Here, utilization of emissive nucleoside mimetics programmed
within the decoding codon provides the potential for directly studying mRNA
movement during translocation and tRNA release from the ribosomal E-site after
translocation. EF-G.GTP dependent translocation was monitored using PRE complex
programmed with fMetLys-tRNALys(prf) and thA-containing mRNAs with substitution
at different positions of the first or the second codon. All PRE complexes used were
functional in translocation as indicated by POST complex formation (Figure 5.3C).
The fluorescence intensity change of

th

A4 and the simultaneous change of

fMetLys-tRNALys(prf) respond to the same translocation step, and their apparent rate
constants are similar to those of PRE complexes programmed with thG4 or thG6, and
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those previously reported using unmodified mRNAs (Pan et al., 2007; Ermolenko and
Noller, 2011), the latter of which corresponds to the transition from hybrid state to
POST complex. However, the measurements using thA1 or thA5 resulted in different
results. The fluorescence intensity change of thA1 was clearly slower than that of
fMetLys-tRNALys(prf) and

th

A4, presumably reporting the tRNA release from the

ribosomal E-site after translocation. Although the rate of thA5 fluorescence intensity
change is similar to thA4, the rate of the dominant phase of fluorescence intensity
change of fMetLys-tRNALys(prf) is faster. These results can be fit in a simple model
for translocation with four steps: i) EF-G.GTP binding to the ribosome; ii)
translocation of tRNA on the 50S subunit seen by D-loop fluorescence change; iii)
translocation of mRNA; and iv) tRNA release from the ribosomal E-site. For thG4,
th

G6 and thA4, steps ii) and iii) appear to proceed close to simultaneously, whereas for

th

A5, ii) clearly precedes iii).

5.4.4 Substitution at the middle codon position – Effects on PRE complex
formation
Substitution at the middle position of the second codon (thG5 and thA5) has an
inhibitory effect in all three steps that are measured here: initial TC binding to the
ribosome, codon:anticodon base pairing and tRNA accommodation, with the effect
more prominent for thA5. Previous results showed that aa-tRNA(prf) fluorescence
change monitors initial TC binding to the ribosome in the absence of mRNA: i.e.,
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without codon:anticodon interaction (Pape et al., 1998). However, the k1 values we
obtain from global fits indicate that this binding step is clearly affected by the identity
of the nucleoside at the middle codon position. The mechanism of TC binding to the
ribosome is still not completely understood, but our results suggest that
mRNA-independent TC binding is not a pre-requisite for codon:anticodon base
pairing, which is contrary to the model put forward by Pape et al. (1998).
According to the crystallographic studies of cognate TC bound to the ribosome
(Demeshkina et al., 2012), codon:anticodon base pairing is monitored by highly
conserved rRNA residues A1492, A1493 and/or G530. Full codon recognition
requires at least three steps in principle, corresponding to the base pair formation at all
three codon positions, but it is unclear whether the formation of these three base pairs
is simultaneous or sequential. The interaction between the middle position of an
mRNA codon and the tRNA anticodon loop was strongly inhibited by thA substitution
(Table 5.3), and in a more nuanced way by thG substitution. In the latter case, a small
(2-fold) decrease in the rate of base pairing with thG5 was only seen in the presence of
Arg-tRNAArg(prf) (Table 5.2). We speculate that this rate effect might result from
small perturbations in tRNA binding to the ribosome resulting from proflavin
substitution in the D-loop of aa-tRNA that are propagated to the anticodon loop.
Different from thG5, the rate of base pairing with thA5 is very slow using either
labeled or unlabeled forms of Lys-tRNALys and fMet-tRNAfMet (Table 5.3),
presumably due to a slowdown of base pairing at the middle codon position. A global
fit for the biphasic thA5 fluorescence changes gives two values for codon:anticodon
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base pairing: 40 ± 16 (minor change) and 0.44 ± 0.07 s-1 (major change) for k2a and
k2b, respectively. The k2a value is very close to the previously reported rate constant
from tRNA fluorescence changes that was assigned to codon recognition (Pape et al.,
1998). It’s likely that the k2a value is a reflection of environmental changes upon fast
base pair formation at the 5’ and/or 3’ codon position. We propose that the k2a value
obtained for thA5 represents the normal rate for initial codon:anticodon base pair
formation with unmodified codon. This is followed by a very slow base pairing step
(rate constant k2b) with the middle codon position, which then becomes the
rate-determining step for full base pairing and subsequent tRNA accommodation. We
further propose that during normal base pairing, as exemplified by the results with
th

A4 and thA6, the three base pairing steps occur in a series of rapid steps that we are

not able to resolve, giving the appearance of a single first-order process with a rate
constant of k2. This accounts for why k2a is 2–6-fold higher than k2 (Table 5.4).
These results are consistent with the observation that misreading by the ribosome
occurs least frequently at the middle codon nucleotide (Szaflarski et al., 2008), and
the tight structural constraints to which codon:anticodon base pairing at the middle
position is subject within the ribosomal decoding center (Ogle et al., 2001;
Demeshkina et al., 2012; Demeshkina et al., 2013). Our results indicate that a
nucleoside mimetic can be utilized not only as a fluorescent probe for kinetic studies,
but also as an activity probe for the functional studies of the effects of base
modifications, using the sensitivity of reaction rate to base modifications.
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5.5 Conclusions
Herein we report the preparation of functional modified mRNAs containing
emissive nucleoside mimetics (thG or thA), and their application in elucidating the
dynamics of mRNA:tRNA pair during the decoding and translocation steps of the
elongation cycle of active ribosomes. Our results indicate that an thG or thA present at
the 5’, middle, or 3’-positions of an mRNA codon is an effective probe of
codon:anticodon interaction at the ribosomal decoding center as well as for mRNA
translocation within the ribosome. Such nucleoside analogues could also serve as
direct reporters of various changes during translation, including mRNA:tRNA
interaction during frame shifting events, or of the melting (e. g., of a downstream
pseudo-knot) or transient formation (e. g., of an internal Shine-Dalgarno sequence
with the 3’-end of 16S rRNA) of secondary structure.
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Table 5.1. Static fluorescence spectral changes during conversions between
different ribosome complexes.

70SIC to PRE

PRE to POST

Δ Intensity

Δ λmax

Δ Intensity

Δ λmax

th

G4

Increase

Blue shift

Decrease

Red Shift

th

G5

Decrease

No change

No change

No change

th

G6

Decrease

No change

Increase

No change

th

A1

No changea

No change

Decrease

No change

th

A4

Decrease

Blue shift

Increase

No change

th

A5

Decrease

No change

Increase

No change

th

A6

Decrease

No change

Increase

No change

a

Due to the necessary background subtraction in the experiments, a ~10% uncertainty
in fluorescence intensity change is expected. Therefore, a slight intensity change may
occur even if no apparent change is observed in static fluorescence experiments.
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Table 5.2. Apparent rate constants for reactions between 70SIC programmed
with thG-containing mRNAs and TCa.

mRNA fMet-tRNAfMet aa-tRNA kapp1b

kapp2c

kapp3d

th

th

G4

G6

MVF

th

G5

MRF

unlabeled

Val-prf

37 ± 2

8.3 ± 0.6

4.9 ± 0.3

prf

Val

–

7.0 ± 0.3

4.1 ± 0.4

unlabeled

Val

–

10.9 ± 0.1

–

unlabeled

Val-prf

37 ± 7

8.3 ± 0.5

5.5 ± 0.4

prf

Val

–

8.9 ± 1.2

3.9 ± 0.1

unlabeled

Val

–

10.5 ± 3.1

–

unlabeled

Val-prf

34 ± 1

–

7.2 ± 1.2

prf

Val

–

–

6.2 ± 0.5

unlabeled

Arg-prf

11± 2

2.3 ± 0.2

1.7± 0.1

prf

Arg

–

5.3 ± 0.1

3.1 ± 0.3

unlabeled

Arg

–

4.0 ± 0.2

–

unlabeled

Arg-prf

22 ± 2

–

3.9 ± 0.1

prf

Arg

–

–

4.8 ± 0.2
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a

Values presented are average ± average deviation from 2 independent determinations
and are fits of stopped-flow data to single exponentials [kapp2 (thG fluorescence
changes) and kapp3 (second entry tRNAfMet(prf) fluorescence changes)] or double
exponentials [kapp1 and kapp3, first entry (tRNAVal(prf) fluorescence changes)]. For thG4,
th
G5 and thG6, rates in the first, second and third rows were determined, respectively,
in the presence of: aa-tRNA(prf) and fMet-tRNAfMet; aa-tRNA and
fMet-tRNAfMet(prf); and aa-tRNA and fMet-tRNAfMet. For MVF and MRF, rates in
the first and second rows were determined, respectively, in the presence of:
aa-tRNA(prf) and fMet-tRNAfMet; and aa-tRNA and fMet-tRNAfMet(prf).
b

Rapid phase of aa-tRNA (prf) fluorescence change.

c th

G fluorescence change: upper, in presence of aa-tRNA(prf); middle, in presence of
fMet-tRNAfMet(prf); lower, in presence of unlabeled tRNAs.
Upper, slow phase of aa-tRNA (prf) fluorescence change; lower, fMet-tRNAfMet (prf)
fluorescence change.
d

155

Table 5.3. Apparent rate constants for reactions between 70SIC programmed
with thA-containing mRNAs and TCa.

mRNA fMet-tRNAfMet aa-tRNA kapp1b

kapp2c

kapp3d

th

th

th

A1

A4

A5

unlabeled

Lys-prf

55 ± 10

7.3 ±1.0

–

prf

Lys

–

5.5 ± 0.3

6.4 ± 0.1

unlabeled

Lys

–

11 ± 4

–

unlabeled

Lys-prf

53 ± 1

8.9 ± 0.5

–

prf

Lys

–

9.1 ± 1.7

5.2 ± 0.6

unlabeled

Lys

–

9.8 ± 0.7

–

unlabeled

Lys-prf

18 ± 5

13.2 ± 3.2

–

–

0.28 ± 0.09

–

–

8.9 ± 1.2

–

–

0.45 ± 0.08

0.43 ± 0.05

–

15.0 ± 1.2

–

–

0.66 ± 0.01

–

prf

unlabeled

th

A6

MKF

Lys

Lys

unlabeled

Lys-prf

62 ± 11

9.8 ± 1.6

–

prf

Lys

–

12.0 ± 1.3

6.6 ± 0.8

unlabeled

Lys

–

11.6 ± 1.3

–

unlabeled

Lys-prf

44 ± 3

–

–

prf

Lys

–

8.1±0.3
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a

Values presented are average ± average deviation from 2 independent determinations
and are fits of stopped-flow data to single exponentials [kapp1 (first entry tRNALys(prf)
fluorescence changes), kapp2 (thA fluorescence changes) and kapp3 (second entry
tRNAfMet(prf) fluorescence changes)]. For thA1, thA4, thA5 and thA6, rates in the first,
second and third rows were determined, respectively, in the presence of: aa-tRNA(prf)
and fMet-tRNAfMet; aa-tRNA and fMet-tRNAfMet(prf); and aa-tRNA and
fMet-tRNAfMet. For MKF, rates in the first and second rows were determined,
respectively, in the presence of: aa-tRNA(prf) and fMet-tRNAfMet; and aa-tRNA and
fMet-tRNAfMet(prf).
b

Aa-tRNA (prf) fluorescence change.

c th

A fluorescence change for thA1, thA4 and thA6: upper, in presence of aa-tRNA (prf);
middle, in presence of fMet-tRNAfMet (prf); lower, in presence of unlabeled tRNAs.
th
A fluorescence change for thA5: upper two, in presence of aa-tRNA (prf),
-0.026±0.005 and -0.059±0.009 in amplitude changes for fast and slow phase,
respectively; middle two, in presence of fMet-tRNAfMet (prf), -0.016±0.003 and
-0.044±0.007 in amplitude changes for fast and slow phase, respectively; lower two,
in presence of unlabeled tRNAs, -0.030±0.007 and -0.037±0.010 in amplitude
changes for fast and slow phase, respectively.
d

fMet-tRNAfMet (prf) fluorescence change
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Table 5.4. Microscopic rate constants (s–1) for 70SIC reaction with TCa.

mRNA

k1

k2 or k2ac

k3 or k2bc

th

G4

82 ± 9

7.2 ± 0.2

15.2 ± 0.7

th

G5b

45 ± 10

1.8 ± 0.2

6.1 ± 1.1

(45–85)c

7.5 – 6.0

9.9 ± 0.4

th

G6

80 ± 11

8.4 ± 0.4

13.7 ± 1.3

th

A4

123 ± 13

10.6 ± 0.3

12.0± 0.4

th

A5d

42 ± 1

40 ± 16

0.44 ± 0.07

th

A6

170 ± 9

11.3 ± 0.1

15.0 ± 0.5

a

Values presented are for results in Figures 5.9, 5.10B–D that are fit to Scheme 5.1 or
Scheme 5.2 (see text).
Upper values: Fit using fluorescence changes of Arg-tRNAArg(prf) and thG5 mRNA;
lower values: Fit using fluorescence changes of fMet-tRNAfMet(prf) and thG5 mRNA.
b

c

For thA5.

d

The values are mean ± standard deviation of two fits, with and without thA5 data
measured with unlabeled fMet-tRNAfMet and unlabeled Lys-tRNALys.
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Table 5.5. Apparent rate constants for POST complex formation on reaction of
PRE complexes programmed with thG- and thA-containing mRNAs and
EF-G.GTPa.
mRNA

kapp

kapp

kapp

(thG or thA)

[fMet-aa-tRNA(prf)]

(Global fit)

th

G4

3.7 ± 1.5

4.6 ± 0.1

4.7 ± 0.3

th

G5

N/Ab

6.2 ± 1.6

N/Ac

th

G6

4.1 ± 0.6

3.1 ± 0.1

3.4 ± 0.2

th

A1

1.3 ± 0.1

4.2 ± 0.2

N/Ac

th

A4

3.5 ± 0.2

5.2 ± 0.3

4.4 ± 0.3

th

th

A5

2.3 ± 0.2

A6

N/Ab

13 ± 1 (0.074±0.022)c
0.94 ± 0.16 (0.044±0.007)
2.6 ± 0.2

c

N/Ad
N/Ad

a

Values presented are average ± average deviation from 2 independent determinations
and are, in most cases, fits of stopped-flow data to single exponentials [second
column, fits of thG or thA fluorescence changes alone; third column, fits
fMet-aa-tRNA(prf) fluorescence changes alone; and fourth column, global fits of both
th
G or thA and fMet-aa-tRNA(prf) fluorescence changes]. The only exception is
fMet-aa-tRNA(prf) fluorescence change of PRE complex programmed with thA5,
which is fit to double exponential.
b

No thA fluorescence change.

c

Values in the parentheses are amplitude changes.

d th

G or thA fluorescence change can not be globally fitted together with
fMet-aa-tRNA(prf) fluorescence change.
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Figure 5.1. mRNAs labeled with isomorphic fluorescent nucleoside mimetics.
Modification positions are shown in red.

160

A

B

/ mRNA

0.6

0.3

0.4

fMet

0.2

fMet-tRNA

fMet-tRNA

fMet

/ mRNA

0.4

0.1
0.0
No mRNA

th

MVF

th

G4

0.2

0.0

G6

MRF

th

G5

Relative PRE formation

D

Relative PRE formation

C

No mRNA

1.2

0.8

0.4

0.0
MVF

th

G4

1.2

0.8

0.4

0.0

th

G6

E

MRF

th

MRF

th

G5

F
1.2

Relative POST formation

Relative POST formation

1.2

0.8

0.4

0.0
MVF

th

G4

th

G6

161

0.8

0.4

0.0
G5

Figure 5.2. Activities of mRNAs containing thG. Formation of various complexes with
ribosomes programmed with thG4 or thG6 (A, C, E) or thG5 (B, D, F). A and B. 70SIC
formation, measured as fMet-tRNAfMet co-sedimented per mRNA added: ribosomes,
1.0 μM, mRNA 0.5 μM. C and D. Normalized PRE complex formation, with
background in the absence of mRNA subtracted: ribosomes, 0.8 μM. E and F.
Normalized POST complex formation. thG4, thG6: ribosomes, 2 μM. thG5: ribosomes
4.8 ± 0.2 μM. Control experiments were performed, as indicated, with either no added
mRNA, or with added unmodified mRNA, or with no added EF-G. Values reported in
C and D were relative to the corresponding unmodified mRNAs (MVF for thG4 and
th
G6; MRF for thG5) after subtraction of background obtained with no mRNA and
normalized to the value obtained for unmodified mRNA. Values reported in E and F
were obtained from Equations 2.1A and 2.1B and normalized to the value obtained for
unmodified mRNA.
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Figure 5.3. Activities of mRNAs containing thA. A. 70SIC formation, measured as
fMet-tRNAfMet co-sedimented per mRNA added: ribosomes, 1.0 μM, mRNA 0.5 μM.
B. Normalized PRE complex formation, with background in the absence of mRNA
subtracted: ribosomes, 0.8 μM. C. Normalized POST complex formation (ribosomes,
4.8 ± 0.2 μM). Control experiments were performed, as indicated, with either no
added mRNA, or with added unmodified mRNA, or with no added EF-G. Values
reported in B were relative to the corresponding unmodified MKF mRNA after
subtraction of background obtained with no mRNA and normalized to the value
obtained for unmodified mRNA. Values reported in C were obtained from Equations
2.1B and normalized to the value obtained for unmodified mRNA.
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Figure 5.4. Excitation and emission spectra of thG- and thA-containing mRNAs. A.
Excitation spectra of free thG-containing mRNAs (0.8 μM). B. Slight bathochromic
shift of fluorescence maximum of thG4 and thG5 but not of thG6 upon binding to the
ribosome as part of a 70SIC. 70SICs programmed with thG containing-mRNAs were
prepared in situ by using 70S (1.2 μM) and thG-containing mRNA (0.6 μM), and
incubating at 37 oC for 5 min. Buffer background fluorescence was subtracted from
the signals of free thG-containing mRNAs (0.6 μM). Background fluorescence from
the mixture of 70S, translation factors and fMet-tRNAfMet with no incubation was
subtracted from the 70SIC programmed with thG-containing mRNAs. The traces
shown in B are average of two independent determinations. C. Excitation spectra of
free thA-containing mRNAs (0.8 μM). D. 70SICs programmed with thA
containing-mRNAs were prepared in situ by using 70S (1.2 μM) and thA-containing
mRNA (0.6 μM), and incubating at 37 oC for 5 min. Buffer background fluorescence
was subtracted from the signals of free thA-containing mRNAs (0.6 μM). Background
fluorescence from the mixture of 70S, translation factors and fMet-tRNAfMet with no
incubation was subtracted from the 70SIC programmed with thA-containing mRNAs.
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Figure 5.5. Fluorescence changes of thG-containing mRNAs. A–C. Traces are shown
for 70SIC (black); PRE complex (red); POST complex (green). 70SIC traces are for
purified samples. PRE complex traces shown are the average of two independently
determined traces: i) PRE complex prepared in situ by addition of TC to 70SIC; ii)
purified PRE complex used in the preparation of POST complex. To account for small
concentration differences arising from the two preparation methods, the traces for
purified PRE complexes were normalized to those for in situ generated PRE
complexes, using an 8 nm window covering the fluorescence maximum to generate a
normalization factor. The resulting two very similar traces were then averaged. POST
complexes were prepared in situ from purified PRE complexes by incubation with
EF-G.GTP (2.5 µM for 20 s), and traces were normalized using the same
normalization factors as above. For all traces and prior to any normalization,
background fluorescence of the corresponding complex made with unlabeled mRNA
was subtracted from the observed fluorescence of each of the labeled ribosome
complexes. Intensities are normalized to the peak intensity value of 70SIC for each
mRNA. D. Fluorescence intensity changes were obtained by subtracting the spectrum
of a purified complex (70SIC or PRE) from the spectrum of a complex prepared in
situ (PRE or POST, respectively) and then normalizing the intensity differences to the
peak intensity value of purified complex (70SIC or PRE, respectively).
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Figure 5.6. Fluorescence changes of thA-containing mRNAs. A–D. Traces are shown
for 70SIC (black); PRE complex (red); POST complex (green). 70S IC traces are for
purified samples. PRE complex traces shown are the average of two independently
determined traces: i) PRE complex prepared in situ by addition of TC to 70SIC; ii)
purified PRE complex used in the preparation of POST complex. To account for small
concentration differences arising from the two preparation methods, the traces for
purified PRE complexes were normalized to those for in situ generated PRE
complexes, using an 8 nm window covering the fluorescence maximum to generate a
normalization factor. The resulting two very similar traces were then averaged. POST
complexes were prepared in situ from purified PRE complexes by incubation with
EF-G.GTP (2.5 µM for 20 s), and traces were normalized using the same
normalization factors as above. For all traces and prior to any normalization,
background fluorescence of the corresponding complex made with unlabeled mRNA
was subtracted from the observed fluorescence of each of the labeled ribosome
complexes. Intensities are normalized to the peak intensity value of 70SIC for each
mRNA. E. Fluorescence intensity changes were obtained by subtracting the spectrum
of a purified complex (70SIC or PRE) from the spectrum of a complex prepared in
situ (PRE or POST, respectively) and then normalizing the intensity differences to the
peak intensity value of purified complex (70SIC or PRE, respectively).
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Figure 5.7. Lack of fluorescence change on adding non-cognate TCs to 70SICs
programmed with thG-containing mRNAs. A–C. Traces are shown for 70SIC alone
(black) and 70SIC with added non-cognate TC (red; EF-Tu.GTP.Arg-tRNAArg for
th
G4 and thG6, and EF-Tu.GTP.Val-tRNAVal for thG5). 70S IC traces are for purified
samples. For all traces, background fluorescence of the corresponding complex made
with unlabeled mRNA was subtracted from the observed fluorescence of each of the
labeled ribosome complexes. D. Time-resolved fluorescence changes on rapid mixing
of 70SIC programmed with thG-containing mRNAs (0.1 µM) with non-cognate TC
(0.4 µM).
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Figure 5.8. Lack of fluorescence change on adding non-cognate TCs to 70SICs
programmed with thA-containing mRNAs. A–D. Traces are shown for 70SIC alone
(black) and 70SIC with added non-cognate TC (red; EF-Tu.GTP.Arg-tRNAArg). 70S
IC traces are for purified samples. For all traces, background fluorescence of the
corresponding complex made with unlabeled mRNA was subtracted from the
observed fluorescence of each of the labeled ribosome complexes.
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Figure 5.9. Kinetics of PRE complex formation of thG-containing mRNAs.
Fluorescence changes on rapid mixing of 70SICs (0.1 μM) programmed with
th
G-containing mRNAs and cognate TCs (0.4 μM) compared with fluorescence
changes of aa-tRNA(prf) (dark blue), present as part of the TC, or of
fMet-tRNAfMet(prf) (cyan), present as part of the 70SIC. Rates of thG fluorescence
change were determined using either unlabeled fMet-tRNAfMet and unlabeled
aa-tRNAaa (green), unlabeled fMet-tRNAfMet and aa-tRNAaa(prf) (red), or
fMet-tRNAfMet(prf) and unlabeled aa-tRNAaa (magenta). A. thG4; B. thG5; C. thG6.
Traces shown are the average of two independently determined traces, which, in each
case were quite similar to one another. Solid black lines are global fittings to Scheme
5.1 values, using rate constant values summarized in Table 5.4. The green, magenta
and cyan curves in part B was fit with the following values (in s–1): k1 65 ± 4, k2 6.6 ±
0.2, k3 9.9 ± 0.4.
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Figure 5.10. Kinetics of PRE complex formation of thA-containing mRNAs.
Fluorescence changes on rapid mixing of 70SICs (0.1 μM) programmed with
th
A-containing mRNAs and cognate TCs (0.4 μM) compared with fluorescence
changes of aa-tRNA(prf) (dark blue), present as part of the TC, or of
fMet-tRNAfMet(prf) (cyan), present as part of the 70SIC. Rates of thA fluorescence
change were determined using either unlabeled fMet-tRNAfMet and unlabeled
aa-tRNA (green), unlabeled fMet-tRNAfMet and aa-tRNA(prf) (red), or
fMet-tRNAfMet(prf) and unlabeled aa-tRNA (magenta). A. thA1; B. thA4; C. thA5; D.
th
A6. Traces shown are the average of two independently determined traces, which, in
each case were quite similar to one another. Solid black lines in B and D are global
fittings to Scheme 5.1 (thA4 and thA6), using rate constant values summarized in Table
5.4. Solid black lines in C are global fittings to Scheme 5.2 with thA5 data measured
with unlabeled fMet-tRNAfMet and unlabeled Lys-tRNALys included, using rate
constant values(in s–1): k1 42, k2 40, k3 0.44. .
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Figure 5.11. Kinetics of POST complex formation of thG-containing mRNAs.
Fluorescence changes on rapid mixing of PRE complexes (0.1 μM) programmed with
th
G-containing mRNAs (black) and EF-G.GTP (2 μM) compared with fluorescence
changes of fMetVal-tRNAVal(prf) (red), present as part of the PRE complex. A. thG4; B.
th
G6. Solid black lines are single exponential fits of both the thG and
fMetVal-tRNAVal(prf) fluorescence intensity changes, with kapp of 4.7 ± 0.3 and 3.4 ±
0.2 sec-1 for thG4 and thG6, respectively. Average deviations are given for the two
independent experiments.
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Figure 5.12. Kinetics of POST complex formation. Fluorescence changes on rapid
mixing of PRE complexes (0.1 μM) programmed with thA-containing mRNAs (black)
and EF-G.GTP (2 μM) compared with fluorescence changes of fMetLys-tRNALys(prf)
(red), present as part of the PRE complex. A. thA1; B. thA4; C. thA5. Solid black lines
in B are single exponential fits of both the thA4 and fMetLys-tRNALys(prf)
fluorescence intensity changes, with kapp of 4.1 ± 0.3 sec-1. Average deviations are
given for the two independent experiments.
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APPENDIX I
MONITORING TRANSLATION WITH MODIFIED mRNAS
STRATEGICALLY LABELED WITH ISOMORPHIC
FLUORESCENT URIDINE AND CYTIDINE MIMETICS
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I.1 Abstract
Here we examine three mRNAs, site-specifically modified at codon positions 2, 5,
and 6 with new emissive and responsive isosteric nucleoside mimetics (thU and thC),
with the goal of developing real time assays for monitoring translation-related events
at nucleotide resolution.

th

U5 and

th

C6, but not

th

U2, form functional initiation

(70SIC), pretranslocation (PRE) and posttranslocation (POST) complexes. Spectral
differences are seen on conversion of 70SIC to PRE complexes and these differences
allow measurement of the kinetics of such conversions by changes in the fluorescence
of labeled mRNAs.

II.2 Introduction
Many of the studies directed toward understanding of the dynamics of ribosome
function rely heavily on both ensemble and single molecule time-resolved
observations made with functional, fluorescent-labeled derivatives of components of
the protein synthesis machinery, for the most part including tRNAs, ribosomal
proteins, and protein auxiliary factors such as EF-Tu and EF-G (Frank and Gonzalez,
2010; Pan et al., 2009; Chen et al., 2011a; Cooperman et al., 2011). Despite the central
role of mRNA in protein synthesis, the use of fluorescent mRNAs has, by contrast,
been quite limited, confined almost exclusively to mRNAs derivatized at the 3’-end
with fluorophores that monitor the movement of this terminus to a position at the
entrance of the mRNA channel during translocation (Savelsbergh et al., 2003; Studer
177

et al., 2003; Liu et al., 2010; Cunha et al., 2013).
In Chapter V, we describe the preparation of functional mRNAs containing
emissive and responsive thGuanosine (thG) or thAdenosine (thA) mimetic based on
thieno[3,4-d]pyrimidine, within the initiation or the first elongation codon. The
fluorescence changes of these mRNAs permit monitoring of the conversion of a
70SIC first to a pretranslocation (PRE) complex, and a specific step corresponding to
codon:anticodon-loop base pair formation was identified (Liu et al., 2013). thG and thA
are isosteric with the nucleoside being mimicked; however,
th

th

Uridine (thU) and

Cytosine (thC) have the effect of converting pyrimidines into isosteres of purines

(Shin et al., 2011). Here, we describe the preliminary characterization of three
mRNAs containing emissive and responsive thU or thC within the initiation or the first
elongation codon. Our results show that mRNAs carrying an thU or thC substitution
within the second codon are functional in 70SIC, PRE or POST complex formation.
The fluorescence changes of these two mRNAs during conversion of 70SIC to PRE
complexes can be used to monitor codon:anticodon base pairing.

I.3 Results
I.3.1 Modified mRNAs
Three short mRNAs containing a single thU or thC within the AUG initiation codon
or the following codon were prepared, and named as thU2, thU5 and thC6, respectively,
according to the positions of the modification at the middle position of initiation
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codon, or middle, and 3’-positions of the second codon (Figure I.1). All these mRNAs
encode Phe at the second codon position. An additional mRNA MFTI containing no
modified nucleotides was also prepared.

I.3.2 Formation of functional initiation and elongation complexes
Modified mRNAs were tested for their activities in different stages of translation:
70S initiation complex (70SIC) formation (Figure I.2A), as measured by
fMet-tRNAfMet co-sedimentation with a 70S ribosome; pretranslocation (PRE)
complex formation (Figure I.2B), as measured by Phe-tRNAPhe co-sedimentation with
a 70SIC; and EF-G.GTP dependent translocation (Figure I.2C), as measured by
fMet-Phe-puro formation. The results in Figure I.2 demonstrate that substantial
functionality is retained on nucleoside mimetic substitution at positions 5 or 6 (thU5
and thC6). The thU substitution at the middle position of AUG codon (thU2) abolishes
fMet-tRNAfMet binding to the ribosome. Therefore, thU2 was not used in following
studies.

I.3.3 Fluorescence changes on functional complex formation
th

U and

th

C are both ideally emissive and responsive fluorescent nucleoside

mimetics with the same quantum yields of 0.41 (Shin et al., 2011). Although
incorporation into oligonucleotides generally lowers the quantum yield of emissive
nucleosides (Sinkeldam et al., 2010), we anticipated that modified oligonucleotides
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shown in Figure I.1 would retain a high level of responsiveness that would allow one
to monitor mRNA binding and movement and subtle environmental changes within
the ribosome during the elongation cycle. Excitation wavelength was chosen for thU5
(320 nm) and thC6 (340 nm) by comparing their maximum emission intensity at
different excitation wavelength, to obtain the high emission intensity and minimize
the background fluorescence from the ribosome (Figure I.3).
Conversion

of

70SIC

to

PRE

complex

via

addition

of

cognate

EF-Tu.GTP.aminoacyl-tRNA ternary complex (EF-Tu.GTP.aa-tRNA, denoted TC)
results in Watson-Crick base pairing of the thU or thC present in the first elongator
tRNA codon, so that observed changes reflect both generalized environmental effects
of converting a 70SIC into the first PRE complex and the specific effects of
codon:anticodon H-bonding at the A-site. Conversion of thU5- or thC6-programmed
70SIC to PRE complex proceeds with a small decrease and a large increase in
fluorescence intensity, respectively. Such fluorescence changes allow us to monitor
changes in the microenvironments of specific codon nucleotides at the decoding
center during the first cycle of polypeptide elongation.

I.3.4 Kinetics of PRE complex formation
Earlier work showed that fMet-tRNAfMet(prf) bound in the P-site monitors
accommodation of aa-tRNAaa within the ribosome in an essentially single-phase
reaction (Pan et al., 2008). Rates of fluorescence change of
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th

U5- and

th

C6-programmed ribosomes on PRE complex formation were determined using

unlabeled fMet-tRNAfMet and unlabeled aa-tRNA, or fMet-tRNAfMet(prf) and
unlabeled aa-tRNA (Table I.1; Figure I.5). In the latter experiments, parallel
measurements were made for the rates of fMet-tRNAfMet(prf) fluorescence change.
Rates of fMet-tRNAfMet(prf) fluorescence change were also determined when MFTI
were substituted. Change of thC6 fluorescence was somewhat slower than that of thG6
and thA6 (see Chapter V), and tRNA accommodation measured by fMet-tRNAfMet(prf)
was slowed down by ~2 fold compared with unmodified MFTI mRNA. Similar to
th

G5 and thA5, thU substitution at the middle position of first elongation codon led to a

decrease for both kapp2 and kapp3 compared with thC6.

I.4 Experimental
Modified mRNAs are kind gifts from Prof. Yitzhak Tor (University of California,
San Diego). Functionality of mRNAs in 70SIC, PRE or POST complexes formation
was tested using the same procedures as thG4 or thG6 (Section 2.2.5.2). Fluorescence
experiments were performed using similar procedures to thG4 or thG6 (Section 2.2.6)
with some modifications. thU5 was excited at 320 nm and fluorescence signal was
collected using a 410 ± 10 nm filter. thC6 was excited at 320 nm and fluorescence
signal was collected using a 410 ± 10 nm filter. Static fluorescence intensity
measurements were performed using purified 70SIC and purified PRE complexes at
the same concentration for both thU5 and thC6.
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I.5 Conclusions
Herein we report the preliminary data showing that mRNAs containing emissive
nucleoside mimetics (thU or thC) can form functional ribosomal complexes and are
effective probes of codon:anticodon interaction at the ribosomal decoding center.
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Table I.1. Apparent rate constants for reactions between 70SIC programmed
with thU- and thC-containing mRNAs and TCa.

mRNA fMet-tRNAfMet aa-tRNA kapp2b

kapp3c

th

th

U5

C6

MFT

prf

Phe

3.2

1.0

unlabeled

Phe

2.6

–

prf

Phe

6.7

0.67

unlabeled

Phe

6.1

–

prf

Phe

–

2.7 ± 0.1

a

Values presented are mostly results from one independent determinations, except for
MFT with fMet-tRNAfMet(prf) and Phe-tRNAPhe, which is average ± average
deviation from two independent determinations; Values are fits of stopped-flow data
to single exponentials [kapp2 (thU or thC fluorescence changes) and kapp3 (tRNAfMet(prf)
fluorescence changes)]. For thU5 and thC6, rates in the first and second rows were
determined, respectively, in the presence of aa-tRNA and fMet-tRNAfMet(prf) or
aa-tRNA and fMet-tRNAfMet. For MFT, rate was determined in the presence of:
aa-tRNA and fMet-tRNAfMet(prf).
b th

U and thC fluorescence change: upper, in presence of fMet-tRNAfMet (prf); lower, in
presence of unlabeled tRNAs.
c

fMet-tRNAfMet (prf) fluorescence change.
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Figure I.1. mRNAs labeled with isomorphic fluorescent nucleoside mimetics.
Modification positions are shown in red.
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Relative PRE formation

0.8

fMet-tRNA

fMet

/ mRNA

1.2

0.4

0.0
no mRNA

MFTI

th

th

U2

U5

th

1.2

0.8

0.4

0.0

C6

MFTI

th

U5

th

C6

Relative POST formation

C
1.2

0.8

0.4

0.0

MFTI

th

U5

th

C6

Figure I.2. Activities of mRNAs containing thU or thC. A. 70SIC formation, measured
as fMet-tRNAfMet co-sedimented per mRNA added: ribosomes, 1.0 μM, mRNA 0.5
μM. B. Normalized PRE complex formation, with background in the absence of
mRNA subtracted: ribosomes, 0.8 μM. C. Normalized POST complex formation.
Ribosomes, 2 μM. Control experiments were performed, as indicated, with either no
added mRNA, or with added unmodified mRNA, or with no added EF-G. Values
reported in C were after subtraction of background obtained with no mRNA and
normalized to the value obtained for unmodified mRNA. Values reported in C were
obtained from Equations 2.2A and normalized to the value obtained for unmodified
mRNA.
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Figure I.3. Determination of excitation wavelength for thU- or thC-containing mRNAs.
Emission spectra of free thU5 (A) or thC6 (B) mRNAs (0.8 μM) were recorded at
different excitation wavelength. Background fluorescence from the buffer used was
subtracted at each excitation wavelength.
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Figure I.4. Fluorescence changes of thU- and thC-containing mRNAs. A–B. Traces are
shown for 70SIC (black) and PRE complex (red). Both 70SIC and PRE complex
traces are for purified samples. Background fluorescence of the corresponding
purified complex made with unlabeled mRNA was subtracted from the observed
fluorescence of each of the labeled ribosome complexes.
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Figure I.5. Kinetics of PRE complex formation of thU- and thC-containing mRNAs.
Fluorescence changes on rapid mixing of 70SICs (0.1 μM) programmed with thU- or
th
C-containing mRNAs and cognate TCs (0.4 μM) compared with fluorescence
changes of fMet-tRNAfMet(prf) (cyan), present as part of the 70SIC. Rates of thU or thC
fluorescence change were determined using either unlabeled fMet-tRNAfMet and
unlabeled aa-tRNA (green), or fMet-tRNAfMet(prf) and unlabeled aa-tRNA (magenta).
A. thU5; B. thC6.
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APPENDIX II
RIBOSOME LABELING WITH GOLD PARTICLE FOR
TRANSLATION IMAGING
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II.1 Abstract
Nanoparticles have great potentials in translation imaging. Here we present
preliminary results to show that ribosomal protein L1 can be specifically labeled with
an Au particle. The reconstituted 70S ribosome containing Au labeled L1 is partially
functional in peptide synthesis.

II.2. Introduction
Protein synthesis takes place on the ribosome. Currently, most of our
understandings of the kinetics of ribosomal translation heavily relies on labeling of
the ribosome, translation factors and/or tRNAs with organic fluorophores, using them
for both ensemble and single molecule studies (Frank and Gonzalez, 2010; Pan et al.,
2009; Chen et al., 2011a; Cooperman et al., 2011). Compared with ensemble strategy,
single molecule FRET (Fluorescence Resonance Energy Transfer) method overcomes
both time- and sample-dependent heterogeneity problems, and promises detection of
short-lived, but functionally essential intermediates (Marshall et al., 2008; Perez and
Gonzalez Jr, 2011). However, single molecule fluorescence techniques have suffered
significantly from numerous requirements imposed on the probes, especially the fast
photobleaching of organic dyes. Nanoparticles are ideal candidates to overcome such
a limitation due to their high quantum yield, photostability and tunable absorption and
emission (Gao et al., 2005; Chang and Rosenthal, 2013). Although nanoparticles have
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recently been extensively used as fluorescent probes or FRET donor or acceptor in
single molecule experiments (Grecco et al., 2004; Vale, 2008), only sparse attention
has been paid to the ribosome translation apparatus [e.g., an Au particle was used to
label L7/L12 protein on prokaryotic ribosome (Montesano-Roditis et al., 2001)]. Here
it is shown that i) ribosomal protein L1 can be specifically labeled with an Au particle;
ii) the L1 derivative is competent in L1 uptake by a mutant 50S ribosome subunit
lacking L1; and iii) the reconstituted 70S ribosome maintains at least part of its
translation function in an in vitro peptide synthesis system.

II.3. Results
II.3.1 L1 labeling with Au particle
The Au particle used here has a uniform diameter of 1.4 nm and molecular weight
of 15 kD, bearing one maleimide group per particle on average. Mutant L1(S40C)
was incubated with 2-fold excess of Au particle. After quenching of free Au particle
with glutathione, the reaction mixture was analyzed by SDS-PAGE with two gels
running in parallel. One gel was silver stained, which detect any protein or Au particle;
and the second gel was stained by LI Silver Stain Plus kit, which only detects Au
particles. Besides the band for L1(S40C) (~ 31 kD), which is only observed on the gel
stained by silver, two bands around ~34–36 kD and one band at ~68 kD were
observable on the gel stained by both silver and LI silver (Figure II.1). The two bands
at 34–36 kD were assumed to be the Au:L1(S40C) conjugate in 1:1 ratio, and the two
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resolved bands and their apparent molecular weight lower than expected (~ 46 kD)
were probably because of the relative conformation of Au particle and L1(S40C)
protein within the conjugate. The higher band at ~68 kD was assumed to be the
Au:L1(S40C) conjugate in 1:2 ratio, resulting from a small amount of Au particle
carrying two maleimide groups. In a control experiment incubating Au particle with
wild type L1 [Au:L1(WT)], the resulting mixture showed bands located at 31, 34 and
64 kD on the gel stained by silver, but these bands disappeared (64 kD) or became
much weaker (31 and 34 kD) on the gel stained by LI silver (Figure II.1), which may
result from non-specific binding of Au particle to wild type L1 protein. These results
demonstrated that ribosomal protein L1 can be specifically and stoichiometrically
labeled with Au particle [L1(S40C)Au] via cysteine-maleimide chemistry.

II.3.2 Reconstitution of functional 50S ribosome
Reconstitution of intact 50S subunit was performed by incubating 50S mutant
lacking L1 (50S-L1) with either L1(S40C)Au conjugate or Au:L1(WT) mixture. The
resulting 50S was purified by centrifugation through sucrose cushion, and the
re-suspended 50S was analyzed on SDS-PAGE gel and stained by LI silver (Figure
II.2). It was shown that L1(S40C)Au can be specifically uptaken by 50S-L1, even in
competition with unlabeled L1(S40C). The labeling efficiency of 50S by Au (50SAu)
was estimated to be roughly 50% by comparing the band intensity with a “standard
curve” made on the same gel using free Au (Figure II.3).
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Labeled 70S ribosome by Au (70SAu) was prepared by incubating reconstituted
50SAu with stoichiometric 30S subunit, and the functionality of 70SAu was evaluated
in a poly(U) dependent poly(Phe) synthesis assay (Pan et al., 2009). The results in
Figure II.4 showed that the activity of reconstituted 70SAu was comparable with 70S
reconstituted from 30S and unlabeled 50S subunit, and both of them are somewhat
less active than intact 70S ribosome.

II.4 Experimental
The following materials were purchased from the indicated suppliers: glutathione
(Sigma); Silver Stain Plus kit (Bio-Rad); LI Silver Stain kit (Nanoprobes); Nanogold
monomaleimide (Invitrogen). Yeast tRNAPhe was aminoacylated and AcPhe-tRNAPhe
was prepared as in Section 2.2.4.

II.4.1 Purification of L1 variants
Overexpression and purification of L1 variants were based on the published
procedures (Stevens et al., 2012). BL21(DE3) competent cell, transformed with
pET16b plasmids carrying wild type or S40C mutant L1, was grown in S.O.C.
medium at 37 °C for one hour. The cell culture was plated onto LB-Agar plate with
100 μg/ml of ampicillin and grown overnight at 37 °C. Single colony on the plate was
inoculated into 6 ml of LB medium with 100 μg/ml of ampicillin for overnight growth
at 37 °C. Then the cell culture was transferred into 1 L of LB medium with 100 μg/ml
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of ampicillin for growth until A260 reached ~0.6–0.8. Protein expression was started
by addition of 1 mM IPTG and lasted overnight at 37 °C.
Harvested cells were resuspended in 30 ml of L1 equilibration buffer (50 mM
NaH2PO4 pH 7.0, 300 mM NaCl) and incubated at room temperature for 30 min after
addition of lysozyme (0.75 mg/ml). Cell was broken by French press twice
(12,000–14,000 psi) and centrifuged (4 °C, 20k rpm with SS34 rotor, 20 min) to
remove the cell debris. The supernatant was mixed with 6 ml of Co(II)-Sepharose
(Talon) resin, pre-washed with 30 ml of L1 equilibration buffer, and shaken at 4 °C
for 1 hour. Resins bound with L1 were pulled down by centrifugation (4 °C, 700 xg, 5
min), washed twice with 30 ml of L1 equilibration buffer, and transferred to a small
gravity small column (18 mm in diameter). The column was washed with 30 ml of L1
equilibration buffer, and L1 was eluted using L1 equilibration buffer with a imidazole
gradient (25 mM, 2 ml; 50 mM, 2 ml; 100 mM, 2 ml; 150 mM, 5 ml; 300 mM, 10 ml).
Fractions containing L1 were confirmed by 12% SDS-PAGE and pooled for dialysis
at 4 °C, first against buffer A (50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7
mM MgCl2 and 1 mM DTT) without MgCl2 overnight and then against buffer A for 3
hours with MgCl2. L1 was concentrated using Amicon Ultra ultrafiltration units
(MWCO: 10,000) and protein concentration was determined by Bradford assay.

II.4.2 Labeling of L1(S40C) and the 50S subunit with Au particle
L1(S40C) or wild type L1 (7 μM after exchange) was exchanged into L1
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labeling buffer (20 mM NaH2PO4 pH 7.0, 150 mM NaCl, 1 mM EDTA) using NAP-5
column (bed volume 0.5 ml), mixed with equal volume of Au particle (21 μM) freshly
dissolved in 20% DMSO, and incubated at room temperature for 2 hours in the
presence of 1 mM of TCEP. Reaction was stopped by adding 1 mM of glutathione to
quench all free Au particles. The samples were directly loaded onto gel or further used
without any purification.
50S mutant lacking L1 (50S-L1) and 30S subunit were prepared as previously
described (Subramanian and Dabbs, 1980). To make reconstituted Au labeled 50S
subunit (50SAu), L1(S40C)Au was incubated with 50S-L1 in 100 μl of 50S
reconstitution buffer (10 mM Tris-HCl pH 7.5, 150 mM NH4Cl, 8 mM MgCl2, 5 mM
2-mercaptoethanol) (see Figure II.2 for amounts of the 50S subunit and L1 used) at
room temperature for 1 hour. Reconstituted 50S subunit was purified by
centrifugation through a sucrose cushion in 50S sucrose cushion buffer (10 mM
Tris-HCl pH 7.5, 30 mM NH4Cl, 10 mM MgCl2, 5 mM 2-mercaptoethanol, 1.1 M
sucrose) (SORVALL S120-AT2 rotor, 110K rpm, 40 min, 4 oC), and the pellets were
resuspended in 50S resuspension buffer (10 mM Tris-HCl pH 7.5, 100 mM NH4Cl, 10
mM MgCl2, 5 mM 2-mercaptoethanol).

II.4.3 Activity of Au labeled ribosome in poly(Phe) synthesis
The poly(Phe) assay was carried out in buffer C (20 mM Tris-HCl pH 7.6, 200
mM NH4Cl, 10 mM MgAc2). All concentrations below are final concentrations after
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mixing. 70S ribosome was prepared by incubating equal amounts of 50S and 30S
subunits at 30 °C for 30 min. Initiation mixture was prepared by mixing 70S ribosome
(0.3 μM, based on 50S or 30S subunits), poly(U) (0.3 g/L) and [3H]-AcPhe-tRNAPhe
(0.36 μM), and incubated at 30 °C for 30 min. Poly(Phe) synthesis was started by
adding 2-mercaptoethanol (3 mM), PEP (0.4 mM), PK (4 mg/L), GTP (0.5 mM),
[3H]-Phe-tRNAPhe (3.6 μM) and EF-G (0.5 μM), and performed by incubating at 30
°C. Fractions ( 3.5 μl) were aliquoted out at different time points (0, 0.7, 2, 8, 30, 60
and 120 min), quenched with 0.3 mL of 5% TCA, and heated to 95 °C for 15 min.
Filter binding was performed using a nitrocellulose filter followed by three washes
with chilled 5% TCA, and the radioactivity of [3H]-Phe-tRNAPhe was determined.

II.5 Conclusions
Here we report the specific and stoichiometic labeling of ribosome protein L1
with Au nanoparticle. L1(S40C)Au was competent in binding to the 50S subunit, and
partial activity is retained for reconstituted 70SAu in in vitro peptide synthesis assay.
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A

B

Figure II.1. Specific and stoichiometric labeling of L1 with Au nanoparticle. Au
particle was incubated with either mutant L1(S40C) or wild type L1. The resulting
mixtures [L1(S40C)Au and Au:L1(WT), respectively] were analyzed by SDS-PAGE
stained by either silver (A) or LI silver (B).
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Lane

1

2

3

4

5

6

7

8

L1(S40C)Au

270 pmol

270 pmol

270 pmol

270 pmol

180 pmol

120 pmol

–

–

Au:L1(WT)

–

–

–

–

–

–

270 pmol

–

L1(S40C)

–

–

100 pmol

200 pmol

90 pmol

150 pmol

–

+

50S-L1

–

80 pmol

80 pmol

80 pmol

80 pmol

80 pmol

80 pmol

–

50S

80 pmol

–

–

–

–

–

–

–

Figure II.2. Reconstitution of 50SAu from L1(S40C)Au. L1(S40C)Au or Au:L1(WT)
was incubated in the presence of 50S-L1 or intact 50S. Unlabeled L1(S40C) was used
as a reconstitution competitor for L1(S40C)Au as indicated. The samples loaded onto
each lane were listed in the table. The gel was stained by LI silver, which is specific
for Au particle.
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Figure II.3. Semi-quantifying of 50SAu labeling efficiency. Samples loaded onto
SDS-PAGE gel were: Lane 1, L1(S40C)Au, 80 pmol; Lane 2, L1(S40C)Au, 60 pmol;
Lane 5, 50SAu, 43 pmol; Lane 4–9, Au particle (60, 50, 40, 30, 20, 10 pmol,
respectively). The gel was stained by LI silver.
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Figure II.4. Function of Au labeled ribosome subunit in peptide synthesis. Poly(U)
dependent poly(Phe) synthesis was measured, as a function of time, for wild type 70S
(black), reconstituted 70S from wild type 50S and wild type 30S (red), and
reconstituted 70SAu from 50SAu and wild type 30S.
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